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ABSTRACT
Currently, there are no therapeutic interventions which fully alleviate the defects
associated with muscular dystrophies and cardiomyopathies. Development of model
systems in which to utilize high-throughput screens for novel compounds will help in
drug discovery for these diseases. In addition, genetic model systems will allow us to
dissect the molecular and cellular pathways activated in response to mutations that
affect muscle function, increasing our understanding of the underlying physiology of
normal and diseased muscles.
Here we present work establishing Drosophila as a model system for human
muscular dystrophies and cardiomyopathies. Characterization of hypercontraction-
induced myopathy caused by mutations in Myosin Heavy Chain has led to a potential
mechanism of hypercontraction through unregulated contraction cycles in mutant
muscles. In addition, hypercontraction defects cause temperature-sensitive myogenic
seizures due to an altered state of the muscle which is fundamentally different than
normal and hypocontracted muscle. Analysis revealed strong parallels between the
genetics of flight behavior in Drosophila and familial hypertrophic cardiomyopathies in
humans, suggesting that the altered state in hypercontraction muscles may reflect
diseased states in mammals.
Expression analysis of hypercontraction suggests a conservation of the cellular
response induced in muscles which have contractile dysfunctions. This response
includes the upregulation of developmentally-regulated transcripts and immune-
response genes, and a downregulation of energy and metabolism genes. In addition to
these parallels in transcriptional regulation in response to hypercontraction and human
myopathies, a potential actin remodeling response has been uncovered. This
remodeling response may be utilized in other contexts such as activity-dependent
synaptic strengthening in the nervous system.
Current studies on the functional consequences of differential regulation have
begun. Loss-of-function mutations in the highest upregulated transcript, dARCI
suggests the dARC1 protein does not mediate essential roles in synaptic transmission,
short-term plasticity, learning and memory of courtship, and circadian rhythms. It may
be that dARCI underlies subtle modulation of these processes which may be
inaccessible by our assays. Future studies will address its role in muscle remodeling
and synaptic metaplasticity.
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Introduction
Muscle Contraction
Muscular dystrophy represents a diverse group of human diseases that
are characterized by a progressive degeneration and weakness of the skeletal
musculature. Connective tissue accumulates with the progression of the
disease, reflecting the slowly deteriorating cycle of degeneration and
regeneration of the muscle. There are no current therapeutic interventions that
fully alleviate the defects of these diseases. With Duchenne's Muscular
Dystrophy alone affecting 1/3500 males, muscular dystrophies represent a
widespread problem requiring the development of novel therapeutics (Hoffman et
al., 1987b).
In order to understand how alterations in a large number of genes can
lead to myopathy, an understanding of normal muscle function is required. The
muscle utilizes specialized mechanisms to transform chemical energy into
mechanical energy through a highly-coordinated and complex network of
proteins. At the center of movement is the contractile machinery-the basal set
of proteins which produce motion.
The contractile apparatus, at its basic form, consists of two, interlocked
filaments, arrayed in a hexagonal pattern in parallel fibers along the axis of the
muscle. The thin filament consists of a polymer of actin, whereas the thick
filament consists of a polymer of myosin heavy chain (Mhc). The actin acts as a
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track for the motor protein Mhc to ratchet along, shortening the length of the
muscle along the axis of the filament array (Figure 1).
The basic mechanism of contraction involves an ATP-dependent process
which begins with the binding of ATP to the Mhc head. The hydrolysis of ATP
into ADP and Pi allows the Mhc to bind to the actin filament. Once bound, actin
stimulates release of Pi, causing a conformational change in Mhc into a high-
force state. Finally, Mhc is released from the actin by exchange of ADP with ATP
(Figure 1). Multiple modes of regulation must occur for effective and efficient
contraction.
The first level of regulation is to limit when Mhc may bind the actin
filaments. This allows for concerted timing of Mhc motor activity, preventing
unregulated contraction from occurring. This regulation is largely provided by a
second protein that is polymerized onto the actin filament, tropomyosin (Tm).
The Tm molecule serves two purposes for contraction. The first is to prevent
unregulated binding of Mhc, and the second is to allosterically enhance Mhc ATP
hydrolysis in order to increase the speed of contraction. In the absence of Tm,
actin acts as a linear catalyst of ATPase activity in Mhc. However, in the
presence of Tm, the ATPase activity becomes sigmoidal, indicating that Tm acts
to create a cooperative reaction when Mhc-ATP binds the actin cytoskeleton.
Therefore, Tm provides a mechanism in which actin can exist in two states
(on/off). Tm regulation provides the off state in order to prevent unregulated
contractions, and the on state for fast, concerted Mhc function.
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Figure 1
Figure 1: The General Structure of the Sarcomere (A) The longitudinal
section of a Drosophila flight muscle illustrates how striations occur in the muscle
from the ordered array of parallel fibers in the sarcomere. Z and M demarcate the
location of the M-line and Z-line. (B) These fibers are arranged in a 6:1 thin:thick
filament hexagonal array as seen in a transverse section. Note the box
highlighting a single hexagonal array. (C) A schematic diagram illustrating the
general ATPase cycle of the myosin heavy chain motor through one cycle of
contraction. (A) and (B) were adapted from (Kronert et al., 1999) and (C) from
(Lehrer and Geeves, 1998).
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The off state induced by Tm results from a physical blockage of Mhc
binding. This blockage underlies a second-order point of regulation for
contraction. This regulation is mediated by the troponin (Tn) complex containing
Tnl, TnT, and TnC, which is bound to the thin filament. For every seven actin
monomers, there is one Tm molecule and one Tn complex (Figure 2). At rest,
the Tn complex keeps the actin filament in a closed state through Tnl, preventing
Tm from exposing the Mhc binding site. Upon muscle activation, the intracellular
Ca2 + concentration increases, allowing Ca2 + to bind to TnC. Once bound, the Tn
complex shifts in conformation, preventing Tnl from maintaining Tm in an
inhibiting state, allowing the thin filament to go into the open complex to activate
contraction. Initially, only a few Mhc heads bind, as most Tnl complexes remain
in the closed state. However, through cooperative mechanisms, once a sufficient
number of Mhc heads have bound to the thin filament, the remaining Tn
complexes transition into the open state, synchronizing the binding of many Mhc
heads, and contraction proceeds. Muscle contraction occurs over a distance
much larger than the single ratchet motion of a Mhc motor, and thus must
continue cyclically in order to gain macroscopic distances. For this to occur, not
all of the Mhc molecules release the filament. Instead, several remain bound to
the actin, keeping the filament in the open state for successive rounds of Mhc
activity (Figure 2; Lehrer and Geeves, 1998).
The filament within the muscle can produce no force without leverage.
Otherwise, the filaments will slide past each other but the membrane will remain
in position. In order to contract the cell, points of architectural support provide
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Figure 2: The contractile machinery represents a tightly regulated
molecular machine (A) A schematic diagram illustrates the major components
of muscle contraction, along with the regulatory components on the thin filament.
For every seven actin monomers, there is one tropomyosin molecule, and one
troponin regulatory complex. (B) A simplified five-state model for a single
contractile cycle, illustrating the roles of Tm, troponin, Ca2+, and the contractile
proteins Mhc and actin. This model is based upon models in which the thin
filament regulates contraction in a classical cooperative/allosteric manner. State
A represents the muscle at rest, with Mhc bound to ATP and the thin filament
inhibited. Upon muscle activation, Ca2+ enters the cytoplasm, binding troponin C
and opening a limited number of Mhc binding sites (State B). Mhc binds these
open sites (State C), and upon a threshold number of bound Mhc, cooperative
mechanisms lead to a coincident binding of the remaining Mhc heads in State D.
Release of Pi causes Mhc to enter the high-force conformation in State E, and
subsequent exchange of ADP/ATP releases the Mhc. (A) is reproduced from
(Seidman and Seidman, 2001) and (B) is reproduced from (Montana and
Littleton, 2004).
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leverage and attach the contractile machinery to the membrane as well as the
extracellular matrix. These structural sites include the Z-line, nuclear membrane,
plasma membrane, and the extracellular matrix. It is these sites which become
critical in the overall function of the muscle, as mutating the molecular
constituents of these key stress points often leads to muscular dystrophies in
humans.
The Genetics of Muscular Dystrophy
Until nearly 20 years ago, the underlying genetic causes of muscular
dystrophies remained a mystery. Beginning with the discovery of the dystrophin
protein in 1987, identification of the genetic causes of a large and diverse
number of muscular dystrophies has increased. The overall theme uniting these
diseases is that mutated genes seem to normally function in providing or
modulating the structural support of the contractile machinery at key stress points
within the cell. However, it is unclear how disruptions of these proteins lead to
degeneration of the muscle. Although many studies have been directed at
determining the genetic causes of muscular dystrophy, much less is known about
the downstream effects and eventual long-term changes that occur in diseased
states of the muscle.
Duchenne's Muscular Dystrophy, and later Becker's Muscular Dystrophy,
was found to be caused by disruptions in a large gene known as dystrophin
(Hoffman et al., 1987a; Hoffman et al., 1987b; Koenig et al., 1987; Monaco et al.,
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1985; Monaco et al., 1986; Ray et al., 1985). This gene spans almost 2.5Mb of
genomic DNA, containing over 85 exons and encoding a 14kb transcript
corresponding to a 427 kDa protein. Given its large size, it is not surprising that
its mutation rate is close to 1/10000 gametes in the human population, which
contributes to its relatively large prevalence (Hoffman and Dressman, 2001).
The dystrophin protein plays a critical role in sarcolemma (muscle plasma
membrane) stability and support, connecting the cytoskeleton to the plasma
membrane.
The dystrophin complex associates the cytoskeleton with the plasma
membrane via interactions involving the dystroglycan complex (DGC) of proteins.
This complex includes a-, -, y-, and 6-sarcoglycan, ca- and -dystroglycan,
syntrophin, and dystrobrevin (Figure 3). Underscoring the central theme of
structural support underlying muscular dystrophies, mutations in these
architectural proteins lead to other forms of muscular dystrophy. Limb-girdle
muscular dystrophy (LGMD) type 2D, 2E, 2F, and 2C correspond to mutations in
u-, -, y-, and -sarcoglycans (Bonnemann et al., 1995; Matsumura et al., 1992;
Nigro et al., 1996; Roberds et al., 1994). Additionally, another protein in the
sarcolemma, dysferlin, has been identified as the gene responsible for LGMD2B
and distal muscular dystrophy of Miyoshi (McNally et al., 2000). Caveolin-3, a
protein that is associated to the DGC and dystrophin, is mutated in LGMD1C
(Minetti et al., 1998).
In addition to providing a point of support connecting the cytoskeleton to
the membrane, the DGC also provides a leverage point for connections to the
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Figure 3: The complexities of muscular dystrophy (A) This figure illustrates
only a subset of genes that have been identified which are affected in a number
of muscular dystrophies. These components form a large complex of proteins
which provide both support for the cell as well as fulcrums for leverage in
contraction. (B) A schematic diagram illustrating the major points of control for
Ca2+ homeostasis in the muscle. These include the sarcolemma, the
sarcoplasmic reticulum, the mitochondria, and cytoplasmic buffers. (A) was
reproduced from (Arahata, 2000) and (B) was reproduced from (Frey et al.,
2000).
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extracellular matrix. This connection is mediated by laminin A and C, the gene
underlying LGMD1B (Muchir et al., 2000). Another protein thought to play a role
in the extracellular matrix is a secreted protein known as fukutin. Deficiencies in
this gene have been shown to lead to Fukuyama Congenital muscular dystrophy
(Kobayashi et al., 1998). Laminin 2 chain, and an important laminin receptor,
integrin 7, are responsible for two forms of congenital muscular dystrophies
(Kobayashi et al., 1998; Mayer et al., 1997).
Although many of the muscular dystrophies so far have focused on
structural elements extending outward from the cytoskeleton, there are other
diseases which affect structural elements from the sarcomere, inward to the
nuclei of the muscle. The nuclear membrane seems to be another key structural
site within the muscle as several proteins on the nuclear membrane have been
implicated in muscular dystrophy. The nuclei require adequate support in order
to withstand the constant force generation produced by muscle contraction. The
proteins involved in strengthening the nuclear membrane include emerin and
lamin A/C. The lamin proteins are intermediate-type filaments found on the
nuclear envelope, a component of a network of proteins which stabilize the nuclei
under the stress forces of contraction. Mutations in these genes are responsible
for two types of Emery-Dreifuss muscular dystrophy (Raffaele Di Barletta et al.,
2000).
Calcium as a Potential Mediator of Muscular Dystophy
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There are many other forms of muscular dystrophy, and in only a subset
of those has there been positive identification of the genetic lesion underlying the
disease. The identification of the mutations is only the first step in understanding
the diseases of the muscle. Understanding of the mechanistic cascades which
follow becomes increasingly important towards developing novel therapeutics
and treatments to alleviate the defects. In recent years, data has suggested that
Ca2 + dysregulation may be central in the pathogenic disease mechanisms and
may be a point of access for therapeutic interventions for muscular dystrophies.
The intracellular Ca2+ of all cells is tightly regulated, as Ca2+ acts as a
second messenger for a large and diverse number of signaling mechanisms. In
the muscle, it is imperative that Ca2+ is controlled, as it functions to regulate the
contractile system through troponinC, in addition to mediating signaling events.
There are several points of control for Ca2+ within the muscle. These include the
sarcolemma, intracellular stores, organelle buffers, and cytoplasmic buffers
(Figure 3). These mechanisms coordinately regulate the internal Ca2+, and have
all been implicated in aspects of disease pathogenesis (Gailly, 2002; Martonosi
and Pikula, 2003).
Regulation of Ca2 + through the sarcolemma involves the identity and
distribution of Ca2+-permeable ion channels. There are several types of ion
channels which flux Ca2 + through the membrane, including voltage-gated
channels and stretch-activated channels. However, in dystrophin-deficient
tissue, one major source of Ca2 + influx seems to be breaks in sarcolemma,
allowing transient large fluxes of Ca2 + and other extracellular material into the
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cell. In the mouse model of Duchenne's muscular dystrophy (mdx), 20% of
mutant fibers showed Ca2 + influxes up to 10- to 30-fold higher than normal fibers
(De Backer et al., 2002). One way in which this Ca2+ may affect muscles is by
inducing Ca2+-mediated cellular apoptosis through the mitochondria (Duchen,
1999; Sandri et al., 1998).
The mitochondria act as Ca2 + buffers for the intracellular environment,
performing two essential functions outside of the generation of ATP. The first is
in the immediate buffering of fast Ca2 + changes, diminishing the spikes of Ca2 + in
the intracellular environment. In addition, they are also integral to the repletion of
Ca2+ into the sarcoplasmic reticulum (SR) during the stimulation of calcium-
induced Ca2 + release (CICR). During large increases in mitochondrial Ca2 +
concentrations, Ca2 + mediated apoptosis may occur, which may contribute to the
decreased viability of diseased muscle fibers. In mdx mice, Ca2 + imaging of the
mitochondria has revealed accumulation of Ca2 + in the mitochondria at 150%-
200% of the normal levels in response to depolarization, indicating that although
90% of fibers have normal intracellular Ca2+ levels, mitochondria may be
compensating for altered Ca2 + , but subsequently become overloaded due to the
overall dysregulation (Robert et al., 2001).
The SR is a third point of intracellular Ca2 + control, reserving the majority
of Ca2 + required to stimulate contraction in the muscle. These stores release
Ca2+ during CICR, stimulated through a complex mechanism involving ion
channels that include voltage-gated Ca2 + channels in the sarcolemma and
ryanodine receptors (RyR) in the SR. Conflicting evidence, however, has made it
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unclear whether the SR plays a role in muscle fiber degeneration. Defects in
SERCA pump activity have been observed in the mdx mouse model, suggesting
alterations in Ca2+ re-uptake. However, corresponding defects have not been
seen in human myotubes (Kargacin and Kargacin, 1996; Takagi et al., 1992;
Vandebrouck et al., 1999).
Finally, the cytoplasm controls its own free-Ca 2 + concentration by use of a
number of cytoplasmic Ca2+ buffers. In mammals, the major buffer is
parvalbumin. These buffers act to keep free Ca2+ concentrations low during rest,
as well as modulate the relaxation rates of muscles by buffering Ca2+ away from
the contractile machinery. In diseased states, it is unclear whether these buffers
are significantly affected to alter the properties of muscles and contribute to the
pathogenesis. Parvalbumin transcription has been shown to be upregulated in
dystrophic fibers, suggesting that parvalbumin could play a role in pathogenesis
(Gailly et al., 1993). Supporting a modulatory role by parvalbumin, mdx mice
which also lack the gene encoding parvalbumin, exhibit a modification of the
defects from mild dystrophic muscle features to a hypertrophic-like defect
(Raymackers et al., 2003; Raymackers et al., 2000).
Data from many labs have suggested that Ca2 + homeostasis is altered in
mutant muscle fibers in both mdx mice and in humans. However, whether this is
central in the disease pathogensis, or is a side-effect of a more important cellular
response is unknown. Further, if Ca2 + homeostasis is altered, the source of this
dysregulation has yet to be elucidated. Regardless, changes in the intracellular
Ca2 + can lead to alterations in Ca2+-dependent signaling and, eventually, affect
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transcription. Changing the transcriptional profile of a muscle can drastically alter
its functional properties. Therefore, it is necessary to understand the differences
in transcriptional output between normal and diseased fibers. Determining
whether alterations in gene expression can account for some of the defects
associated with muscle disease, or can act to alleviate the defects induced by
mutations will help in understanding the pathogenesis of disease.
Changes in the Transcriptional Profile of Diseased Muscle Fibers
One method utilized for studying the changes in gene expression under
altered conditions involves microarray analysis. These arrays are either ssDNA
oligomers or cDNA spotted onto a solid support, with each spot corresponding to
a specific gene within the organism's genome. Using labeled RNA from a
specific tissue/organism, one can then assay transcription by measuring the
amount of RNA hybridized to a gene of interest by visualizing the intensity of
signal provided by the RNA label. Comparing two tissue samples in the
expression of any single gene can be done by either comparing the intensity of a
specific spot between two samples, or alternatively, labeling the two samples
with different flourophores and measuring the ratio between the two flourophores
within the same spot on a single array. Using these types of techniques, studies
on the expression profiles of several muscular dystrophies have been done.
Expression profiling has yielded some new insights into the pathology of
muscle disease. These studies have been done on tissue representing a few of
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the known muscular dystrophies, including Duchenne's muscular dystrophy,
dyferlinopathies, limb-girdle muscular dystrophy, and Emery-Dreifuss muscular
dystrophy (Campanaro et al., 2002; Chamberlain, 2000; Chen et al., 2000;
Noguchi et al., 2003; Tsukahara et al., 2002). From these studies, knowledge
gained of the transcriptional profiles of diseased tissues has indicated a
possibility of common cellular responses to muscle dysfunction.
In Duchenne's muscular dystrophy, expression analysis has been
performed on both pooled tissue samples from several patients, as well as
individual patients (Chamberlain, 2000; Chen et al., 2000; Noguchi et al., 2003).
Common features in the transcriptional profile have been observed between
these two experiments. Genes that have been consistently upregulated include
cell surface and extracellular matrix proteins. Some of these genes include
fibronectins, collagens, and crystallins. In addition, certain types of sarcomere-
related genes are upregulated as well. These include myosin light chains, actin,
and myosin binding proteins. Several of these upregulated sarcomere-related
genes normally have differential expression through development, with high
expression during fetal stages and low to undetectable expression in adults.
Immune-response related genes also include a large number of upregulated
transcripts. These include HLA-DR genes of the major histocompatibility
complex (type I and II). This upregulation may reflect activated dendritic cell
infiltration into diseased tissue.
Downregulation of genes related to energy and metabolism, especially
nuclear-encoded mitochondrial genes, make up the predominant class of
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downregulated transcripts. This regulation is thought to be indicative of Ca2+
homeostasis problems leading to Ca2+ overloading of the mitochondria and Ca2+-
mediated apoptosis. However, these observations are correlational at best, and
do not indicate a positive causality in the pathogenesis of disease.
Comparing these observations with other types of muscle diseases has
proven difficult. In addition to the variability among patients, there is a large
variability in experimental methods, microarray design and implementation, and
non-standardized annotation. However, some limited comparisons can be made.
In particular, when tissue from different muscular dystrophies is assayed within
the same experimental protocol, direct comparisons can be made. This type of
analysis was done between Duchenne's muscular dystrophy and LGMD2C
(Chamberlain, 2000; Chen et al., 2000).
When compared within the same experimental procedure, LGMD2C
showed similar changes to those observed in Duchenne's Muscular Dystophy.
Extracellular matrix proteins and embryonic sarcomeric proteins were found to be
upregulated, whereas those involved in energy and metabolism were
downregulated. Transcriptional differences between the two diseases
represented only a small number of genes (131 in Duchenne's and 89 in
LGMD2C). Additionally, most of these genes were close to the statistical cutoffs
used within the experiment, likely representing biological signal noise rather than
biological significance. Therefore, the pathogenesis of distinct muscular
dystrophies may share common underlying cellular mechanisms that are
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activated in response to genetic lesions affecting proteins involved in maintaining
structural integrity.
Data obtained with dysferlinopathies (LGMD2B and distal muscular
myopathy of Miyoshi) showed some overlap in the transcriptional profile, with the
upregulation of developmentally expressed saromeric proteins including
developmentally-regulated isoforms of myosin light chain, as well as immune
response-related genes. However, unlike the studies in DMD and LGMD2C,
there did not seem to be a significant decrease in genes involved with energy
and metabolism (Campanaro et al., 2002).
Further, from the profiles obtained in these diseases, all showed a marked
regulation of calcium handling proteins, including S100 calcium binding proteins.
The alteration in these calcium handling proteins may further support the idea
that Ca2 + homeostasis is altered in diseased states of the muscle. However,
these types; of experiments are correlational and difficulties exist in extending
hypotheses on causality.
To summarize, muscular dystrophies represent a genetically diverse set of
diseases. The common feature of the genetic lesions underlying these diseases
is that the mutated genes are all involved in maintaining the structural integrity
that the muscle requires to leverage forces, as well as withstand forces exerted
onto the muscle during contraction. The primary mutations may lead to overall
Ca2+ homeostasis alterations in the cytoplasm, which could contribute to Ca2 +
mediated apoptosis due to Ca2 + overload of the mitochondria, as well as lead to
downstream changes in the transcriptional profile of the muscle. This alteration
(c)Enrico Sakai Montana. All rights reserved. 27
in transcription includes the upregulation of developmentally-regulated
sarcomeric proteins, Ca2+ handling proteins, and immune response-related
proteins and a downregulation of genes involved in energy and metabolism.
However, though this transcriptional profile is well documented, it is unknown
whether these genes act in a compensatory or contributory manner in
pathogenesis. For a specific gene of interest, this distinction may change in a
time-dependent manner. Though observations have been made within the
cellular responses and transcriptional profiles, determining causality in context of
disease pathogenesis remains to be done. One way to begin forming a more
thorough picture of muscle disease is to study evolutionarily conserved
responses to muscle dysfunction. In muscular dystrophies, although focus has
been placed on the skeletal muscle, cardiac muscles also are affected in many
cases, as they use share much of the same molecular machinery mediating
contraction (Fadic et al., 1996; van der Kooi et al., 1997).
The Genetics of Cardiomyopathy
Heart failure affects up to 4.5 million people in the United States alone,
and represents, like muscular dystrophy, a widespread health problem requiring
novel therapeutic interventions for those afflicted (Seidman and Seidman, 2001).
Within these diseases, the heart is often morphologically remodeled in one of two
ways-dilation and hypertrophy. In dilation, the cardiac chamber volumes
increase, whereas in hypertrophy, ventricular wall mass increases (Figure 4).
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Figure 4
A
B
Table I Hypertrophic Drosophila Gene FlightlessCardiomyoPathy Homolog Mutation
f3-cardiac myosin heavy Myosin heavy chain yes
chain
troponin I wings upA yes
troponin T upheld yes
a -tropomyosin tropomyosin2 yes
myosin binding protein C n/a n/a
Essential myosin light chain Mlc1 no
RegUlatory myosin light Mlc2 yes
chain
Titin bent yes
sallimus no (lethal)
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Figure 4: Drawing parallels between hypertrophic cardiomyopathy and
Drosophila flightless mutations (A) Human hearts showing the effects of
cardiomyopathy. (I-r) Hypertrophic cardiomyopathy, Normal, Dilated
cardiomyopathy. Note the large ventricular wall thickness in the heart affected by
hypertrophic cardiomyopathy and increased chamber volume of the heart
affected by dilated cardiomyopathy. (B) The effect of hypercontraction on
Drosophila flight muscles can be easily visualized using polarized light
microsophy. (Clockwise from top left) Normal dorsal longitudinal muscles from a
wildtype fly, wupAhdp 2 pupa at 72h APF, wupAhdp 2; Tm2D5 3/+, and wupAhdp2 post-
eclosion. These micrographs illustrate the sensitivity of the flight muscles to
mutations in contractile proteins, as well as the strong interactions that have
been isolated in genetic screens. (A) was adapted from (Seidman and Seidman,
2001) and (B) from (Naimi et al., 2001).
Table I: A comparison between mammalian cardiac genes implicated in
hypertrophic cardiomyopathy and homologous Drosophila genes. The third
column indicates whether mutations have been isolated in the Drosophila
homolog that lead to flightless behavior.
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These types of changes can occur in response to a variety of stimuli such as
mechanical stress, genetic mutations, and aortic valve complications. In
addition, there is a subset of heart diseases caused by genetic mutations that do
not have external pathologies such as associated muscular dystrophies. These
types of diseases are known as primary cardiomyopathies.
Primary cardiomyopathies are a defined set of genetically determined
heart diseases which lead almost exclusively to the remodeling of the cardiac
structure. Like muscular dystrophies, these diseases have been well defined in
the gross anatomical and histological properties, and recently, in the underlying
genetic mutations which cause them. In addition, as in the case of muscular
dystrophies, although the genetic lesions and transcriptional alterations of the
disease are well studied, the cellular processes and molecular cascades
responsible for cardiomyopathy are largely unknown. The genetic lesions for
hypertrophic cardiomyopathies are better known, with most cases occurring due
to mutations in one of ten loci. Dilated cardiomyopthies, however, remain more
elusive.
Unlike the muscular dystrophies, primary hypertrophic cardiomyopathies
do not affect genes involved in the structural integrity of the heart. Rather, they
tend to be mutations in the sarcomere, altering the contractile machinery itself.
Of the mutations currently identified, the proteins affected include TnT, titin,
myosin binding protein-C, Mhc, actin, Tm, Tnl, and the regulatory and essential
myosin light chains (Bonne et al., 1995; Geisterfer-Lowrance et al., 1990; Kimura
et al., 1997; Mogensen et al., 1999; Poetter et al., 1996; Satoh et al., 1999;
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Tanigawa et al., 1990; Thierfelder et al., 1994; Watkins et al., 1995). How these
mutations affect the contractile machinery is still under debate. However, most
mutations which lead to the disease involve missense mutations and small
truncations, suggesting that the mutant proteins do not result in unstable proteins
,and haploinsufficiency problems. If haploinsufficiency were the problem, the
most likely mutations causing hypertrophic cardiomyopathy would involve
complete loss-of-function mutations such as deletions and early stop codons.
Therefore, these mutations more likely act as dominant effectors of the
contractile machinery.
As most of the mutations underlying hypertrophic cardiomyopathy act in a
dominant Mendelian fashion, they likely act as activated proteins, negative
inhibitors, or carry novel functions due to the mutant residue(s). However, due to
the lack of biophysical data on these mutations, it is still unclear as to which of
these cases exist for hypertrophic cardiomyopathy. Further studies are required
in order to determine whether hypertrophic cardiomyopathies result from general
contractile dysfunction or specific vectorial changes (i.e. all mutations lead to
hypercontraction versus hypocontraction). This may become more complex
when correlating biophysical data to in vivo contexts. For a specific mutation in
the mammalian cardiac Mhc, R403Q, data has indicated that it could act as both
a dominant negative of contractile function and a dominant activator in a tissue-
dependent manner (Cuda et al., 1997; Tyska et al., 2000). Therefore, more data
on the nature of all the known mutations in context of cardiac muscle will be
required to further our understanding of these diseases.
(c)Enrico Sakai Montana. All rights reserved. 32
Calcium as a Potential Mediator of Cardiomyopathy
Like muscular dystrophies, Ca2+ has been implicated in being important in
the pathogenesis of heart disease. It has been suggested that the alterations in
the contractile machinery may lead to an increase of intracellular Ca2 + in the
myocytes (Bustamante et al., 1991; Marban et al., 1987). Altering the activity of
contractile proteins may perturb the balance of the on/off states of the thin
filament. Given that the on state requires the binding of Ca2+ to the troponin
complex, then alteration in the activity of myosin may secondarily cause a
buffering of Ca2 + in the cytosol through sequestration of Ca2 + onto the thin
filament. In addition, transcriptional downregulation of SERCA pumps has been
observed in cardiomyopathy expression profiles (Hwang et al., 2002). This
downregulation may exacerbate abnormal Ca2+ handling properties by
preventing Ca2+ re-uptake into the SR, creating a cyclic progression towards
diseased states.
Additional evidence in support of Ca2+ being central to the disease
process of cardiomyopathy is its responsiveness to calcineurin modulating
chemicals. Cardiac myocytes in culture can be induced to undergo hypertrophy
by addition of hypertrophic agonists. Some of these include angiotensin II,
phenylephrine, norepinephrine, and endothelin-l -- activators of Ca2+-dependent
signal transduction systems (Karliner et al., 1990; Leite et al., 1994; Molkentin et
al., 1998; Sadoshima and Izumo, 1993; Sadoshima et al., 1993). Changes in
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Ca2+ are thought to transduce signals via calcineurin, a calmodulin-dependent
phosphatase, inducing hypertrophy. Inhibiting calcineurin activity with
characterized immunosuppressant drugs such as cyclosporin A and FK506 can
prevent angiotensin II- and phenylephrine-induced hypertrophy in culture
(Molkentin et al., 1998; Olson and Molkentin, 1999).
Supporting data in culture studies, transgenic mice were created to
express constitutively active calcineurin A in the heart. These mice developed
hypertrophic cardiomyopathy which progressed into dilated cardiomyopathy,
heart failure, and finally death. Interestingly, hypertrophy in these transgenic
mice could be prevented by systematic dosage of cyclosporin A or FK506.
Therefore, it seems likely that hypertrophy, and possibly dilated cardiomyopathy,
is dependent upon intracellular Ca2 + signals that are transduced via a
calcineurin-dependent pathway (Molkentin et al., 1998; Olson and Molkentin,
1999).
Transcriptional Changes Associated with Cardiomyopathies
The functional effects of hypertrophic-inducing mutations on the
transcriptional profile show similarities to those found in muscular dystrophies.
Again, the difficulty in drawing conclusions as well making comparisons exists in
the large variability in the experimental design and procedures. Even in the case
of model systems, there exists a diversity of models utilized to induce
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hypertrophic cardiomyopathy in an animal. However, some progress has been
made in identifying transcriptional changes in cardiac diseased states.
A number of transcriptional changes occur in response to cardiomyopathy.
The most striking of these changes is an upregulation of the fetal cardiac
sarcomeric genes with a concomitant downregulation of the adult isoforms and
an upregulation of immediate-early genes such as c-fos and c-myc (Chien et al.,
1991; Komuro et al., 1991; Sadoshima and Izumo, 1997; Sadoshima et al.,
1992). It is still unclear how this dramatic transcriptional change occurs, as many
signaling pathways have been implicated in the process. One common feature is
that these signaling pathways have been shown to lead to increases in
intracellular Ca2+, further supporting a central role of Ca2+ in muscle disease
pathogenesis. It may be that several signaling pathways, in addition to general
Ca2 + dysregulation, lead to Ca2+-dependent signaling and a prototypical response
in the terminal stages of the hypertrophic process. This response includes the
activation of the fetal cardiac genes and immediate-early genes, an event
dependent upon several transcription factors, including serum response factor,
TEF-1, AP-1, Spl, and GATA4 (Kariya et al., 1994; Karns et al., 1995; Kovacic-
Milivojevic et al., 1996; Liang et al., 2001; Sadoshima and Izumo, 1993). Further,
evidence has shown that the process of transcriptional re-programming requires
a repression of transcriptional histone deacetylases that act to repress the
transcription of fetal cardiac genes in adult tissues (Zhang et al., 2002).
Parallel Comparisons between Skeletal and Cardiac Muscle Diseases
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In review of the literature between cardiomyopathies and muscular
dystrophies, there are strong parallels that seem to exist between these
diseases. Indeed, some animal models of dystrophin deficiency display
hypertrophy of the skeletal muscle rather than degeneration as the primary
defect, as in the case of rats and mice (Hoffman and Dressman, 2001). Thus, it
seems that the underlying molecular mechanisms are shared between these
types of diseases, and modulation of this unknown common pathway could
determine the outcomes of hypertrophy or degeneration.
Muscular dystrophies are caused by mutations in genes that function in
the structural support of the muscle, whereas cardiomyopathies are caused by
mutations in the contractile machinery proteins. However, many muscular
dystrophy mutations have associated heart defects. It may be that the absence
of contractile mutations in muscular dystrophy may reflect inviability, rather than
a fundamental difference between the two diseases. Despite the differences in
genetic basis, both diseases have implicated Ca2 + as a central mediator of
disease pathogenesis. Further, Ca2+-dependent signaling may result in the
activation of transcripts which are normally expressed early in development and
repressed in adult tissue.
The parallels drawn between muscular dystrophy and cardiomyopathy
remain tenuous until more experimentation is done. Several issues exist, some
of which have been touched upon, in strengthening a comprehensive study of
muscle disease. Foremost is the diversity of diseases which exist in human and
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mammalian models. There are many ways in which these diseases occur in
humans, as well as many ways to induce similar phenotypes in higher
vertebrates such as mice. Elucidation of the underlying cellular mechanisms
remains difficult in such diversity. Further, characterization of the diseases in
mammalian models lacks a standardization of protocol, especially in the
assessment of alterations in the transcriptional profiles. Using different types of
tissue/models in different stages of pathogenesis, different microarrays, and lab-
specific annotation systems has led to difficulties in understanding commonalities
between multiple experiments. Even if standardization could occur in assaying
transcriptional profiles, understanding the functional consequences of these
alterations becomes a problem due to incapacity for human experimentation and
the slow progression in murine molecular genetics. It takes several months to
years to create transgenic mice with single mutations, preventing high-throughput
follow up of a microarray experiment. Although we may be able to determine
how the transcriptional profile is altered in mutant muscle tissue, whether these
changes are compensatory or contributory to disease pathogenesis is an
unanswered question. Despite these difficulties, there remains an apparent
parallel between different model systems of muscle disease in mammals,
suggesting that the pathways underlying these diseases have been conserved
throughout evolution. Therefore, invertebrate model systems with a diverse
repertoire of genetic tools are likely to be important for modeling human
myopathies..
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Lower Invertebrate Model Systems for the Study of Muscle Disease
For high-throughput genetic and cellular analysis of muscle dysfunction,
there are two well characterized model systems-C. elegans and Drosophila.
These invertebrate model systems offer a large breadth of genetic tools in order
to manipulate the organism. In addition, completed genome sequencing
facilitates the identification of novel genes by acting as a tool in both forward and
reverse genetic analyses. Their small size and short generation times also lend
these organisms to large-scale screening and behavioral genetics.
C. elegans as a Model System for Muscle Disease
Invertebrate models offer the ability for high-throughput analysis of muscle
structure and function and provide a platform for identifying conserved pathways
which may be activated in many forms of muscle dysfunction. In C. elegans,
many important genetic parallels have been found in muscular dystrophies.
Although the body wall muscles of the nematode differ from mammals in that
they do not form syncitia and are completely post-mitotic (no satellite cell
equivalents), the underlying molecules and mechanisms are conserved. The C.
elegans dystrophin homolog, dys-1, when mutated, causes a mild dystrophic
defect. This result is similar to the murine mdx model, where mutations in the
dystrophin locus result in a mild dystrophic defect as well (Bessou et al., 1998).
In support of evolutionarily conserved mechanisms underlying muscle function,
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double mutants in both mice and worms involving dystrophin and MyoD (hlh-1)
show severe myopathy and degeneration, though debate remains as to whether
the mechanism of this synergy is similar (Gieseler et al., 2000; Megeney et al.,
1996). In addition, genetic analysis has supported the role of Ca2+ being an
integral part of this process, as RNAi knockdown of egl-19, the major subunit of
voltage-gated calcium channels in the body wall muscles, can partially suppress
the dys-1;hlh-1 degeneration, while gain-of-function mutations in egl-19 act as
enhancers of dys-1 (Mariol and Segalat, 2001).
C. eegans as a model system for cardiomyopathies is less characterized.
Although the genetic power of the organism has identified many of the same
players and interactions in muscle contraction, cellular consequences and
transcriptional profile alterations are less defined (Gengyo-Ando and Kagawa,
1991; Greenwald and Horvitz, 1982; Moerman et al., 1982; Park and Horvitz,
1986). In addition, the role of calcium is yet to be fully explored. Data in C.
elegans has revealed a physical interaction between IP3 receptors and myosin
heavy chain. Disruption of this interaction by overexpression of interfering
peptides results in pharyngeal pumping defects without effect on defecation, both
of which are IP3-dependent behaviors. This suggests that myosin heavy chain
may also contribute to the specificity of IP3 receptor signaling, which has been
shown to localize and regulate Ca2+ signals in the cell. This interaction may
provide clues to hypertrophic cardiomyopathies and the alterations in Ca2+
homeostasis (Walker et al., 2002a; Walker et al., 2002b).
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Drosophila as Model System for Muscle Disease
Using Drosophila as a model system for the study of muscle diseases,
much like C. elegans, is still in the early stages of establishment.
Complementary to the C. elegans model system, the work established on
Drosophila musculature lends itself more readily to cardiomyopathies rather than
muscular dystrophy.
The Drosophila muscles for flight include six indirect flight muscles (IFM)
in the adult thorax. Structurally, these muscles resemble mammalian striated
skeletal muscle. In addition, the molecular components underlying contraction,
as well as the regulation of the contractile machinery are well conserved from
flies to humans. However, unlike skeletal muscle, the IFM share similarity to
vertebrate cardiac muscles in that they are stretch-activated, requiring
mechanical tension for full activation (Peckham et al., 1990). As a model system,
these muscles provide a prototypical muscle that can be used for studying the
common features between skeletal and cardiac muscles of vertebrates.
Using traditional forward genetic screens, mutations in muscle function
were identified through use of a readily assayable behavior, flight. Flight lends
itself well as a behavioral tool, as the flightless mutants are easily identifiable in
genetic screens. The simplicity of screens searching for flightless behavior
allows for a high-throughput identification of mutations which affect genes
involved muscle function using forward-genetic techniques. These types of
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screens provide a non-biased way to identify genes with biological relevance to
an in vivo complex process.
Flightless behavior in Drosophila can be caused by several defects. Many
of the genes in the Drosophila flight muscles are sensitive to dosage.
Haploinsufficiency can account for several mutations which display flightless
defects. Loss-of-function mutations in Mhc, dMLC2, Tm2, and act88F lead to
flightless behavior due to the sensitivity of muscle function and the amounts of
protein encoded by these genes (Bernstein et al., 1993). Further, four copies of
Mhc cause IFM defects, whereas four copies of act88F have little effect (Cripps
et al., 1994b; Homyk and Emerson, 1988). Therefore, not only are the IFM
sensitive to dosage, but the dosage requirement for each gene is specific.
Another form of flightlessness can arise from hypercontraction of the
muscle. Hypercontraction of the muscle is defined as muscles which show
proper development of the sarcomere and its support structures, but show use-
dependent degradation post-development. These types of mutations are of great
interest as they may reflect the diseased states of cardiomyopathies and
muscular dystrophies. Rather than representing a developmental or gene
dosage defect, these mutants have otherwise normal musculature, but once
muscle activity occurs, the muscles quickly degrade.
Many of the hypercontraction mutants were isolated in the original screens
for flightless mutants (Figure 4, Table I). The genes which have shown this type
of defect include Mhc, act88F, wings up A (troponin I), and upheld (troponin T)
(Beall and Fyrberg, 1991; Cripps et al., 1994a; Deak et al., 1982; Ferrus et al.,
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2000; Mogami and Hotta, 1981; Vigoreaux, 2001). Most of these mutations have
a secondary defect of wing positioning, with wings held up in a vertical position.
This defect allowed for simple identification of modifiers of the improper wing
positions. From these secondary screens, two classes of mutations were mainly
isolated. The first were intragenic suppressors, allowing detailed
structure/function analysis of these proteins in an in vivo context. The second,
extragenic suppressors, was useful in dissecting the functional relationships
between genes of the sarcomere.
When identifying suppressors for wings up Ahe ldup2 (wupAhdp2 ), two
important functional relationships were identified in an in vivo context. The first is
an allele specific suppression of Tnl induced hypercontraction by Mhc (Kronert et
al., 1999). The suppressor alleles of Mhc clustered around the ATP
binding/hydrolysis site of the Mhc globular head. The study suggested that a
physical link, direct or indirect, between Mhc and Tnl may exist, and Mhc could
be a source of regulation on the activity of Tnl. However, this data is in conflict
with another study suggesting that instead of Mhc regulating thin filament
dynamics through direct interactions, suppression of hypercontraction by
mutations in Mhc occur by decreasing force production in the muscle, thereby
decreasing forces produced in the altered regulation of troponinl and troponinT
mutants (Nongthomba et al., 2003). Regardless of the mechanism, a clear
functional relationship is established between Mhc and the thin filament
regulatory system.
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A second important suppressor of abnormal wing positioning identified
was an allele of Tm2, Tm2D5 3 (Naimi et al., 2001). The significance of this finding
was that there exists no direct interaction between Tm2 and Tnl in models of thin
filament regulation in muscle contraction. It is likely that the mode of suppression
by this allele abrogates the altered regulation by mutations in Tnl by changing the
motility of Tm2 on the actin filament. Thus, although wupAhdp 2 acts to derepress
the thin filament, this derepression does not occur due to inability of Tm2D5 3 to
undergo proper movement along the thin filament. Genetic interactions such as
these give functional insight into the roles mediate by these genes in the muscle.
Using Drosophila to Study Mutations in Mhc and Comparisons to Hypertrophic
Cardiomyopathy
In comparison to hypertrophic cardiomyopathies, the mutant alleles
identified in Drosophila screens provide a genetic model system to understand
the defects associated with contractile disruption. In particular, many of the
mutations isolated in Drosophila are clustered near mutations known to cause
primary hypertrophic cardiomyopathy. In fact, P-cardiac Mhc mutations account
for 10-30% of cases of hypertrophic cardiomyopathy, with over 29 different
alleles representing this subpopulation (Rayment et al., 1995). Given that nearly
100 mutations exist for the Drosophila Mhc locus, detailed structure/function
analysis can be done to determine the effects of different types of mutations on
the overall physiology of the muscle.
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In primary hypertrophic cardiomyopathies, over 29 different mutations can
account for.those in which the 3-cardiac Mhc gene is altered. These mutations
are distributed throughout the protein in a non-random fashion, clustering in
specific regions within the protein (Figure 5). However, whether the disease is
due to similar vectorial changes in the contractile activity (ie. increased
contraction or decreased contraction), or whether any alteration in the
biophysical properties can lead to hypertrophic cardiomyopathy is still under
debate. Therefore, understanding the alterations of a mutation in a defined and
reproducible in vivo context is important in understanding the pathology of
card iomyopathies.
The Drosophila Mhc locus was originally identified using two independent
lines of experimentation. The molecular identification occurred through use of
cross-hybridization techniques under non-stringent conditions using probes
generated from C. elegans Mhc sequences (Bernstein et al., 1983; Rozek and
Davidson, 1983). Unlike most animals, the Drosophila genome contained only
one muscle specific Mhc locus, rather than different isoforms being encoded in
separate loci. C. elegans contains 4 muscle-specific isoforms of Mhc, encoded
by unc-54, myo-1, myo-2, and myo-3 ((Ardizzi and Epstein, 1987). Further
characterization of the Drosohila Mhc gene has revealed a complex locus
spanning 20kb of DNA containing 19 exons (Collier et al., 1990; George et al.,
1989; Hess and Bernstein, 1991; Wassenberg et al., 1987). These exons
include seven alternative exons, 13 constitutive exons, and two alternative start
sites. Theoretically, the locus could encode up to 484 molecularly distinct
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Figure 5: Mutations identified in -cardiac Mhc that cause hypertrophic
cardiomyopathy Mutations that have been identified in 3-cardiac Mhc which
cause hypertrophic cardiomyopathy are mapped onto equivalent residues in the
chicken Mhc crystal structure based upon BLAST analysis. Note the clustering
of the mutations in specific regions of the protein. Data from (Rayment et al.,
1995).
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transcripts, although only 14 of these have been further identified to be
expressed. Studies on the alternative exons suggest that alternative splice forms
have differential biophysical activity, and thus act to modulate the overall output
of the muscles in which these splice forms are expressed (Collier et al., 1990;
George et al., 1989; Hess and Bernstein, 1991; Wassenberg et al., 1987). The
alternative start site encodes only the rod domain of the Mhc molecule, utilized in
specific muscles in Drosophila to act as spacers, limiting the number of available
active head domains, therefore decreasing overall power output of the muscle
(Standiford et al., 1997).
In parallel studies, Mhc was identified in forward genetic screens to isolate
flightless mutations. Interestingly, both loss-of-function and gain-of-function
mutations in Mhc alter the flight ability of the fruit fly. Loss-of-function mutations
disrupt the gene dosage sensitivity of the IFM, whereas gain-of-function
mutations alter the kinetics of contraction, creating excess force on the IFM,
leading to eventual degradation of the muscle fibers (Homyk and Emerson, 1988;
Kronert et al., 1995). Further, Mhc alleles were isolated in modifier screens of
hypercontraction defects found in alleles of wupA which affect contractile activity.
These alleles have led to insights in the functional and structural connectivity
between different proteins of the sarcomere (Kronert et al., 1999; Nongthomba et
al., 2003).
Here, we describe the analysis of hypercontraction mutations in Mhc, and
the effects they have on the physiology of the muscle in Drosophila. We extend
beyond the biophysical consequences of these mutations and investigate the
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cellular responses which occur. In addition, we show parallels between the
Drosophila model system and vertebrate model systems in order to establish
Drosophila as a model for hypertrophic cardiomyopathy. Not only has this
system provided a genetic model in which to identify the key players of muscle
function, but we demonstrate that the cellular responses of muscle dysfunction
imay be conserved as well. Further, these responses may utilize a conserved
Ca2 -dependent signaling mechanism that functions other cellular contexts, such
as memory formation and stabilization in neurons. In this system, parallel studies
may be done in order to understand the role of Ca2+-dependent signaling in the
modification and stabilization of the actin cytoskeleton in response to external
signals, whether those signals originate from synaptic transmission or
mechanical stress induced by contractile mutations.
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Characterization of a hypercontraction-induced myopathy in
Drosophila caused by mutations in Mhc
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This work began with a screen for temperature-sensitive behavioral mutants
performed by Troy Littleton as a postdoctoral fellow in the lab of Barry Ganetzky.
From the original screen, he isolated Mhc s ', SwingX l', and BreakdanceJ 2 9 . He
further performed rough recombination mapping of the dominant mutations and
isolated potential gamma-ray revertants of each of the mutants. Finer mapping
and the rest of the experiments were done by me under the guidance of Troy.
This work has been published in J. Cell Biology 164: 1045-1054.
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Abstract
The Myosin heavy chain (Mhc) locus encodes the muscle-specific motor
mediating contraction in Drosophila. In a screen for temperature-sensitive
behavioral mutants, we have identified two dominant Mhc alleles that lead to a
hypercontraction-induced myopathy. These mutants are caused by single point
mutations in the ATP binding/hydrolysis domain of Mhc and lead to degeneration
of the flight muscles. Electrophysiological analysis in the adult giant fiber flight
circuit demonstrates temperature-dependent seizure activity that requires
neuronal input, as genetic blockage of neuronal activity suppresses the
electrophysiological seizure defects. Intracellular recordings at the third instar
neuromuscular junction show spontaneous muscle movements in the absence of
neuronal stimulation and extracellular Ca2+, suggesting a dysregulation of
intracellular calcium homeostasis within the muscle or an alteration of the Ca2+-
dependence of contraction. Characterization of these new Mhc alleles suggests
that hypercontraction occurs via a mechanism which is molecularly distinct from
mutants previously identified in troponin I and troponin T.
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Introduction
Muscle contraction is a highly complex and coordinated process, involving
a molecular machine tightly regulated to provide ATP-dependent motion in
response to neuronal stimulation. Activation of the muscle from the innervating
neuron results in a postsynaptic action potential which stimulates release of Ca2+
from internal stores. Ca2+ binds to regulatory proteins on the thin filament of the
muscle. This leads to coordinated conformational changes in a large number of
proteins, allowing myosin to shorten the length of the sarcomere in an ATP-
dependent process. In addition to proteins required during contraction,
numerous secondary proteins are required for its continued maintenance,
structural support, and force transduction (Huxley, 2000; Lamb, 2000; Poage and
Meriney, 2002; Pollard, 2000; Ruff, 2003). Characterization of this complex
system may lead to molecular understanding of human diseases such as
cardiomyopathies, which arise from perturbations in several known cardiac
muscle proteins (Seidman and Seidman, 2001).
The genetic tractability of Drosophila has made it an ideal system to
characterize mutations affecting neuromuscular function. Many of these mutants
have been identified by screening for temperature-sensitive (TS) behavioral
defects, allowing the identification of gene products important for neuromuscular
function (Ganetzky and Wu, 1983; Littleton et al., 1998). Additionally, the
Drosophila flight system has provided an efficient genetic model for hypertrophic
cardiomyopathies. Mutated genes leading to flightless behavior in Drosophila
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are also disrupted in many forms of primary hypertrophic cardiomyopathies,
including Myosin heavy chain (Mhc), Tropomyosin2 (Tm2), wings up A (wupA-
troponin I), actin88F (act88F), and upheld (up-troponin T). Mutations in these
genes also show extensive genetic interactions, providing key insights into the
regulatory pathways underlying muscle function (Ferrus et al., 2000; Vigoreaux,
2001).
Flightless behavior in Drosophila can arise from mutations which lead to
muscle hypercontraction. Hypercontraction of the Drosophila indirect flight
muscles (IFM) occurs due to specific mutations of the contractile machinery
which lead to either decreased structural integrity of the sarcomere, or
dysregulation of the contractile process in vivo. These mutations result in a
degeneration of the IFM of adult flies following muscle differentiation and
development (Beall and Fyrberg, 1991; Deak et al., 1982; Fekete and Szidonya,
1979; Homyk and Emerson, 1988). Hypercontraction mutants can be genetically
suppressed by specific mutant alleles of Mhc. The mechanism of suppression
has been suggested to be a potential Mhc-Troponin I direct interaction (Kronert
et al., 1999). However, additional data suggests that an overall decrease in
actomyosin force is sufficient to explain suppression of hypercontraction by
mutant Mhc (Nongthomba et al., 2003). The identification of Mhc alleles that
directly cause hypercontraction and enhance the hypercontraction defects of
other mutants may facilitate defining the role of myosin in the regulation of
contraction.
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To further understand the molecular and cellular processes underlying
neuromuscular function, we performed a screen for Drosophila TS behavioral
mutants. One complementation group isolated in our screens, Samba, disrupts
the Mhc locus, leading to hypercontraction and muscle degeneration.
Characterization of the Samba mutants has revealed potential molecular
mechanisms which lead to muscle degeneration through hypercontraction via
distinct mechanisms from previously characterized hypercontraction mutants. In
addition, these mutants give insight into the role of Mhc in the regulation of the
contractile process in addition to its role in the ATP-dependent motor function.
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Results
Isolation and characterization of the Samba mutants, Mhcs' and Mhcs 2
The Samba (Samba1 and Samba2 ) mutants were isolated in an
ethylmethane sulfonate mutagenesis, screening for X-linked and autosomal
dominant TS behavioral mutants. Samba adults exhibit dominant TS behavioral
defects that include a rapid onset of seizure-like behavior and TS loss of
rnesothoracic leg function. This behavior is readily evident in all flies by one
minute of exposure to 38°C (Figure 1A). Samba mutants also display defects at
permissive temperatures. Samba/+ flies are flightless, with thoracic indentations
similar to those found in ether-ago-go1 , Shaker13 3 (eag1, Sh1 33 ) mutant flies
(Figure 1 B). Thoracic indentations in eag1 , Sh13 3 flies occur through
hypercontraction of the indirect flight muscles (IFM) thought to be induced by
excessive neurotransmitter release in the presynaptic neuron, which is caused by
loss of voltage-gated potassium channels and subsequent reduction in
repolarization (Ganetzky and Wu, 1983; Wu et al., 1983). Although homozygous
Samba mutants are lethal, rare Samba1 escapers with femur hypercontration
defects can be found.
In addition to Samba, two other complementation groups, Swing (SwgXl'8)
and Breakdance (BrkdU2 9), were isolated in our screens that exhibited similar
dominant TS behavioral defects and showed genetic interactions with Samba.
Double heterozygotes of SwgX118 and Samba1 or Samba2 and double
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Figure 1: Characterization of the Samba mutants, MhcSl and MhCS 2. (A)
Temperature-sensitivity curves of several mutant strains that affect muscle
function. TS behavioral defects are found only in hypercontraction mutants. (B)
Thoraces of CantonS (left), eag', Sh' 33/Y (center), and Samba'/+ (right) adult
male flies. (C) Schematic of a normal fly leg (left), a leg dissected from CantonS
(center), and a leg showing femur hypercontraction from a SwgXl'8/+;BkdeJ29/+
double heterozygote (right). Arrows indicate femoral segment. (D) Schematic
depicting the genetic interactions of the Samba locus. (E-G) Polarized light
micrographs showing hypercontraction of the IFM are shown in sagittal views of
the thorax from adult flies of CantonS (E), Samba'/+, (F)and Samba/+;Tm2D 53
(G). Partial suppression is observed in Samba1/+;Tm2D53 , as IFM are found less
degraded despite the presence of thoracic indentations (arrows).
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heterozygotes of SwgX118 and Brk 29 are semi-lethal with escapers having
hypercontracted femurs (Figure 1C). Double heterozygotes of Samba or
Samba2 and Brkd 2 9 are synthetic lethal (Figure 1 D). These genetic interactions
and similarities to eag1, Sh133 double mutants suggest that Samba, Swing, and
Breakdance define a genetic pathway required in the regulation of membrane
excitability, and when disrupted, lead to abnormal muscle hypercontraction.
Segregation analysis of Samba revealed an autosomal dominant mutation
on the second chromosome, refined to 2-52 cM by recombination mapping.
Deficiency mapping by lethality narrowed the cytological interval between 36A8
and 36C4 on the left arm of chromosome 2. To help identify the Samba locus,
we screened for revertants of TS seizure behavior in a y-irradiation reversion
screen in order to isolate potential loss of function mutations in the Samba locus.
Three revertants were identified by loss of TS behavioral defects. These
revertants were embryonic lethal with normal morphological development, but
showed complete loss of muscle wave propagation in late stage embryos (data
not shown). Non-complementation to Mhc1 by both the TS mutants and the three
revertants identified the Samba mutations as new alleles of the Myosin Heavy
Chain (Mhc) locus (Mogami and Hotta, 1981). We designated the Samba1 and
Samba2 alleles MhcS1 and MhcS2, respectively, and the revertants Mhc"'1, Mhcr v2,
and Mhc r v3.
The Mhc locus is complex, encoding all muscle-specific isoforms through
the use of extensive alternative splice patterns (Bernstein et al., 1983; Rozek and
Davidson, 1983). The locus contains 19 coding exons, 5 of which are
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alternatively spliced, and one that is either included or excluded (Collier et al.,
1990; George et al., 1989; Hess and Bernstein, 1991; Wassenberg et al., 1987;
Zhang and Bernstein, 2001). A previously isolated allele, Mhc5 (G200D), causes
similar hypercontraction defects to the Samba mutants. Mhc5 introduces a point
mutation in exon 4 of the Mhc locus, disrupting the ATPase domain of Mhc
(Homyk and Emerson, 1988). Due to the phenotypic similarities with Mhc5, exon
4 of these new alleles was sequenced. Both MhcSl and Mhc s 2 were found to be
point mutations (V235E and E187K, respectively) mapping to the ATP binding
and hydrolysis site of the protein (Figure 2A-E).
Seizure activity in Samba flies is dependent upon neuronal activity
Extracellular dorsal longitudinal muscle (DLM) recordings were utilized in
order to characterize the behavioral seizures at restrictive temperatures (Engel
and Wu, 1992). Electrical activity was observed in adult flies at room
temperature, shifted to 380°C, and returned to room temperature. Correlating with
the behavioral defects, abnormal spiking activity in the DLMs was recorded at
restrictive temperatures that was not observed at permissive temperatures, nor in
Cantons at 380 C (Figure 3A, 3B, 3D, 3F). Similar seizure activity was observed
in SwgX1 8 and Brkd J2 9 (Figure 3H, 3J). This abnormal activity could be either
muscle autonomous or dependent upon synaptic input. To address these
possibilities, we utilized a mutation in the voltage-gated Na+ channel, paralytic
(parat'), which is required for action potential propagation in the motor neuron
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Figure 2: Localization of the MhcSl and MhcS2 mutations onto the crystal
structure. (A) Schematic of the Mhc locus. Constitutive exons are depicted in
black, and alternative exons in gray. Exon 4 has been expanded to show the
relative positions of the point mutations in Mhc5 , MhcS1, and Mhcs2 . (B) A view of
the crystal structure of chicken Mhc depicting the mutations Mhc5 (green), Mhc s3
(blue), and Mhc s 2 (red). (C) The region corresponding to the red box has been
expanded from a crystal structure from the motor domain of Dictyostelium Mhc
showing the mutation positions in relation to the ATP analog (yellow) and bound
Mg2 + (magenta). (D) Sequence data showing the base pair changes in MhcS1
and MhcS2 and the corresponding amino acid point mutations. (E) An alignment
of exon 4 of Drosophila Mhc with. -cardiac myosin heavy chain (MYH7) from
humans. Red corresponds to identical amino acids, and yellow identifies similar
amino acids. Positions of Drosophila mutations are indicated in green relative to
amino acids that are mutated in several primary hypertrophic cardiomyopathies,
shown in blue.
(c)Enrico Sakai Montana. All rights reserved. 72
(Suzuki et al., 1971). This mutation specifically abolishes neuronal action
potentials at elevated temperatures, as para expression is not detected in
muscles (Hong and Ganetzky, 1994). In paratS'/Y;MhcX/+ (X indicating 5, S1 or
S2) flies, we observed a suppression of the seizure activity at 380°C (Figure 3C,
3E, 3G). Similarly, suppression of activity was observed with paratS'/Y;SwgX118/+
and paratS'/YBrkdJ29/+ (Figure 31, 3K). These data suggest that mutant muscles
are hyperexcitable at restrictive temperatures. This hyperexcitable state,
however, cannot lead to autonomous muscle firing, but must be triggered by an
initial input by the innervating motor neuron.
Samba mutations lead to hypercontraction
To further define how the Samba mutants affect Mhc function, we
analyzed genetic interactions with known muscle mutants that increase or
decrease the contractile state of the muscle. We characterized genetic
interactions with mutations in Troponin I, Troponin T, and Tropomyosin 2.
Troponin I is encoded by the wings up A locus. A mutation in troponin I, heldup2
(wupAhdp 2 ), has been previously identified as a hypercontraction mutation (Beall
and Fyrberg, 1991; Deak et al., 1982). A mutation in Troponin T, upheld1 0 1
(up° 1), is similar to wupAhdp2, also causing hypercontraction (Fekete and
Szidonya, 1979; Homyk et al., 1980). Hemizygous flies for either wupAhdp2 or
up101 and heterozygous for Mhc s1 or Mhc s 2 are synthetic lethal, whereas double
heterozygous females have femur hypercontraction defects (data not shown). A
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Figure 3: Extracellular DLM recordings reveal abnormal activity at
restrictive temperatures which is dependent upon neuronal activity.
Recordings were done on male flies of genotypes (A) CantonS, (B) MhcS/+, (C)
paraTS ';Mhcs'/+, (D) MhcS 2/+, (E) paraTS';MhcS 2/+, (F) Mhc 5/+, (G)
paraTS;Mhc 5 /+, (H) SwgXl8/+, (I) paraTS';SwgXllB/+, (J) Bkde 29 /+, and (K)
paraTS';Bkde 29/+. Representative traces are shown from a single male fly of the
indicated genotype at room temperature, 38°C, and subsequent recovery to room
temperature. Scale bar indicates 500 ms, 10mV.
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mutation in Tropomyosin 2 (Tm2D5 3 ) suppresses the hypercontraction of both
up101 and wuipAhdp 2 (Naimi et al., 2001). Similarly, Tm2D5 3 suppresses the
recessive lethality of Mhcsl, increasing viability of the homozygotes from 2.38%
to 80.92% (Mhcs1 n=435, MhcS1;Tm2D 53 n=505). These results indicate that the
Samba alleles of Mhc cause hypercontraction defects similar to wupAhdp2 and
up101. Interestingly, both up'01 and wupAhdp2 exhibit abnormal TS behavior
similar to Mhcsl and MhcS2, suggesting that the behavioral defects are most likely
a TS susceptibility resulting from an altered state of the muscle secondary to
hypercontraction, as opposed to a specific TS dysfunction of the Mhc protein
(Figure 1A). In contrast to the TS seizure behavior in hypercontraction mutants,
Tm2D53 flies do not show abnormal behavior at 38°C, nor do heterozygotes of
the Mhc null (Mhc1 /+) and heterozygotes of a hypercontraction suppressor
mutant (MhcD 45/+) (Figure 1A).
To confirm that the Samba phenotype results from hypercontraction, we
analyzed the structure of the IFM in MhcSl/+ flies. The ordered array of filaments
in muscles leads to birefringent properties, allowing muscle visualization under
polarized light microscopy. In previously characterized hypercontraction
mutants, the IFM exhibit one of two defects. Some show loss of birefringence in
the middle of the muscles due to breakage or degradation, with the bulk of the
muscle fiber at either one or both of the attachment sites. Others show
separation from the attachment sites, with birefringence found only in the middle
of the fiber (Nongthomba et al., 2003). MhcS1/+ flies exhibited the former defect,
showing birefringence at the attachment sites, with loss of birefringence in the
(c)Enrico Sakai Montana. All rights reserved. 76
middle of the IFM. This defect was partially suppressed in the background of
Tm2D53, as the IFM of double mutants displayed less degradation despite the
presence of indented thoraces compared to similarly aged Samba flies (Figure
1E-G). These data confirm that the Samba mutants lead to hypercontraction
defects in the muscle.
Samba mutant muscles do not alter synaptic function but move independently of
neuronal input
Hypercontraction in Drosophila muscles induced by the Samba mutants
leads to progressive degradation of fibers, similar to degeneration observed in
muscular dystrophies. In some animal models of muscular dystrophy, loss of
acetylcholine receptor clustering results in the functional denervation of diseased
fibers (Rafael et al., 2000). Because Mhcsl and Mhcs 2 were isolated by TS
behavioral defects and abnormal extracellular DLM activity, we hypothesized that
these mutations may cause functional or structural changes at the NMJ.
Bouton number at the NMJ is tightly regulated and is sensitive to
disruptions in both presynaptic and postsynaptic function. Though poorly
understood, postsynaptic defects can alter presynaptic structural and functional
properties through homeostatic regulatory pathways (Davis et al., 1998; Petersen
et al., 1997). To analyze the morphology of the NMJ in Samba mutants, we
stained third instar larvae with uo-synaptotagmin I antisera, a marker for
presynaptic terminals, and analyzed muscle fibers 6 and 7 (CantonS n=18
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larvae, 97 muscles; MhcSl/+ n=27, 157). Type I innervation from glutamatergic
motor neurons was not altered in MhcS1/+ animals, suggesting little effect of
dysfunctional muscles on excitatory innervation (Figure 4J). The number of
muscles showing ectopic innervation, however, was found to be more frequent
than wildtype, increasing from 4.1% in control animals to 15.9% in Mhcs'/+
animals (Figure 4A-F, 4K). These were determined to be Type II synapses due
to their morphology and the absence of postsynaptic DLG staining (Figure 4G-
41). Type II synapses are neuromodulatory, influencing the state of excitation in
body wall muscles through release of octopamine (Gramates and Budnik, 1999).
Increases in type II innervation have also been reported in mutants such as tipE
and nap, which reduce nerve excitability (Jarecki and Keshishian, 1995). The
increase in Type II innervation suggests that alterations in muscle function can
lead to altered neuromodulation. Similar data was obtained with MhcS2/+ larvae
(data not shown).
To determine whether the altered innervation pattern correlated with
abnormal synaptic transmission, we characterized miniature excitatory junctional
potential amplitude (mEJP), excitatory junctional potential amplitude (EJP), and
mEJP frequency from the muscle 6 NMJ in 0.4 mM Ca2 + using intracellular
recording techniques (Figure 5A, Table I). Wildtype fibers were found to have a
mEJP of 0.95 + 0.04 mV and EJP of 39.6 1.9 mV (n=8, 23). In mutant fibers,
these values were 0.79 0.02 mV and 34.2 1.7 mV, respectively (n=11, 29).
Although these differences are statistically significant and may reflect subtle
changes in synaptic function, the change in release is small and the differences
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Figure 4: Structural properties of the neuromuscular junction in MhcSl/+
mutants. Third instar larvae neuromuscular junctions from (A-C) CantonS and
(D-l) MhcS'/+ labeled with the indicated markers. Arrows indicate an axonal
branch containing Type II synapses as evidenced by the absence of postsynaptic
DLG staining. Scale bar represents 50pm. (J) Excitatory Type I glutamatergic
innervation on muscles 6/7 does not change in mutant muscles despite altered
muscular function. (K) Ectopic Type II innervation increases in mutant muscles.
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more likely reflect the complication caused by an apparent oscillation of the
resting membrane potential due to spontaneous muscle movement in Samba
mutants (Figure 5B). Movements such as these can lead to apparent voltage
changes due to electrode motion. Spontaneous muscle movements did not
resemble action potential-induced contraction events. Instead, a slow, cyclic
activity that did not utlilize the full contractile potential of the muscle cell was
continuously observed in the Samba mutants. Because contraction usually
depends upon Ca2 + influx through L-type calcium channels in the sarcolemma,
we hypothesized that alterations of Ca2+ influx through these channels may be
responsible for the spontaneous contractions in Samba mutants. To test this, we
recorded from mutant muscles in Ca2+-free saline. Spontaneous contractions
were still observed in Ca2+-free saline similar to those in high extracellular Ca2+
(Figure 5B). An alternative possibility is that spontaneous contractions may
reflect altered signaling from the innervating neuron. Although these recordings
are normally done in preparations in which the axon has been severed from the
cell body, we further tested this possibility in brain-intact preparations in the
presence or absence of 3M TTX. Spontaneous movements were seen
regardless of neuronal activity (Figure 5B). These results indicate that
hypercontraction in Samba mutants is not due to an increase in neuronal activity
or neurotransmitter release, nor to multiple release events per axonal action
potential, but can be explained by autonomous movement in the absence of
neuronal input. This movement is not dependent upon extracellular Ca2 +,
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Figure 5: Electrophysiological properties of the MhcSl/+ third instar
neuromuscular junction. Despite the increased presence of ectopic
innervation, physiological properties are not altered in Mhc51/+. (A)
Representative samples of EJPs in CantonS and Mhc51/+. Scale bar indicates
5mV, 200 rns. (B) Resting potential oscillations found in MhcSl/+ are present in
both 0.4 mM and OmM Ca2+, as well as in the presence (-TTX) and absence
(+TTX) of neuronal activity. Asterisk marks activity from the central pattern
generator. Scale bar indicates 10mV, 500 ms.
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Table I. Physiological properties of the NMJa
Genotype Resting Potential (mV) Miniature frequency (mEJP/s) mEJP Amplitude (mV) EJP Amplitude (mV)
CantonSb -69.4 + 1.6 2.10 + 0.21 0.95 ± 0.04 39.6 ± 1.8
MhlcS1/+ c -62.6 1.0'* 1.53 0.14* 0.79 + 0.02** 34.2 + 1.7*
a) Represented as Value±SEM b) n=8,23 c' n=11,29
* = F'-value < 0 05, = P-value < 0 001
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suggesting a defect in either intracellular Ca2+ homeostasis or the Ca2 +
requirements of muscle contraction.
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Discussion
Muscle contraction requires the coordinated action of many proteins under
the regulation of defined stimuli. Dysregulation of this system leads to myopathy
and dystrophy syndromes in humans. Drosophila provides an efficient model to
dissect the molecular and cellular functions of the individual components and
their roles in the coordinated machine that underlies this process. To this end,
we have begun a molecular and cellular characterization of muscle dysfunction in
Drosophila using the hypercontractive Samba mutants, MhcS1 and MhCS2.
Hypercontraction and Mhc
Hypercontraction in the Drosophila IFM is thought to occur by two
mechanisms. These mechanisms both lead to increased actomyosin force
production by' either 1) decreasing structural integrity of the sarcomere or 2)
altering thin filament regulation of the crossbridge cycle. Mutations which lead to
hypercontraction through the former mechanism include Mhc 6, Mhc13 (19) and fin°,
whereas wupAhdp2 and upo0 occur through the latter mechanism (Kronert et al.,
1995; Reedy et al., 2000). Hypercontraction by the latter group of mutations are
suppressed by mutations in Mhc in a seemingly non-allele specific relationship,
suggesting a decrease in actomyosin force is sufficient to suppress
hypercontraction (Nongthomba et al., 2003). However, this model is
complicated by data suppoting a role of Mhc in regulating thin filament dynamics
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through a direct Mhc-Tnl interaction (Kronert et al., 1999). Here we present work
characterizing two new alleles of Mhc, MhcsI and Mhcs2. These mutants
represent dominant hypercontraction alleles, as defined by genetic interactions.
These alleles enhance defects in wupAhdP2 and up101 , both of which lead to
hypercontraction as single mutants. Both WUpAhdp2 and up'01 are fully
suppressed by Tm2D5 3 , whereas the Samba mutants are only partially
suppressed, suggesting that although these alleles lead to hypercontraction, they
do so through a different molecular mechanism than wupAhdp2 and up'01 . In
confirmation of the genetic data, the Samba mutants exhibit hypercontraction of
the IFM when analyzed under polarized light microscopy. Due to their similarities
with a previously isolated allele of Mhc (Mhc5 ), we sequenced exon 4 of the
locus, and identified two point mutations, V235E (SI) and E187K (S2), which
map onto the ATP binding/hydrolysis site of the protein. Though
hypercontraction occurs in Mhc6 and Mhc' 3, these mutations do not display
indented thoraces, suggesting that Mhc5, MhcS 1 , and Mhc s2 represent a
functionally distinct mechanism of hypercontraction. Another known enhancer of
wupAhdP2, Mhc8 (a mutation in the lever arm of Mhc) also leads to indented
thoraces and is included with Mhc5, MhcSl, and Mhc s2, presumably by indirectly
leading to similar changes in the functionality of Mhc as the point mutations
which localize to the ATPase domain (Homyk and Emerson, 1988). Interestingly,
two other alleles of Mhc, MhcD4 and MhcD4 5, map to the ATP binding/hydrolysis
site, but seem to have different effects on contraction as they are genetic
suppressors of hypercontraction induced by wupAhpd 2 and up'0 1 (Kronert et al.,
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1999). This may be due to an opposite effect at the same step within the
ATPase cycle in relation to the MhcS 1, MhcS2, Mhc5 , and Mhc 8 alleles.
Alternatively, these mutations may affect a different step of the ATPase cycle, but
lead to decreased contraction, rather than hypercontraction.
Given the large body of work surrounding the IFM and hypercontraction,
coupled with the data presented here, we propose possible general models for
hypercontraction based upon the allosteric/cooperative model previously
described (Lehrer and Geeves, 1998) (Figure 6). In the wildtype sarcomere, a
simplified 5 state model can be used to describe contraction. In the first state
(A), the troponin complex is keeping the thin filament in the closed state. If
myosin-nucleotide complex binds this state, it is referred to as "blocked," as it is
not conducive! to contraction. Neural stimulation shifts the equilibrium between
state A to state B by allowing calcium to enter the sarcomere, which binds the
troponin complex via troponin C, increasing the proportion of state B complexes.
State B is open to contraction. Myosin binds state B in a non-cooperative
manner, state C, provided myosin has bound and hydrolyzed its ATP substrate.
Once state C is reached, cooperative mechanisms facilitate binding of multiple
myosin heads, leading to state D, the low-force state of the sarcomere. From
state D, state E is reached by release of Pi, entering a high-force contraction
state of the muscle with myosin in its rigor state. Hypercontraction by upl°0 and
wupAhd p2 may occur by altering the state A/state B equilibrium in the absence of
calcium, and thus increasing the fraction of blocked versus open states. If the
proportion of complexes in state B were significantly high during unstimulated
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Figure 6: A working model for hypercontraction. A simplified 5-stage model
of contraction is depicted. The resting state of muscle (A) contains myosin
unbound to the thin filament. During activation of the muscle (B), intracellular
Ca2+ increases, allowing a limited number of troponin complexes to shift into the
open state. The open state allows non-cooperative binding of myosin (C) to the
thin filament. When enough myosin heads bind, cooperative mechanisms
facilitate binding of multiple heads (D). Release of Pi then allows contraction to
occur (E), followed by ADP/ATP exchange to complete the cycle. Drosophila
mutants are listed next to proposed steps at which they alter this simplified cycle.
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phases of the muscle, then a large number of isolated myosin heads would bind
and enter rigor state, increasing steady-state force on the thin filament during
periods of relaxation. Mutations such as Tm2D53 suppress this defect by shifting
this altered equilibrium towards more wildtype values, possibly by increasing the
energy required for the A-)B transition. Mutations in Mhc can suppress this
hypercontraction by decreasing the actomyosin force through 3 molecularly
distinct ways. In one mechanism a mutation may prevent the state B to state C
transition by altering the actin binding properties of Mhc. Thus, despite the
increased proportion of state B complexes, there is a lower probability that Mhc
molecules will bind and enter rigor state, therefore decreasing actomyosin forces
during relaxation to tolerable levels in the presence of wupAhdp2 or up'01 .
Mutations acting through this mechanism of altering actin binding properties
include MhcD', MhcD6 2, Mhc2A- c, and Mhc2D. In a second mechanism, mutations
can decrease the number of available heads, and thus steady-state force can be
decreased. The headless constructs suppress hypercontraction through this
second mechanism. Finally, suppression can be obtained by decreasing the
number of myosins which are able to bind at any given time by decreasing ATP
binding ability or initial hydrolysis. These mutations include MhcD4 I, MhcD4 5, and
Mhc 2F (Nongthomba et al., 2003).
Hypercontraction defects caused by Mhc mutations are manifested by two
mechanisms. One mechanism, previously mentioned, leads to hypercontraction
by decreasing the structural integrity of the thick filament (Mhc 6 and Mhc1 3 (19)).
The second mechanism involves the group of mutations Mhc5, MhcS1, and
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MhcS2 . These mutations lead to hypercontraction by stabilizing a transition state
between state E and state A by preventing ADP/ATP exchange. If a sufficient
number of myosins remain bound, this state may perform a role similar to state C
and allow contraction cycles to continue. During normal contraction, it has been
estimated that 20-30% of myosins remain bound in order to allow for multiple
contraction cycles during one stimulated muscle contraction event (Lehrer and
Geeves, 1998). However, if the balance between structural support and
contractile forces determines the number of contraction cycles per stimulation,
this further stabilization can lead to an excess number of cycles and thus an
excess in force production during the latter stages of a contraction event. In
addition, this stabilization could lead to local contraction oscillations in muscle
long after the Ca2 + transient has dissipated, increasing steady-state actomyosin
force during relaxation states. This latter prediction is indeed true, as shown by
the oscillatory muscle movement observed during intracellular recordings in third
instar larvae. Alternatively, these mutations may cause A-C transitions by
displacing the regulatory complex on the thin filament through direct interactions
with troponin I as previously proposed. However, this seems unlikely as the
Mhc5, MhcSl, and MhcS 2 mutations are single amino acid substitutions localizing
near the ATP binding/hydrolysis sites, as opposed to surfaces more accessible to
a troponin I interaction. In double mutants of this class of Mhc alleles and either
wupAhdp2 or p1 0 1 , lethality may reflect the additive effects of two distinct
molecular mechanisms of hypercontraction. In addition, the partial suppression
of Tm2D53 in the background of Samba supports these distinct mechanisms, as it
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does not re-establish normal contraction mechanisms as observed with wupAhdp2
and up101, but rather decreases the number and extent of unregulated
contraction cycles. Therefore, hypercontraction by Mhc5 and the Samba mutants
is caused by excess force at the end of a regulated contraction event as well as
increased steady-state force resulting from unregulated contraction cycles, rather
than alterations in thin filament state transitions through direct interactions with
troponin I.
Excitability and hypercontraction mutants
The TS seizure activity in Mhc5, Mhcs1, and Mhc s2 as well as up10' and
wupAtdp2 is likely to reflect a temperature-dependent defect caused by an
alteration in the cellular state of a hypercontractive muscle, rather than direct
temperature-dependent defects of mutant proteins. The model proposed for
hypercontraction may account for the activity through a dysregulation of calcium
homeostasis. In normal muscles, calcium levels dramatically increase in the
sarcomere in order to increase the fraction of troponin complexes in state B
during regulated contraction. However, in mutants such as up101 and wupAhdp2,
rather than calcium returning to intracellular stores, the calcium remains buffered
in the sarcomere. This may be due to two possibilities. One possibility is that
these mutations respond to lower calcium concentrations, where calcium ions are
continually binding a mutant complex, transitioning to state B, released upon
return to state A, then repeating this binding cycle long after the large calcium
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transient has passed for regulated contraction. Although the [Ca2+]free remains
relatively low, there is an overall buffering of a significant amounts of calcium in
the sarcomere by the troponin complex. The other possibility, though not
mutually exclusive, is that these mutations lead to a lower activation energy for
the A-B transition in the absence of calcium. State B, having a higher affinity for
calcium, allows binding of calcium away from endogenous muscle calcium
buffers. This can also lead to an overall aberrant buffering of calcium. Likewise,
Mhc 5, MhcsI, and MhcS 2 lead to buffering because the sarcomere is continually
cycling through states CD-E-)(C). After a single cycle of unregulated
contraction, calcium may unbind the troponin complexes. However, a significant
number of myosins remain bound in Mhc' Mhc s2, Mhc5, stimulating a second
cycle through cooperative mechanisms, allowing state B troponin complexes to
bind calcium. Buffered calcium in both mutant groups is thus continually binding
and unbinding troponin complexes. During an increase in temperature, diffusion
rates increase, allowing Ca2+ to diffuse farther from the contractile machinery
when unbound. At sufficiently high temperatures, calcium may reach the
membrane, effectively depolarizing the membrane and leading to a
hyperexcitable state. This state would allow for multiple muscle action potentials
once threshold is reached, but neuronal input would be required to stimulate the
spike train. The suppression of seizure activity by para"ts occurs by preventing
threshold through loss of presynaptic release.
Alternatively, though not mutually exclusive, excitability defects may be
caused by further increases in ectopic innervation at the adult IFM. Although the
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innervation defects at the third instar neuromuscular junction are modest, defects
may be exacerbated at adult muscles. However, at the adult flight muscles, type
II innervation seems to represent a more molecularly diverse set of synapses,
and it is unknown whether muscle hypercontraction would induce increased
innervation of any, a subset, or all type II- like synapses in the adult (Rivlin et al.,
2004). Moreover, it is unclear how increases in type II innervation may alter
excitability of muscles in a temperature-dependent fashion.
Although more experimentation will be required in order to discern
between these possibilities as well as other potential mechanisms, it is clear that
hypercontraction creates a distinct muscle state which is different from
hypocontracted and normal muscles. In support of this, hypercontraction
mutants have TS behavioral defects which are not evident in hypocontraction
mutants or iin wildtype flies. In addition, TS behavioral defects are not likely due
to mixtures of differentially active myosins being expressed in the IFM, as
MhcD4 5/+ heterozygotes do not display TS behavioral defects such as those
found in Mhc8 1/+, MhcS2/+, and Mhc5/+. Future studies in determining the
components which contribute to this altered state will be critical in understanding
the underlying causes of excitability defects in hypercontraction mutants.
Characterization of genetic interactors of Mhc s1 and Mhc s2 mutants such as the
Swing and Breakdance loci described here may also provide insights into the
molecular pathways underlying hypercontraction myopathies, as well as
contribute to understanding of the mechanisms underlying human muscle
diseases such as hypertrophic cardiomyopathy.
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Materials and methods
Fly strains and crosses
Flies were cultured on standard medium at 22°C. All crosses using
appropriate genotypes were cultured at 25°C. MhcS1 and MhcS2 were generated
in an F1 EMS screen for X-linked and autosomal dominant TS behavioral
defects. Samba mutants were recombination mapped to 2-52 cM on the second
chromosome with Sp J L P marker chromosomes, deficiency mapped to 36A8-
36C4, and tested for non-complementation with P{w+mC=lac1/Mhck 1042 3 and
Mhc1 (Mogami and Hotta, 1981; Spradling et al., 1999). The SwgX1 88 and BrkdJ 2 9
mutations were also generated in screens for TS behavioral defects, and these
have been mapped to 42A and 88F, respectively. In addition, revertants of
MhcS1 TS dysfunction were isolated by y-irradiation. Mhcsl/CyO males were
exposed to 6000 rads, crossed to Gla/CyO, and F1 progeny were tested at 38°C
for loss of TS behavior. Three revertants (Mhcv , Mhc' 2, and Mhc v3 ) were
isolated. All three were embryonic lethal with normal morphological
development, but showed complete loss of muscle wave propagation in late
stage embryos. In addition, all three revertant alleles show non-complementation
to Mhc1. Suppression of lethality was scored as live flies which were able to
survive eclosion and feed with enough motor coordination to prevent becoming
trapped in the media.
Adult behavior analysis
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Ten flies were placed into a preheated glass vial at 38°C. Flies showing
TS behavioral defects were scored in fifteen second intervals. The analysis was
done with ten repetitions for each genotype and each repetition contained an
independent set of ten flies.
Polarized light miocrographs
Polarized light micrographs of the adult flight muscles were analyzed as
previously described with the modification of using Xylenes as a clearing agent
(Fyrberg et al., 1994). Thoraces were mounted using Permount (Fisher
Scientific) and analyzed under Nomarski optics.
Mutation and crystal structure analysis
Mutations were determined by PCR and sequencing. Genomic DNA was
isolated from CantonS and MhcSl/Df(2L)H20 flies (Simpson, 1983). Exons 4-6
were amplified by PCR and the product was sequenced at the MIT Cancer
Center sequencing facility. Genomic DNA from homozygous MhcS2 embryos
was isolated and similarly processed. Amino acids are numbered according to
the Mhc-P11 sequence. Crystal structure analysis of the mutations was done
using the Swiss PDB Viewer software available at http://us.expasy.org/spdbv/.
Crystal structures 2MYS and 1MMG were downloaded from NCBI and mutations
mapped according to BLAST alignments done through the NCBI BLAST website.
(Fisher et al., 1995; Rayment et al., 1995; Rayment et al., 1993).
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Antibodies and immunohistochemistry of third instar larvae
Wandering third instar larvae were raised at 25°C, then dissected and
fixed by standard procedures. Affinity purified rabbit o-sytl antibodies (Littleton et
al., 1993) were used at 1:1000 and Cy2-conjugated goat -rabbit secondary
antibodies at 1:200 (Jackson Labs). Texas red-conjugated phalloidin was
incubated simultaneously with the secondary antibody at 1:500 (Molecular
Probes). Visualization and quantification was performed under light microscopy
using a 40X oil-immersion lens. Images were taken using confocal microscopy
under similar conditions and processed with Zeiss PASCAL software.
Electrophysiology
Extracellular DLM recordings Extracellular DLM recordings were done in male
flies raised at 25CC. 1-5MQ electrodes were filled with 3M KCI. The recording
electrode was inserted into the lateral thorax with the ground electrode inserted
into the eye. Basal activity was recorded for two minutes at 22°C. Temperature
was then shifted to 380°C for one minute, and returned to 22°C. Recordings were
done using an Axoclamp-2B amplifier (Axon) and digitized with an Instrunet
Model 100 digitizer at 10 kHz and analyzed with Superscope 3.0 software (GW
Instruments). In order to attenuate extracellular signals from the eye,
experiments were done in constant light.
Intracellular recordings Intracellular recordings were done at room temperature
in wandering third instar larve raised at 250°C. Dissections and recordings were
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done in 0.4 mM Ca2+ HL3 (Stewart et al., 1994) with 4 mM MgCI2. Recordings
were done from muscle 6 at segments A3-A5. 50-100M~electrodes were filled
with 3 M KCI. Muscles were analyzed if the resting membrane potential was
below -50mV Data was digitized with a Digidata 1322, filtered at 10 kHz online,
and analyzed using pCLAMP v8.0 software (Axon). mEJP amplitude and
frequency was determined by manual analysis, analyzing representative samples
from each muscle recording. EJP amplitude was similarly analyzed, utilizing the
maximal response to suprathreshold stimulation (determined for each individual
muscle). Ca2 -free recordings were done in a similar manner. Failure to evoke
release was used to verify that Ca2+ was minimal in the external solution.
Recordings with an intact CNS were done in 0.2 mM Ca2 + to prevent substantial
depolarization during central pattern activity in the presence or absence of 3 pM
TTX.
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Abstract
We have recently identified and characterized mutations in Myosin Heavy
Chain that lead to hypercontraction of the indirect flight muscles in Drosophila.
These Mhc mutations disrupt Ca2+-dependent calcium contraction cycles in the
larval body wall muscles and cause temperature-induced myogenic seizure
activity in adult animals. Analysis of the hypercontraction mutants wings up
A h e lpdup2 and upheld1 01 revealed temperature-sensitive behavioral defects occur
specifically in hypercontraction mutants, suggesting a fundamental difference
between hypercontraction and normal or hypocontracted muscles. To
characterize the genomic response to hypercontraction-induced muscle
myopathy, we have utilized expression analysis with high-density oligonucleotide
microarrays. The transcriptional profile indicates a remodeling of the muscle
architecture in response to hypercontraction. Specifically, a subset of the highly
upregulated genes has been shown or is putatively involved in actin regulation
and structural support for the contractile machinery. Further, we show that these
genes may be involved in remodeling key structural sites within the muscle.
(c)Enrico Sakai Montana. All rights reserved. 107
Introduction
Human cardiomyopathies can occur from single gene mutations which
alter the properties of the contractile machinery. These diseases are often
characterized as either hypertrophic (increase in myocyte size) or dilated
(increase in ventricular volume). Mutated genes responsible for these diseased
states include Myosin heavy chain, troponin I, troponin T, tropomyosin and
myosin light chain (Seidman and Seidman, 2001). In response to these defects,
cardiac cells undergo a transcriptional response which includes the upregulation
of fetal cardiac genes and immune response genes, as well as a downregulation
of nuclear-encoded mitochondrial genes and calcium handling proteins (Aronow
et al., 2001; Barrans et al., 2002; Chien et al., 1991; Komuro et al., 1991; Lowes
et al., 2002; Sadoshima and Izumo, 1997; Sadoshima et al., 1992). This
response, however, has been heterogeneous between studies in mammals. This
may be due to differences in both the experimental procedures and the
cardiomyopathy models utilized for each study, as well as differences in the
pathogenic progression at which the study was performed. Alternatively, this
heterogeneity may reflect distinct mechanisms underlying specific
cardiomyopathies. In addition, due to differences in microarray production,
annotation, and incomplete genomic information, cross-referencing these studies
remains difficult. Regardless, the molecular signaling which mediates the
transcriptional response is thought to involve a calcineurin-dependent signaling
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cascade, leading to the deacetylation of histones, and the consequent activation
of genes which are normally expressed at low levels in adult tissue (Frey et al.,
:2000; Molkentin et al., 1998; Zhang et al., 2002a). Defining the transcriptional
response across the entire genome and the signals that mediate this re-profiling
is essential for determining the functional consequences of differential gene
expression in the mechanisms of disease pathogenesis.
Analiysis of flightless behavior in Drosophila has provided a genetic model
system to study the molecular mechanisms underlying cardiac dysfunction in
humans. Many of the genes that are mutated in cardiac dysfunction in humans
also lead to flightless defects in Drosophila. Among these genes are Myosin
Heavy Chain (Mhc), actin88F (act88F), wings up A (wupA: troponin I), and
upheld (up: troponin T) (Ferrus et al., 2000; Vigoreaux, 2001). As the molecular
lesions provide strong parallels between the underlying molecular causes of
cardiomyopathies and flightlessness in Drosophila, there may also be parallels in
the concomitant cellular changes in response to these single gene mutations.
Recently, we have identified mutations in Mhc which lead to
hypercontraction of the adult indirect flight muscles (IFM) (Montana and Littleton,
2004). This hypercontraction is likely due to unregulated contraction cycles that
occur in mutant muscles. These mutations were isolated as dominant,
temperature-sensitive (TS) behavioral mutants which showed TS seizure-like
behavior at restrictive temperatures. In an analysis of several known muscle
mutants, this TS state is specific to hypercontraction mutations, as all
hypercontraction mutants assayed showed similar TS defects. These data
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suggested that hypercontracted muscles are fundamentally different than
hypocontracted and normal muscles. Further, this difference may reflect the
underlying cellular mechanisms which lead to human diseases such as
hypertrophic cardiomyopathy.
In order to characterize the differences between hypercontracted and
normal muscles, we have begun a genome-wide expression analysis of a
Drosophila hypercontraction-induced myopathy utilizing high-density
oligonucleotide DNA microarrays. Definition of the transcriptional response to
hypercontraction-induced myopathy in Drosophila may identify conserved cellular
responses to muscle dysfunction, and could potentially reveal novel targets for
therapeutic treatment of muscle diseases.
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Results
Expression analysis of MhcS' and MhcS2
Previous data suggests a fundamental difference exists between
hypercontracted muscles and normal or hypocontracted muscles. This
difference may reflect abnormal Ca2+ regulation, causing myogenic seizures in a
temperature-dependent manner (Montana and Littleton, 2004). This altered
muscle state may also parallel differences between normal human cardiac
muscles and cardiomyopathies, providing not only a genetic model system for
identifying new genes involved in mammalian cardiac dysfunction, but also a
cellular model in which to understand the cellular mechanisms underlying
diseased states in response to altered contractile function. In order to
characterize the differences between these muscles states in Drosophila, we
performed expression profiling with Affymetrix® high-density oligonucleotide
GeneChip® arrays. These microarrays contain representative sequences for
most of the 14,000 genes thought to be encoded in the Drosophila genome. In
our expression analysis, we utilized two independent alleles of Mhc, Mhc s1 and
MhCS2, that lead to indirect flight muscle (IFM) hypercontractions. These alleles
are both missense mutations (V235E and E187K) that localize near the ATP
binding/hydrolysis domain of the Mhc protein. Using two independent alleles has
allowed us to look for conserved responses to Mhc dysfunction by reducing
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background and allele specific changes. In addition, these two mutations map to
a region in the Mhc protein in which at least nine different mutations have been
identified that lead to hypertrophic cardiomyopathy (Figure 1; Rayment et al.,
1995). A total of 8 independent arrays were performed: 4 CantonS, 2 MhcSl/+,
and 2 MhcS2 /+. The data were processed using the Affymetrix® statistical
expression algorithm in a total of 16 pairwise comparisons between mutant and
wildtype arrays. To analyze the four mutant chips as a group against the four
wildtype controls, SAM v1.20 analysis was used using the two-class unpaired
response type (Tusher et al., 2001). To increase the chances of making relevant
gene change calls, we set stringent conditions to analyze the data. For a gene to
be differentially regulated, it must have been called up- or downregulated by the
Affymetrix®) algorithm in 75% of the pairwise comparisons. To further rank this
data, it was subdivided into two categories: 1) differentially regulated in 75% of
all pairwise comparisons and, 2) differentially regulated in only one of the two
mutants. We analyzed which of the genes identified by the Affymetrix®
statistical expression algorithm were also identified by the SAM analysis. Once
the gene set was defined, we individually placed each gene through a BLAST
analysis to look for similarities with known proteins or known protein domains.
Finally, genes were functionally categorized according to known or putative
functions based on current literature or sequence similarity. Under theses
criteria, 228 genes were upregulated and 118 were downregulated in response to
hypercontraction-induced myopathy (Table I, Figure 2).
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Figure 1
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Figure 1: Mhc mutations mapped onto the chicken Mhc crystal structure
Nine known mutations that map near or in the ATPase active site in human
hypertrophic cardiomyopathes and three dominant hypercontraction mutations in
Drosophila are mapped onto a crystal structure of Mhc (Rayment et al., 1995;
Rayment et al., 1993). The locations of the human mutations are shown in green
and the Drosophila mutations are shown in red.
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Table I. Microarray Summary
Upregulated Genes
Category Number
Muscle Structure/Function 35
Serine Proteases 24
Novel 54
Chaperones 8
NLIclear Biology 13
Metabolism and Energy 55
Immune Response 15
Signaling 8
Other 16
Total 228
Downregulated Genes
Category Number
Metabolism and Energy 77
Muscle Structure/Function 6
Other 22
Novel 13
Total 118
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To verify that vectorial changes in gene expression were correct, seven
genes were tested using semi-quantitave RT-PCR. These seven genes showed
similar vector changes, confirming that the expression profiles reflect the
representation of transcripts isolated (Figure 2). Analysis of the identified genes
shows similarities between this analysis and expression analyses performed in
mammalian hypertrophic cardiomyopathies and muscular dystrophies. In
mammalian cardiomyopathies, differential gene regulation has focused on the
activation of fetal protein isoforms involved in cardiac function (Lim et al., 2001;
Molkentin et al., 1998). In addition to fetal gene activation, induction of
immediate-early genes has also been implicated in response to
cardiomyopathies (Sadoshima and Izumo, 1997). Interestingly, there are
parallels between cardiac dysfunction and skeletal muscle dysfunction. Many
skeletal muscular dystrophies include cardiomyopathy within the pathology, likely
reflecting shared components and mechanisms underlying the function of these
types of tissues (Fadic et al., 1996; van der Kooi et al., 1997). Expression
analysis of' muscular dystrophies has revealed a downregulation of nuclear-
encoded mitochondrial genes and alterations in developmentally-regulated
components of the contractile machinery (Campanaro et al., 2002; Chamberlain,
2000; Chen et al., 2000; Noguchi et al., 2003). For both skeletal and cardiac
dysfunction, dysregulation of intracellular Ca2+ homeostasis has been suggested
to be important for pathogenesis and altered transcriptional regulation (Frey et
al., 2000; Gailly, 2002; Leinwand, 2001; Martonosi and Pikula, 2003; Semsarian
et al., 2002).
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Figure 2: Expression analysis of the Samba mutants using Affymetrix®
high-density oligonucleotide GeneChip® microarrays. (A) Schematic
depicting the pairwise comparison matrix used to analyze the microarray data
with the Affymetrix® statistical algorithm. (B) A sample pairwise comparison
between CantonS and MhcSl/+ expression analyses. Green lines indicate a 2-
fold difference in expression. (C) The output of SAM analysis v.1.20 using a two-
class unpaired data set and A-value set to give -25% false detection rate. (D)
Semi-quantitative RT-PCR shows similar vector changes identified by the
microarrays. GAPDH2, Act57B, and CG2330 represent quantitative
comparisons, as both control and mutant reactions are within the linear regions
of the RT-FPCR.
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The differential regulation in the Mhcsl and Mhc s2 mutants includes the
upregulation of developmentally controlled genes which are required for earlier
stages of development. Mlp60A and MIlp84B, which normally show high
expression during the initial setup of embryonic and adult musculature, are
upregulated in the Mhc mutants (Stronach et al., 1996). Likewise, Act57B, the
predominant actin of the larval body wall musculature, rather than the adult
musculature, also shows upregulation (Labuhn and Brack, 1997). In
cardiomyopathies and muscular dystrophies, embryonic sarcomeric genes are
upregulated (Chen et al., 2000; Chien et al., 1991). Although we see an
upregulation of developmentally-regulated transcripts, this does not include the
sarcomeric genes. This may be due to the fact that the Drosophila genome only
encodes a single gene for muscle Mhc, Tnl, and TnT. If embryonic splice
variants were upregulated by myopathy in Drosophila, they would not be
detectable by this assay, as the microarrays do not distinguish between
alternative transcripts encoded by the same locus.
Interestingly, a subset of the genes altered in our hypercontraction-
induced myopathy model has been implicated in activity-dependent synaptic
plasticity in several mammalian model systems. These include the Drosophila
homologs of the mammalian proteins ARC (CG12505 and CG13941),
neurochonclrin/norbin (CG2330), and CPG2 (Msp-300) (Lyford et al., 1995;
Nedivi et al., 1996; Shinozaki et al., 1997; Zhang et al., 2002b). These activity-
regulated genes are thought to modulate actin dynamics to strengthen activated
synapses during plasticity (Lyford et al., 1995; Shinozaki et al., 1997).
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Overall, the most striking gene set identified is the upregulation of genes
known or predicted to be involved in muscle structure and function on the level of
the actin cytoskeleton, suggesting a remodeling of the actin cytoskeleton and its
structural support occurs in response to hypercontraction (Figure 3, Table II). Of
the ten most upregulated genes across all statistical analyses, six fall within this
category. Another class of upregulated genes we have includes chaperones and
serine proteases, further supporting a remodeling of the muscle architecture
(Table S1).
Like muscular dystrophies, Drosophila hypercontraction mutants exhibit an
upregulation of immune-response related genes. In Duchenne's muscular
dystrophy, this response is thought to reflect infiltration of degrading muscle
tissue by activated dendritic cells, as immunohistochemical analysis of muscle
biopsies show increases in dendritic cell infiltration into the muscle (Chen et al.,
2000). Whether the immune-response related genes upregulated in Drosophila
reflect a similar biological phenomenon is unknown. Known and putative
metabolic genes form the majority of downregulated genes (77/118), many of
which are known or predicted to function in the mitochondria. This response has
been shown to occur in Duchenne's and Limb-girdle muscular dystrophies,
suggesting a metabolic crisis in myopathic flight muscles similar to muscular
dystrophies..
One additional gene of interest is the downregulation of the calcium pump
responsible for transporting calcium back into the sarcoplasmic reticulum, Ca-
P60A (Aronow et al., 2001). This downregulation may contribute to or reflect
(c)Enrico Sakai Montana. All rights reserved. 120
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Figure 3: A potential muscle remodeling response in the Mhc mutants (A)
A subset of known muscle genes shows differential-regulation in mutant tissue.
Note that most contractile genes are not upregulated. Genes identified as
significantly altered in expression level are indicated (*). (B) A putative set of
genes with domain structures which suggest a muscle remodeling role that show
altered transcription in the Mhc mutants. Both graphs depict normalized
expression values + SEM.
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general Ca2 + homeostasis dysfunction in the flight muscles. Indeed, our previous
work suggested that intracellular Ca2 + is likely to be dysregulated in Mhc mutant
fibers, as third instar body wall muscles exhibited spontaneous contraction cycles
in the absence of external Ca2+ (Montana and Littleton, 2004).
A subset of differentially-regulated genes are expressed in somatic musculature
Most of the genes that have been found to be differentially regulated in
this analysis are largely uncharacterized. To determine whether these genes
may be important for muscle function, we analyzed the expression patterns of
several with domain structures that suggested a role in the muscle. These
include CG12505 (dARC1), CG2330 (dNeurochondrin), CG32030 (CG5797 and
CG5775; dFHOS), CG2471 (dSCLP), CG6972 and CG9025 (dFEM-1).
FEM-1, an ankrin repeat protein, was originally isolated in C. elegans and
has been shown to be important in sex determination through programmed cell
death (Kimble et al., 1984). dSCLP, a leucine rich repeat-containing protein, is a
homolog of SCLP, a gene originally identified in Manduca that was found to be
upregulated in skeletal muscle cells undergoing programmed cell death (Kuelzer
et al., 1999). Although dFEM-1 showed differential expression in the CNS, it
does not exclude the possibility of function within the mesoderm. dSCLP,
however, showed strong expression in the mesoderm, suggesting its primary
function resides in the muscle. CG6972 is an insect specific protein, with a
homolog found in Anopheles. This gene contains a low homology armadillo
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repeat. The expression pattern shows expression only in somatic musculature,
suggesting a function in the muscle.
dARC1 is one of three homologs (CG12505, CG13941, and CG10102) of
the mammalian ARC gene The in situ hybridization expression pattern for
dARC1 shows a broad expression pattern with many tissue types. However,
there is differential expression in both somatic and visceral musculature.
Additionally, there is a higher expression in the CNS. Interestingly, the CNS
expression pattern is localized to the synaptic regions of the ventral ganglion
within the (:NS. In the mammalian CNS, ARC mRNA is trafficked to activated
synapses and locally translated in the dendrites (Steward and Worley, 2002).
This suggests a potential conservation of ARC function in synaptic plasticity and
provides a secondary system in which to analyze dARC1 function in vivo.
Neurochondrin was originally isolated as a transcript that is upregulated in
neurons that have undergone tetraethylammonium-induced long-term
potentiation. Additionally, neurochondrin overexpression in Neuro2a cells
induces neurite outgrowth (Shinozaki et al., 1997). The Drosophila homolog,
dNeurochondrin, shows expression in both somatic and visceral musculature,
suggesting it functions primarily within the muscle.
dFHOS is an FH1 and FH2-domain containing protein with armadillo
repeats in the N-terminus. This gene is the Drosophila homolog of FHOS, a
human "formin-homology containing protein overexpressed in the spleen"
(Westendorf et al., 1999). Recent evidence has shown that formin-containing
proteins regulate polymerization of non-branched actin filaments (Pruyne et al.,
(c)Enrico Sakai Montana. All rights reserved. 125
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Figure 4: In situ analysis confirms that many of the putative muscle
remodeling genes are expressed in the somatic mesoderm. Above each in
situ is a schematic showing the overall domain structure of the protein.
Expression patterns are (A) Mhc, stage 15, (B) CG6972, stage 14, (C) dSCLP,
stage 16 () dNeurochondrin, stage 16, (E) dFEM-1, stage 16, (F) dFHOS, both
stage 13, and (G) dARC1, late stage 15 (top and middle are same embryo at
different focal planes) and stage 16 (bottom). Note the differential expression in
somatic mesoderm as well as in the axonal tracts (arrows). Most embryos are
positioned anterior to the left and dorsal to the top, except dFEM-1, the second
dFHOS, and the third dARC1 embryos, which show the ventral face and anterior
to the left.
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2002; Sagot et al., 2002). The expression pattern of dFHOS shows strong
somatic muscle expression, as well as cells along the midline of the CNS. These
midline CNS cells may represent mesectodermal cells that are thought to
differentiate into glial cell fates.
With the exception of dFEM-1, the somatic muscle expression of these
genes occurs during late mesodermal differentiation, turning on around stage 13
of embryogenesis, when the body wall myoblasts begin to fuse and form the
body wall musculature. This indicates that these genes are more likely to be
involved with the structure or function of muscle cells, rather than the
specification and determination of mesodermal derivatives (Figure 4).
The expression profiling data indicate that the hypercontraction Mhc
mutants lead to a specific transcriptional response that is similar to that of human
muscular dystrophies and hypertrophic cardiomyopathies. This response does
not represent a re-activation of the entire developmental program of the
mesoderm, as early mesodemal determinants are not upregulated. Rather, it
seems to be a program of genes which are required for the structure or function
of muscle cells. It is still unclear how this transcriptional response affects the
function of the muscle. Future studies will determine whether the differentially-
regulated genes contribute to dysfunction, or are involved in the remodeling of
damaged and diseased tissue.
Muscle remodeling may occur on the actin cytoskeleton or at key structural sites
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To begin understanding the role of differentially-regulated genes in muscle
dysfunction, it is important to identify the possible sites of action at which the
proteins these genes encode may act within the muscle. For this, we analyzed
the immunolocalization of MSP-300, the Drosophila nesprin (Rosenberg-Hasson
et al., 1996; Zhang et al., 2002b). As previously reported, localization of MSP-
300 was found in four distinct places in larval body wall muscles (Figure 5).
These sites include the Z-line, the muscle attachment sites, the nucleus, and at
an unknown structure resembling an attachment site between muscles 6 and 7.
This data suggests that possible sites of action for this subset of genes that are
differentially regulated in post-differentiated diseased or damaged muscle may
be these four sites. In support of this, the muscle LIM protein MIp84B has been
shown to accumulate at muscle attachment sites and Z-lines as well (Stronach et
al., 1999). Additionally, flap wing has been shown to be important for the
integrity of muscle attachment sites and the organization of the Z-lines in the IFM
(Raghavan et al., 2000). The Drosophila titin (sis, Kettin, and titin) has been
shown to be important for both myoblast fusion as well as structural integrity of
the sarcomere, with immunolocalization to Z-lines (Hakeda et al., 2000; Lakey et
al., 1993; van Straaten et al., 1999).
As many of the genes we have identified as potential muscle remodeling
genes are uncharacterized, we assayed whether the most upregulated gene,
dARC1 can potentially localize to the actin cytoskeleton. For this analysis, we
created transgenic flies which express dARC1 fused to the N-terminus of GFP
under the UAS/GAL4 expression system (Phelps and Brand, 1998). In addition,
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Figure 5
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Figure 5: Potential sites of action for muscle remodeling in
hypercontraction mutants. Four distinct structures are labeled with antisera
raised against the MSP-300 protein. Redistribution of the protein is not detected
in mutant animals. (A) Phalloidin-labeled actin cytoskeleton (top), ct-MSP-300
(middle), and merge (bottom) indicate the presence of MSP-300 at the Z-line.
(B,E) Structures around the nuclei are cu-MSP-300 positive (nuclei labeled with
n). (C,F) MSP-300 is found at inter-muscular connections between muscles 6
and 7, and (D,G) at intersegmental muscle attachment sites. Genotypes are (A-
D) Canton S, (E,G) Mhcs1/+, and (F) MhcS2/+. Scale bars indicate 10im.
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we generated flies which overexpress non-tagged dARC1. The GFP-tagged
dARC1 protein did not fold correctly when overexpressed in the muscle (Figure
6). However, when co-expressed with untagged dARC1, the GFP localization
resembled sarcomeric structures in the muscle. Co-staining with Texas-red
phalloidin was not possible, as fixation disrupted the GFP localization, causing
GFP-dARC1 to disassociate from this structure and form aggregates (data not
shown). Interestingly, the co-expression of these proteins in the CNS shows
GFP fluorescence at synaptic sites (Figure 6). This suggests that dARC1 may
mediate a function in Drosophila synapses, consistent with data in mammals
(Guzowski et al., 2000; Lyford et al., 1995). Given this data, it is likely that
dARC1 may bind to the sarcomere in vivo. Future experiments to co-localize this
signal with known markers of sarcomeric substructures will determine the precise
localization of dARC1 in this overexpression system.
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Figure 6: dARC1 potentially localizes to the sarcomere in the muscle and
synaptic regions within the CNS (A) Expression of dARC1-GFP fusions were
unstable in the muscle, forming aggregates within the muscle. (B) DIC image of
the muscle containing dARC1-GFP aggregates. (C) Merged image of (A) and
(B). (D) Co-expression of both dARC1 and dARC1-GFP shows localization to
structures resembling the sarcomere in the muscle. In addition, co-expression in
the CNS shows synaptic-like localization in the (E) neuromuscular junction, (F)
neurophil region of the ventral ganglion, (G) mushroom bodies of the brain lobes,
and (H) the developing visual system. Genotypes shown are (A-C) w;Mhc-
GAL4,+/+, UAS-dARC1-GFP (D) w; Mhc-GAL4, UAS-dARCI,+/+,+,UAS-dARC1-
GFP and (E-H) C155; UAS-dARC1,+/+,UAS-dARC1-GFP.
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Discussion
Muscle contraction is a highly-coordinated and specialized process that
requires the proper functioning of a large number of proteins. Mutations which
affect this process lead to a large array of diseases which include muscular
dystrophies and cardiomyopathies. Although the molecular lesions underlying a
number of these diseases are well known, the downstream consequences
underlying disease pathogenesis are less understood. Often, changes in the
overall transcriptional profile occur in response to genetic lesions. Defining the
alterations in gene expression can aid in understanding the pathogenesis of
disease. In addition, functional studies on differentially-regulated genes with can
help in identifying novel therapeutic targets for treatment of the disease.
Altered gene expression in response to hypercontraction in Drosophila
In a previous study, we showed that hypercontraction mutations in
Drosophila lead to an altered muscle state when compared with normal muscles.
This state alteration was reflected in temperature-sensitive seizures in the adult
animal and external Ca2+ -independent contraction cycles in the larval body wall
muscles. By using microarray analyses, we can begin to gain insight into this
altered state and identify differences which may contribute to muscle dysfunction,
as well as differences in gene expression which functionally compensate for
alterations induced by mutation.
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The striking difference between normal and hypercontraction muscles
identified is the robust upregulation of genes that are either known to or
putatively act at the level of the actin cytoskeleton. Some of the previously
characterized genes that we have identified as differentially-regulated in
response to myopathy include Mp60A, Mp84B, Kettin, MSP-300, fw, sqh,
capulet, slingshot, act88F, act57B, Mbs, and talin. Mp60A, MIp84B, Kettin,
MSP-300, fiw, capulet, and talin, have all been shown to play roles in providing or
modulating the structural supports of the cytoskeleton (Baum et al., 2000; Brown
et al., 2002; Lakey et al., 1993; Raghavan et al., 2000; Rosenberg-Hasson et al.,
1996; Stronach et al., 1999). This suggests that in Drosophila muscles,
hypercontraction and degredation can trigger a transcriptional response to
remodel the cytoskeleton and its associated support structures. This may
represent a functionally beneficial compensation mechanism by which the
muscle responds to the increased forces induced by hypercontraction. The
upregulation of sqh supports the idea of compensatory mechanisms. In wildtype
animals, sqh normally acts as a regulatory light chain of the non-muscle type II
myosin, zipper (Karess et al., 1991). This upregulation could potentially alter the
overall activity and force output of the muscle by changing the properties of Mhc.
On the other hand, the downregulation of fin may reflect a deleterious alteration
in transcription. Loss-of-function mutations in fn lead to sarcomeric instability
and defects in thick filament assembly (Baum et al., 2000). In addition to the
increased forces produced by mutant Mhc, decreasing fn transcription may lead
destabilization of the thick filament structure.
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Among the known genes we have identified through the microarray,
several have defined expression patterns through development, but normally are
not highly expressed in the adult animal. The muscle LIM proteins, for example,
have peak" expressions at the terminal stages of muscle development in the
embryo and pupa (Stronach et al., 1996). In addition, act57B is the predominant
actin for the larval somatic musculature, while act88F is predominantly an adult
actin (Tobin et al., 1990). This may indicate that, like fiber regeneration by
satellite cells in human muscular dystrophy, Drosophila could have mechanisms
for fiber regeneration in response to myopathy (Jejurikar and Kuzon, 2003).
However, early mesodermal determinants do not show upregulation, suggesting
this is unlikely. Further, many of the genes which encode the contractile
machinery are not upregulated, suggesting that the subset of upregulated genes
function within the mature myopathic fibers rather than function in fiber
replenishment.
Many of the genes which we have identified as differentially-regulated in
response to hypercontraction are novel and have not been characterized.
However, it seems likely that many will act within this muscle remodeling
pathway. The domain structure and homology of these genes suggest they play
roles in regulating or supporting the cytoskeleton. Further, the in situ
hybridization experiments indicate that many of these are differentially expressed
in the muscle. Therefore, not only do the novel genes have sequences which
indicate a role in cytoskeletal regulation and show similar regulatory patterns in
response to myopathy, but they also are preferentially expressed in muscle. One
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of these genes, dFHOS, is a formin-domain containing protein. Recent data has
shown that formin domains promote the formation of unbranched actin polymers
in an ARP2/3-independent manner (Pruyne et al., 2002; Sagot et al., 2002). This
may indicate that dFHOS plays a role in polymerizing the unbranched actin
filaments in the sarcomere. Current work in the lab will address the role of
dFHOS in Drosophila muscles.
Therefore, the transcriptional profile seems to indicate that in Drosophila,
hypercontraction-induced myopathy leads to a remodeling of the cytoskeletal
architecture. This remodeling most likely occurs on the level of modulation and
support of the actin cytoskeleton. Further, the likely subcellular domains at which
they act include muscle attachment sites, nuclear membrane, and at the Z-line
structures of the sarcomere-known localization sites for many of the
differentially-regulated transcripts which have been previously characterized.
In addition to the potential muscle remodeling response, the upregulation
of immune response genes suggests an infiltration of immune cells involved in
degradation of dying muscle cells. The downregulation of nuclear-encoded
mitochondrial genes and genes involved in energy and metabolism indicates a
general metabolic crisis of the animal. Whether this occurs due to the declining
health of the IFM, or if this response is causative to the myopathy is unknown.
This downregulation may also be indicative of Ca2+ overloading of the
mitochondria and subsequent Ca2+-activated cell death. Mitochondrial staining in
Mhc mutant third instar body wall muscles appears normal (unpublished data),
suggesting that this downregulation does not correspond to decreased
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mitochondrial number, but rather supports a loss of metabolic function and
subsequent energy depletion in the muscle.
Synaptic plasticity and muscle remodeling
An intriguing observation in the expression profile was an upregulation of
a subset of genes which have been isolated in mammalian systems as activity-
regulated transcripts in the nervous system. These genes include dARC1,
dNeurochonrdrin, and MSP-300. The mammalian homologs (ARC,
neurochondrin/norbin and CPG2) are upregulated in response to synaptic
activity. Although loss-of-function studies have not been done on these genes,
cell culture studies suggest the proteins are involved in regulating the
morphological properties of the synapse in an activity-dependent manner
(Fosnaugh et al., 1995; Lyford et al., 1995; Nedivi et al., 1996; Shinozaki et al.,
1997; Steward, 2002; Steward et al., 1998; Steward and Worley, 2002; Wallace
et al., 1998). Activity-dependent synaptic modification is dependent upon Ca2+
signals originating from influx through NMDA receptors at synapses (Malenka,
1991). Potentially, the Ca2+-dependent processes that have been implicated in
muscular dystrophies and cardiomyopathies may also function in activity-
dependent synaptic plasticity, utilized to remodel actin-dependent structures in
response to defined stimuli.
Drosophila as a model system to study human muscle diseases
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The transcriptional response to hypercontraction-induced myopathy in
Drosophila suggests a conserved cellular response to muscle dysfunction from
flies to humans. The general classes of genes which show differential regulation
include an upregulation of developmentally-regulated muscle transcripts, an
upregulation of immune response genes, and a downregulation of energy and
metabolism genes. These responses have been seen in both muscular
dystrophies and cardiomyopathies. Further, the expression analysis has
indicated a potential remodeling of the cytoskeleton and its support architecture.
This response could be indicative of compensatory mechanisms utilized to slow
the degredation process. Alternatively, it may reflect an endogenous response
that normally occurs in muscle injury, but may not be sufficient to compensate for
genetic lesions. The parallels found in Drosophila to human muscle diseases
suggests that the cellular responses to genetic lesions affecting muscle function
and, subsequently, leading to myopathic states, may be conserved. Therefore,
Drosophila, offers a system in which to perform high-throughput pharmaceutical
discovery for compounds which alleviate the defects of contractile dysfunction.
Further, using the molecular genetic tools available, we can begin to understand
the functional consequences of altered transcription in context of muscle disease,
as well as to dissect the pathways activated by the primary mutations which lead
to the altered state observed in hypercontraction.
(c)Enrico Sakai Montana. All rights reserved. 140
Materials and methods
Fly strains and crosses
Flies, were cultured on standard medium at 22°C. All crosses using
appropriate genotypes were cultured at 25°C. Overexpression of dARC1 was
done using the C155 driver for neuronal expression. Muscle expression was
driven using the Mhc-GAL4 driver.
Mutation and crystal structure analysis
Crystal structure analysis of the mutations was done using the Swiss PDB
Viewer software available at http://us.expasy.org/spdbv/. The 2MYS crystal
structure was downloaded from NCBI and mutations mapped according to
BLAST alignments done through the NCBI BLAST website. (Fisher et al., 1995;
Rayment et al., 1995; Rayment et al., 1993).
Tissue samples
Tissue was derived from 3-4 day old adult male flies of the appropriate
genotype raised at 25°C. Flies were frozen in liquid nitrogen and vortexed in
order to obtain isolated heads and bodies (wings and legs were discarded).
Circadian differences were minimized by processing tissue between 11am-2pm.
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A total of 8 independent microarrays were analyzed (four control, two MhcSl/+,
and two MhcS2/+).
Tissue processing
Total RNA was isolated using Trizol (GibcoBRL). 7-12 flies were
processed in 200dtl of Trizol. Five batches (1 ml) of processed tissue were then
used to isolate the total RNA. From the total RNA, mRNA was isolated using the
Qiagen Oligotex mRNA extraction kit. cDNA was created with random hexamer
and T7-polyT oligonucleotides using the GibcoBRL/lnvitrogen cDNA kit. cDNA
was then purified by phenol/chloroform extraction and Phase Lock Gel extraction
tubes (Eppendorf) as suggested by Affymetrix®. Biotin-labeled cRNA was made
with the Enzo High-yield Bioarray kit using the supplied protocol with the
modification of running half reaction mixes. Reactions were cleaned with the
Qiagen RNEasy kit, precipitated overnight, and resuspended into 13pl of DEPC-
treated ddH20. Fragmentation was done with fragmentation buffer (200 mM Tris-
acetate, pH 8.1, 500 mM KOAc, 150 mM MgOAc) at 94°C for 35 min then
brought up into 33pLl total volume, and appropriate amount of cRNA was then
sent to the Affymetrix® processing lab at MIT for hybridization and signal
detection.
Expression Analysis
Statistical analysis was done with the Affymetrix® Microarrary Suite
software using the following normalization values:
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Scaling target: 1500
Alpha1: 0.04
Alpha2: 0.06
Tau: 0.015
GammalL: 0.0025
GammalH: 0.0025
Gamma2L: 0.0030
Gamma2H: 0.0030
Perturbation: 1.1
Gene changes were called based upon the stringency criteria that differential
regulation must be reported by Affymetrix software for at least 75% of the
pairwise comparisons. Additionally, an analysis utilizing Significance Analysis of
Microarrays (SAM) v.120 was done in order to provide an independent analysis
of the normalized data, giving higher stringency in differential regulation hits.
Analysis with SAM was done as two-class, unpaired data sets, setting delta to
-25% false positive rate. Raw and normalized data can be obtained by request
at http://web.mit.edu/flybrain/littletonlab/.
Semi-quantitative RT-PCR
Semi-quantitative RT-PCR was utilized to verify select genes from the
microarray analysis. PCR primers were designed to sequences used in the
design of probe pairs by Affymetrix. cDNA isolated was diluted into the
equivalent amount isolated from 1tg total RNA per 1l. This solution was
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further diluted 1:100 and 0.1 to 1 plI used in the reactions depending upon
transcript abundance and primer efficiency. Reaction samples were taken from
cycles 21-:30 in order to determine linear regions of the reactions. If linear
regions were overlapping, comparisons were made in those cycles. If linear
regions were not overlapping, reactions were run until mutant reactions were
within linear cycles.
In situ analysis
In situ expression analysis was performed using standard procedures.
Probes were designed to -200 bp fragments, amplified by PCR using a 3' primer
that includes the T7 sequence. Sequences used for in situ hybridization coincide
to sequences used by Affymetrix for probe pair design. In most cases, the same
sequence used for semi-quantitative RT-PCR was used for in situ analysis.
Primer sequences for semi-quantitative RT-PCR and in situ probe production can
be obtained upon request.
Immunostaining of third instar larvae
Immunostaining of third instar larval fillets was done as previously described
(Montana and Littleton, 2004). For labeling MSP-300, we utilized c-MSP-300
antisera at 1:500 (Volk, 1992). Secondary goat (x-rabbit conjugated to Cy2 was
used at 1:500 (Jackson Labs). F-actin was labeled with Texas red-conjugated
phalloidin at 1:500, incubated simulateously with the secondary antibody
(Molecular Probes).
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Overexpression of dARC1
Transgenic flies were generated by cloning the dARC1 open reading frame and
the dARC1-GFP fusion construct into the pUAST vector. Both constructs were
cloned using Xhol/Xbal restriction sites built into the primers. The fusion of
dARC1 and GFP was created by using standard gene-fusion PCR techniques.
Transgenic flies were obtained using Genetic Services, Inc. (Cambridge, MA).
Imaging of GFP was done similar to immunostained larvae with the exception
that the larvae were mounted live and visualized under a 40X/0.8NA water-
immersion lens (Zeiss).
(c)Enrico Sakai Montana. All rights reserved. 145
Acknowledgements
We thank Avital Rodal, Motojiro Yoshihara, and Bill Adolfsen for helpful
discussions about the manuscript and Affymetrix® for help in setting up the
software and taking the time to help us get acquainted with its use. We would
also like to thank the Bloomington Stock Center and T. Volk for Drosophila
strains. The -MSP-300 antibody was a gift from T. Volk. This work was
supported by grants from the NIH, the Human Frontiers Science Program, the
Searle Scholars Program, and the Packard Foundation. J. Troy Littleton is an
Alfred P. Sloan Research Fellow.
(c)Enrico Sakai Montana. All rights reserved. 146
Aronow, B.J., T. Toyokawa, A. Canning, K. Haghighi, U. Delling, E. Kranias, J.D.
Molkentin, and G.W. Dorn, 2nd. 2001. Divergent transcriptional responses
to independent genetic causes of cardiac hypertrophy. Physiol Genomics.
6:19-28.
Barrans, J.D., P.D. Allen, D. Stamatiou, V.J. Dzau, and C.C. Liew. 2002. Global
gene expression profiling of end-stage dilated cardiomyopathy using a
human cardiovascular-based cDNA microarray. Am J Pathol. 160:2035-
43.
Baum, B., W. Li, and N. Perrimon. 2000. A cyclase-associated protein regulates
actin and cell polarity during Drosophila oogenesis and in yeast. Curr Biol.
10:964-73.
Brown, N.H., S.L. Gregory, W.L. Rickoll, L.l. Fessler, M. Prout, R.A. White, and
J.W. Fristrom. 2002. Talin is essential for integrin function in Drosophila.
Dev Cell. 3:569-79.
Campanaro, S., C. Romualdi, M. Fanin, B. Celegato, B. Pacchioni, S. Trevisan,
P. Laveder, C. De Pitta, E. Pegoraro, Y.K. Hayashi, G. Valle, C. Angelini,
and (3. Lanfranchi. 2002. Gene expression profiling in dysferlinopathies
using a dedicated muscle microarray. Hum Mol Genet. 11:3283-98.
Chamberlain, J.S. 2000. Muscular dystrophy meets the gene chip. New insights
into disease pathogenesis. J Cell Biol. 151 :F43-6.
Chen, Y.W., P. Zhao, R. Borup, and E.P. Hoffman. 2000. Expression profiling in
the muscular dystrophies: identification of novel aspects of molecular
pathophysiology. J Cell Biol. 151:1321-36.
Chien, K.R., K.U. Knowlton, H. Zhu, and S. Chien. 1991. Regulation of cardiac
gene expression during myocardial growth and hypertrophy: molecular
studies of an adaptive physiologic response. Faseb J. 5:3037-46.
Fadic, R., Y. Sunada, A.J. Waclawik, S. Buck, P.J. Lewandoski, K.P. Campbell,
and B.P. Lotz. 1996. Brief report: deficiency of a dystrophin-associated
glycoprotein (adhalin) in a patient with muscular dystrophy and
cardiomyopathy. N Engl J Med. 334:362-6.
(c)Enrico Sakai Montana. All rights reserved. 147
Ferrus, A., A. Acebes, M.C. Marin, and A. Hernandez-Hernandez. 2000. A
genetic approach to detect muscle protein interactions in vivo. Trends
Cardiovasc Med. 10:293-8.
Fosnaugh, J.S., R.V. Bhat, K. Yamagata, P.F. Worley, and J.M. Baraban. 1995.
Activation of arc, a putative "effector" immediate early gene, by cocaine in
rat brain. J Neurochem. 64:2377-80.
Frey, N., T.A. McKinsey, and E.N. Olson. 2000. Decoding calcium signals
involved in cardiac growth and function. Nat Med. 6:1221-7.
Gailly, P. 2002. New aspects of calcium signaling in skeletal muscle cells:
implications in Duchenne muscular dystrophy. Biochim Biophys Acta.
1600:38-44.
Guzowski, J.F., G.L. Lyford, G.D. Stevenson, F.P. Houston, J.L. McGaugh, P.F.
Worley, and C.A. Barnes. 2000. Inhibition of activity-dependent arc protein
expression in the rat hippocampus impairs the maintenance of long-term
potentiation and the consolidation of long-term memory. J Neurosci.
20:3993-4001.
Hakeda, S., S. Endo, and K. Saigo. 2000. Requirements of Kettin, a giant muscle
protein highly conserved in overall structure in evolution, for normal
muscle function, viability, and flight activity of Drosophila. J Cell Biol.
148:101-14.
Jejurikar, S.S., and W.M. Kuzon, Jr. 2003. Satellite cell depletion in degenerative
skeletal muscle. Apoptosis. 8:573-8.
Karess, R.E., X.J. Chang, K.A. Edwards, S. Kulkarni, I. Aguilera, and D.P.
Kiehart. 1991. The regulatory light chain of nonmuscle myosin is encoded
by spaghetti-squash, a gene required for cytokinesis in Drosophila. Cell.
65:1 177-89.
Kimble, J., L. Edgar, and D. Hirsh. 1984. Specification of male development in
Caenorhabditis elegans: the fem genes. Dev Biol. 105:234-9.
Komuro, I., Y. Katoh, T. Kaida, Y. Shibazaki, M. Kurabayashi, E. Hoh, F. Takaku,
and Y. Yazaki. 1991. Mechanical loading stimulates cell hypertrophy and
(c)Enrico Sakai Montana. All rights reserved. 148
specific gene expression in cultured rat cardiac myocytes. Possible role of
protein kinase C activation. J Biol Chem. 266:1265-8.
Kuelzer, F., P. Kuah, S.T. Bishoff, L. Cheng, J.R. Nambu, and L.M. Schwartz.
1999. Cloning and analysis of small cytoplasmic leucine-rich repeat
protein (SCLP), a novel, phylogenetically-conserved protein that is
dramatically up-regulated during the programmed death of moth skeletal
muscle. J Neurobiol. 41:482-94.
Labuhn, M., and C. Brack. 1997. Age-related changes in the mRNA expression
of actin isoforms in Drosophila melanogaster. Gerontology. 43:261-7.
Lakey, A., S. Labeit, M. Gautel, C. Ferguson, D.P. Barlow, K. Leonard, and B.
Bullard. 1993. Kettin, a large modular protein in the Z-disc of insect
muscles. Embo J. 12:2863-71.
Leinwand, L.A. 2001. Calcineurin inhibition and cardiac hypertrophy: a matter of
balance. Proc Natl Acad Sci U S A. 98:2947-9.
Lim, D.S., R. Roberts, and A.J. Marian. 2001. Expression profiling of cardiac
genes in human hypertrophic cardiomyopathy: insight into the
pathogenesis of phenotypes. J Am Coil Cardiol. 38:1175-80.
Lowes, B.D., E.M. Gilbert, W.T. Abraham, W.A. Minobe, P. Larrabee, D.
Ferguson, E.E. Wolfel, J. Lindenfeld, T. Tsvetkova, A.D. Robertson, R.A.
Quaife, and M.R. Bristow. 2002. Myocardial gene expression in dilated
cardiomyopathy treated with beta-blocking agents. N Engl J Med.
346:1357-65.
Lyford, G.L., K. Yamagata, W.E. Kaufmann, C.A. Barnes, L.K. Sanders, N.G.
Copeland, D.J. Gilbert, N.A. Jenkins, A.A. Lanahan, and P.F. Worley.
1995. Arc, a growth factor and activity-regulated gene, encodes a novel
cytoskeleton-associated protein that is enriched in neuronal dendrites.
Neuron. 14:433-45.
Malenka, R.C. 1991. The role of postsynaptic calcium in the induction of long-
term potentiation. Mol Neurobiol. 5:289-95.
Martonosi, A.N., and S. Pikula. 2003. The network of calcium regulation in
muscle. Acta Biochim Pol. 50:1-30.
(c)Enrico Sakai Montana. All rights reserved. 149
Molkentin, J.D., J.R. Lu, C.L. Antos, B. Markham, J. Richardson, J. Robbins, S.R.
Grant, and E.N. Olson. 1998. A calcineurin-dependent transcriptional
pathway for cardiac hypertrophy. Cell. 93:215-28.
Montana, E.S., and J.T. Littleton. 2004. Characterization of a hypercontraction-
induced myopathy in Drosophila caused by mutations in Mhc. J Cell Biol.
164:1045-54.
Nedivi, E., S. Fieldust, L.E. Theill, and D. Hevron. 1996. A set of genes
expressed in response to light in the adult cerebral cortex and regulated
during development. Proc Natl Acad Sci U S A. 93:2048-53.
Noguchi, S., T. Tsukahara, M. Fujita, R. Kurokawa, M. Tachikawa, T. Toda, A.
Tsujimoto, K. Arahata, and . Nishino. 2003. cDNA microarray analysis of
individual Duchenne muscular dystrophy patients. Hum Mol Genet.
12:595-600.
Phelps, C.B., and A.H. Brand. 1998. Ectopic gene expression in Drosophila using
GAL4 system. Methods. 14:367-79.
Pruyne, D., M. Evangelista, C. Yang, E. Bi, S. Zigmond, A. Bretscher, and C.
Boone. 2002. Role of formins in actin assembly: nucleation and barbed-
end association. Science. 297:612-5.
Raghavan, S., I. Williams, H. Aslam, D. Thomas, B. Szoor, G. Morgan, S. Gross,
J. Turner, J. Fernandes, K. VijayRaghavan, and L. Alphey. 2000. Protein
phosphatase 1 beta is required for the maintenance of muscle
attachments. CurrBiol. 10:269-72.
Rayment, I., H.M. Holden, J.R. Sellers, L. Fananapazir, and N.D. Epstein. 1995.
Structural interpretation of the mutations in the beta-cardiac myosin that
have been implicated in familial hypertrophic cardiomyopathy. Proc Natl
Acad Sci U S A. 92:3864-8.
Rayment, I., W.R. Rypniewski, K. Schmidt-Base, R. Smith, D.R. Tomchick, M.M.
Benning, D.A. Winkelmann, G. Wesenberg, and H.M. Holden. 1993.
Three-dimensional structure of myosin subfragment-1: a molecular motor.
Science. 261:50-8.
(c)Enrico Sakai Montana. All rights reserved. 150
Rosenberg-Hasson, Y., M. Renert-Pasca, and T. Volk. 1996. A Drosophila
dystrophin-related protein, MSP-300, is required for embryonic muscle
morphogenesis. Mech Dev. 60:83-94.
Sadoshima, J., and S. Izumo. 1997. The cellular and molecular response of
cardiac myocytes to mechanical stress. Annu Rev Physiol. 59:551-71.
Sadoshima, J., L. Jahn, T. Takahashi, T.J. Kulik, and S. Izumo. 1992. Molecular
characterization of the stretch-induced adaptation of cultured cardiac cells.
An in vitro model of load-induced cardiac hypertrophy. J Biol Chem.
267:10551-60.
Sagot, I., A.A. Rodal, J. Moseley, B.L. Goode, and D. Pellman. 2002. An actin
nucleation mechanism mediated by Bnil and profilin. Nat Cell Biol. 4:626-
31.
Seidman, J.G., and C. Seidman. 2001. The genetic basis for cardiomyopathy:
from mutation identification to mechanistic paradigms. Cell. 104:557-67.
Semsarian, C, I. Ahmad, M. Giewat, D. Georgakopoulos, J.P. Schmitt, B.K.
McConnell, S. Reiken, U. Mende, A.R. Marks, D.A. Kass, C.E. Seidman,
and .J.G. Seidman. 2002. The L-type calcium channel inhibitor diltiazem
prevents cardiomyopathy in a mouse model. J Clin Invest. 109:1013-20.
Shinozaki, K., K. Maruyama, H. Kume, H. Kuzume, and K. Obata. 1997. A novel
brain gene, norbin, induced by treatment of tetraethylammonium in rat
hippocampal slice and accompanied with neurite-outgrowth in neuro 2a
cells. Biochem Biophys Res Commun. 240:766-71.
Steward, O.. 2002. mRNA at synapses, synaptic plasticity, and memory
consolidation. Neuron. 36:338-40.
Steward, O., C.S. Wallace, G.L. Lyford, and P.F. Worley. 1998. Synaptic
activation causes the mRNA for the EG Arc to localize selectively near
activated postsynaptic sites on dendrites. Neuron. 21:741-51.
Steward, O., and P. Worley. 2002. Local synthesis of proteins at synaptic sites
on dendrites: role in synaptic plasticity and memory consolidation?
Neurobiol Learn Mem. 78:508-27.
(c)Enrico Sakai Montana. All rights reserved. 151
Stronach, B.E., P.J. Renfranz, B. Lilly, and M.C. Beckerle. 1999. Muscle LIM
proteins are associated with muscle sarcomeres and require dMEF2 for
their expression during Drosophila myogenesis. Mol Biol Cell. 10:2329-42.
Stronach, B.E., S.E. Siegrist, and M.C. Beckerle. 1996. Two muscle-specific LIM
proteins in Drosophila. J Cell Biol. 134:1179-95.
Tobin, S.L., P.J. Cook, and T.C. Burn. 1990. Transcripts of individual Drosophila
actin genes are differentially distributed during embryogenesis. Dev
Genet. 11:15-26.
Tusher, V.GC., R. Tibshirani, and G. Chu. 2001. Significance analysis of
microarrays applied to the ionizing radiation response. Proc Natl Acad Sci
USA. 98:5116-21.
van der Kooi, A.J., M. van Meegen, T.M. Ledderhof, E.M. McNally, M. de Visser,
and P.A. Bolhuis. 1997. Genetic localization of a newly recognized
autosomal dominant limb-girdle muscular dystrophy with cardiac
involvement (LGMD1 B) to chromosome 1 q1 1-21. Am J Hum Genet.
60:891-5.
van Straaten, M., D. Goulding, B. Kolmerer, S. Labeit, J. Clayton, K. Leonard,
and B. Bullard. 1999. Association of kettin with actin in the Z-disc of insect
flight muscle. J Mol Biol. 285:1549-62.
Vigoreaux, J.O. 2001. Genetics of the Drosophila flight muscle myofibril: a
window into the biology of complex systems. Bioessays. 23:1047-63.
Volk, T. 1992. A new member of the spectrin superfamily may participate in the
formation of embryonic muscle attachments in Drosophila. Development.
116:721-30.
Wallace, C.S., G.L. Lyford, P.F. Worley, and O. Steward. 1998. Differential
intracellular sorting of immediate early gene mRNAs depends on signals
in the mRNA sequence. J Neurosci. 18:26-35.
Westendorf, J.J., R. Mernaugh, and S.W. Hiebert. 1999. Identification and
characterization of a protein containing formin homology (FH1/FH2)
domains. Gene. 232:173-82.
(c)Enrico Sakai Montana. All rights reserved. 152
Zhang, C.L., T.A. McKinsey, S. Chang, C.L. Antos, J.A. Hill, and E.N. Olson.
2002a. Class II histone deacetylases act as signal-responsive repressors
of cardiac hypertrophy. Cell. 110:479-88.
Zhang, Q., C. Ragnauth, M.J. Greener, C.M. Shanahan, and R.G. Roberts.
2002b. The nesprins are giant actin-binding proteins, orthologous to
Drosophila melanogaster muscle protein MSP-300. Genomics. 80:473-81.
(c)Enrico Sakai Montana. All rights reserved. 153
Characterization of the Drosophila ARC Homolog,
dARC 1
Enrico S. Montana 1 , Mark Mattaliano 3 , Jose Augusto 3 , Leslie Griffith3, & J. Troy
Littleton1 2
'Department of Biology, Picower Center for Learning and Memory, 2Department
of Brain and Cognitive Sciences, 3 Department of Biology, 3Brandeis University,
Waltham, MA, 02454, 1'2 Massachusetts Institute of Technology, Cambridge, MA
02139, USA
*These authors contributed equally to this work
This work initially started as two parallel projects. As the projects progressed, it
became clear that we would need to fully collaborate on this characterization.
Presented here is mostly the work I have done on my half of this collaboration
with a few exceptions. Mark generated the antibody that is utilized in the in vivo
immunohistochemistry, as well as performed the behavioral analyses of the
dARC1 mutants. Further studies on the characterization of the dARC1 mutant
are still in progress. This work will be published pending the results of Mark and
Leslie.
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Abstract
The dARC1 gene is one of two Drosophila homologs of the mammalian
activity-regulated cytoskeleton-associated gene ARC, an immediate-early gene
that has been implicated in the process of long-term memory consolidation. The
dARC1 gene was identified in two independent expression analyses as
differentially-regulated in response to three stimuli, including heat, neuronal
activity, and hypercontraction-induced myopathy. Here, we present the
characterization of a loss-of-function mutation in dARC1 in the context of
synaptic function and plasticity. The dARC1 protein is expressed in a large
subset of cells within the CNS, the larval body wall muscles, and epidermal cells
of the larvae. Loss-of-function mutations in dARC1 result in no defects
associated with synaptic transmission, high-frequency stimulation-induced
vesicle depletion in the presynaptic terminal, paired-pulse facilitation, and post-
tetanic potentiation. In addition, overexpression of dARC1 does not alter
synaptic transmission. Further, loss or overexpression of dARC1 does not
change the structural parameters of the third instar neuromuscular junction
(NMJ). Finally, loss of dARC1 results in no learning and memory defects in
courtship conditioning, nor defects in circadian rhythm. These results indicate
that in Drosophila, dARC1 does not play a central role in synaptic transmission,
nor mediates short- or long-term plasticity mechanisms.
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Introduction
Synaptic plasticity can be divided into short-term and long-term
components, depending upon the longevity of the plasticity trace. Short-term
changes can occur via several mechanisms, including alterations in release
probability, changes in postsynaptic receptor sensitivity, and alterations in Ca+
concentrations in the presynaptic terminal (Blitz et al., 2004). Long-term
changes, however, can last for the lifetime of the organisms and requires the
synthesis of new transcripts and proteins (Steward, 2002; Steward and Worley,
2002). These long-term alterations can be manifested in both changes in activity
and structure (Bailey et al., 2004; Malenka and Bear, 2004). Understanding the
mechanisms by which the brain works to form and modify memories may
facilitate the development of treatments for learning deficiencies and diseased
states such as Parkinson's and Alzheimer's diseases.
During the transition from short-term to long-term plasticity, the first round
of transcription prior to the initial protein synthesis includes a large,
heterogeneous group of genes known as immediate-early genes (lEG) (Lanahan
and Worley, 1998). Activity-regulated cytoskeleton-associated protein (ARC) is
one of these EGs, originally identified as a gene highly upregulated in response
to strong neuronal activity (Lyford et al., 1995).
Since its original identification, ARC has been shown to be regulated by a
diverse number of neuronal stimuli. These include activation in response to
seizure induction, brain-derived neurotrophic factor (BDNF), light, and cocaine
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(Donai et al., 2003; Guzowski et al., 2000; Nedivi et al., 1996; Nishimura et al.,
2003; Ying et al., 2002). In addition, immunohistochemical and in situ
hybridization studies on the ARC transcript and protein have localized the ARC
mRNA and protein to recently activated dendritic spines (Donai et al., 2003;
Moga et al., 2004; Steward et al., 1998). Biochemical analysis suggests ARC
associates with the actin cytoskeleton in vitro (Lyford et al., 1995). In cell culture
studies, overexpression of ARC and CamKII (calmodulin-dependent kinase II) in
neuroblastoma cells modulates neuritic outgrowth (Donai et al., 2003). These
studies suggest ARC may mediate long-term synaptic changes by modifying the
actin cytoskeleton in response to synaptic activation. When antisense DNA
oligomers are used to disrupt ARC expression in hippocampal slices, the
maintenance phase of long-term potentiation (LTP) is disrupted, without effects
on induction. Further, intrahippocampal infusions of these interfering oligomers
into mice can disrupt memory in spatial water maze tasks at 48hr without
affecting the initial training or short-term memory (Guzowski et al., 2000). These
findings suggest ARC plays a critical role in forming long-term memories in mice
by modulating the actin cytoskeleton in activated postsynaptic dendrites.
However, genetic loss-of-function studies have yet to be performed to verify
these findings.
The genetic tractability of Drosophila makes it a unique system to study
the in vivo roles of ARC. The large breadth of genetic tools allows both loss-of-
function and gain-of-function studies to be done within a relatively short period of
time. Previously, work in Drosophila has shown that the homolog of ARC,
(c)Enrico Sakai Montana. All rights reserved. 157
dARC1, is upregulated in response to muscle dysfunction induced by
hypercontraction mutations in Myosin Heavy Chain (Mhc) (Chapter 3).
Expression analysis studies on Mhc revealed a potential actin-remodeling
pathway in response to hypercontraction (Chapter 3). Many of the genes
identified had been previously shown to associate with key structural support
sites for the muscle actin cytoskeleton. In addition, BLAST analysis on a number
of novel transcripts suggested a similar role in actin remodeling. Expression
patterns of some of these genes showed differential expression in the muscle,
suggesting a role in the biology of the muscle. Further, this transcriptional
response included a subset of genes whose mammalian homologs have been
shown to be regulated by neuronal activity. These include the Drosophila
homologs of ARC, neurochondrin, and CPG2 (Lyford et al., 1995; Nedivi et al.,
1996; Shinozaki et al., 1997). Work in mammalian muscle dysfunction models
suggests that calcium plays a critical role in the pathogenesis of muscle disease
(Frey et al., 2000; Gailly, 2002; Leinwand, 2001). These data suggest that both
synaptic plasticity and muscle dysfunction may require a shared signaling
pathway that activates the expression of genes involved in actin remodeling.
Here, we describe the characterization of a dARC1 mutation in
Drosophila. Using a P-element transposon located upstream of the open reading
frame, we have generated loss-of-function mutations in dARC1. Further, we
have created transgenic animals which overexpress the dARC1 protein in a
spatially and temporally restricted manner, allowing us to analyze the gain-of-
function consequences of dARC1 upregulation. The characterization of dARC1
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suggests that it may play a role in subtle modifications of the synapse, but does
not participate in essential roles which govern synaptic function and plasticity.
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Results
Isolation of loss-of-function mutation in dARC1
We previously identified CG12505 as a transcript that was highly
upregulated in response to hypercontraction-induced myopathy caused by point
mutations in the Mhc locus (Chapter 3). In parallel studies, we have also
identified the CG12505 transcript as a transcript upregulated in response to heat-
induced neuronal activity in temperature-sensitive seizure mutants. Although
CG12505 seems to be regulated by heat shock protocols in wildtype flies, its
induction is higher in the background of the activity mutants seizure and
slowpoke (Figure 1). CG12505 encodes a protein with homology to the
mammalian gene ARC (activity-regulated cytoskeletal-associated protein; Figure
1). The homology consists of 23% identity and 40% similarity. In addition, the N-
terminal 213 amino acids of the mouse ARC protein are not represented in the
Drosophila gene CG12505. We have renamed this gene dARC1. The dARCI
gene is situated within a complex locus containing three potential homologs of
the mammalian ARC gene (Figure 1). CG13941 and CGI1002 also show
homology to the mammalian ARC gene, and we have named these dARC2 and
dARC3, respectively. However, dARC3 (CG10102) has never been detected
above the noise limit of any of the microarrays we have performed (unpublished
data). In addition, no corresponding cDNAs have been isolated, suggesting that
this gene may not be expressed and represents a partial open reading frame due
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to the duplication of a portion of the dARC1 gene. In order to facilitate the
generation of a mutation in the dARC1 locus, we obtained a P-element
transposon insertion which was situated about 250 base pairs upstream of the
dARC1 coding region (Figure 1). To create a loss-of-function (lof) mutation, we
utilized standard P-element excision screens to generate imprecise excision
events detectable by PCR. In total, we isolated six viable lof mutations from our
screen. The extent of these deletions as determined by PCR analysis is
summarized (Figure 1). In addition, we isolated eight lethal mutations from the
screen. Cmplementation testing revealed three complementation groups, with
only one group which did not complement a deficiency that removes the dARC1
locus. Further complementation testing revealed that the lethality within this
group can be attributed to loss of the Tfbl locus (which resides upstream of
dARC'1, immediately downstream of dARC2), as they fail to complement a lethal
P-element insertion within Tfb 1.
In order to verify our six potential mutations, we utilized Northern analysis
to assay whether deletions of dARC1 corresponded to a loss of transcript.
Sequence analysis of the deletions was complicated by the presence of the
direct duplication within the genomic region (Figure 2). Indeed, the deletions
removed dARC1 transcript as assayed by Northern blot, confirming that we have
isolated lof mutations in dARC1.
Next, we assayed whether these mutations removed dARC1 protein in
adult flies. For this analysis, rabbit antisera was raised against a peptide
corresponding to the N-terminal region of dARC1. The antisera was further
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Figure 1: Identification and mutation of the dARC1 locus (A) The dARC1
gene was identified as a transcript upregulated in response to both heatshock
and neuronal activity. Although the temperature shift induces dARC1 expression
in CantonS, the amount of induction in seizureTS1 and slowpokeTS1 is greater than
heatshock alone. (B) The alignment between the mouse ARC and dARC1
showing the amount of conservation between these homologs. Note that the
homology begins only after the first 218 amino acids of ARC. (C) A schematic
diagram of the dARC cluster in the Drosophila genome. Black arrows represent
the mRNA while green represents the open reading frame. A yellow triangle
marks the position of the P-element used to create a lof mutation in dARC1. The
red blocks represent the sequence duplication. The pink bars show the extent of
the deletions isolated as deduced by PCR analysis.
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purified using affinity purification to either the peptide utilized in the antibody
generation or full-length GST-fused recombinant dARC1 protein. Western blot
analysis on whole fly extracts using affinity purified antibodies revealed loss of
dARC1 protein in these six deletions, further confirming we have isolated six
independent lof mutations in dARC1 (Figure 2). For most of the following
analysis, we used the ESM18 deletion allele and the ESM115 precise excision in
our experiments unless otherwise indicated.
Localization of the dARC1 protein
Previously, we have shown that the dARC1 transcript is expressed
ubiquitously throughout late-stage embryos with differential expression within the
body-wall muscles and central nervous system (CNS) (unpublished data). In
order to determine the subcellular localization of dARC1 protein, we performed
immunocytochemistry on third-intar larval preparations and adult brain
dissections using antisera raised to the N-terminal region of dARC1 which was
specific to dARC1 and not present within the coding regions of dARC2 and
dARC3. Previous studies on the mammalian ARC protein have shown that ARC
localizes to dendritic spines, within the region associated with actin-based
structures (Lyford et al., 1995; Moga et al., 2004). In addition, ARC has been
found to localize to actin-based structures in non-neuronal tissues (Maier et al.,
2003). In third instar larvae, dARC1 protein was diffusely expressed in the
cytoplasm at low levels throughout the body-wall muscles, in a large subset of
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Figure 2: Verification of the dARC1 mutation (A) Northern blot analysis
confirms that the small deletions isolated in the P-element excision screen are lof
mutations in the dARC1 locus. Note the upregulation of dARC1 transcript in
Mhcs1 /+ as compared to CantonS. (B) Western blot analysis of two precise
excisions as well as the largest and smallest deletions isolated in the screen.
The predicted size of dARC1 is about 28kDA, which corresponds to the band that
is missing in the mutant extracts. (C) Further confirmation of the mutation, as
well as antibody specificity using a western blot. The 28kDa band that is absent
in the mutant also shows upregulation in the transgenic overexpression lines.
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unidentified neurons in the brain lobes and ventral ganglion, and in the epidermis
(Figure 3).
To assay the subcellular localization of dARC1 under higher expression
levels, we utilized overexpression constructs of dARC1 under the control of the
yeast GAL4/UAS system (Phelps and Brand, 1998). Overexpression of dARC1
using the C155 driver, a brain-specific GAL4 expression construct, reveals
localization of dARC1 to synaptic regions in the CNS and NMJs (Figure 3).
When overexpressed in the muscle, dARC1 localized to structures resembling
the contractile machinery in the sarcomere. However, in both overexpression
conditions, substantial diffuse cytoplasmic staining was still observed throughout
the cells. Therefore, the overexpression localization suggests that dARC1 may
localize to synaptic regions and the actin cytoskeleton, consistent with the known
localization of mammalian ARC to dendritic spines and the actin cytoskeleton.
Electrophysiological analysis of the dARC1 ESM18 mutant
Previous studies in mammals have focused predominantly on the
regulation of ARC transcript and protein. These studies have shown that in
response to synaptic activity, ARC transcript localizes to the activated dendrite
within 30 minutes of activation in response to light. In addition, ARC protein
accumulates within these dendrites in a similar time-frame (Moga et al., 2004).
These studies suggest that ARC may function to modify synapses in an activity-
dependent manner by altering the cytoskeleton in the dendritic spines. However,
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Figure 3: Localization of dARC1 (A) The localization of dARC1 in vivo shows
expression in a subset of neurons in the central brain lobes and ventral ganglion
in the brain lobes that goes away in the dARC1EsM8 mutant. Note the staining in
the synaptic region of the visual system. In addition, diffuse staining in the
muscle as well as in epithelial cells is absent in the mutant when compared with
the precise excision. (B) Overexpression of dARC1 can lead to dARC1
expression throughout the brain, with staining in the synaptic region of the
mushroom body. Genotypes shown are (I-r) w;UAS-dARC1/+, C155/+, and
C155/w; UAS-dARC1/+. Note the mushroom body staining in the far right panel.
(C) Overexpression localization in the muscle and motor neuron in the body wall
muscles 6/7. Genotypes shown are (-r) w;UAS-dARC1/+, C155/+, w; Mhc-
GAL4/+, C155/w; UAS-dARC1/+, and w Mhc-GAL4/UAS-dARC1. Note that
CNS overexpression can lead to staining in at the NMJ. Scale bars 50pm.
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genetic loss-of-function studies of ARC in synaptic modification have yet to be
performed. Using the lof mutation, dARCIEsM18, we assayed the physiological
consequences of loss of dARC1 function at the third instar NMJ. Although the
regulation suggests that dARC1 may mediate long-term synaptic modification,
we utilized physiological analyses to determine if loss of dARC1 alters synaptic
function on several time-scales. We reasoned that dARC1 may play a role in
developmental plasticity, as synaptic maturation occurs in an activity-dependent
manner throughout development of Drosophila. Loss of dARC1 may, therefore,
lead to alterations of the structure or function of the synapse due to chronic
defects over the course of development.
First. we analyzed the effect of lof dARC1 on spontaneous miniature
excitatory junctional potentials (mEJP). Given the localization and regulation of
ARC in mammals, ARC may play a role in modifying the density of glutamate
receptors in the postsynaptic membrane. For this analysis, we recorded mEJPs
from CNS-intact third instar larvae in the presence of 1.5mM [Ca2+]ext and 3M
TTX. No statistical differences were found in mEJP amplitude between control
and dARC1ESM18 larvae (KS-test p-value > 0.05; Figure 4). In addition,
overexpression of dARC1 in either the muscle or the CNS did not reveal
differences in the amplitude of mEJPs, suggesting that dARC1 does not play a
role in regulating the density of glutamate receptors at third instar NMJs (KS-test
p-values > 0.05).
Next, we assayed whether dARC1 plays a role in basal synaptic
transmission. For this analysis, we measured excitatory junctional potentials
(c)Enrico Sakai Montana. All rights reserved. 170
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Figure 4: mEJP analysis of the dARC1 mutant and overexpression shows
no change in mEJP amplitude (A) Normalized miniature histogram of mEJP
events recorded in the precise excision and dARC1ESM18 flies shows no change
in mEJP amplitude (top). The same data is represented as a cumulative
histogram (bottom). (B) Normalized miniature histogram of mEJP events
recorded from flies overexpressing dARC1 in either the CNS or the muscle
shows no change in mEJP amplitude (top). The same data is represented as a
cumulative histogram (bottom).
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(EJP) in the presence of varying levels of external [Ca2 + ] (0.1 mM, 0.2mM, 0.4mM
and 1.5mM). For the high Ca2 + condition, we increased the Mg2+ concentration
from 4mM to 20mM, as a single action potential was often sufficient to illicit a
contraction event in the muscle, perturbing the electrophysiological recording.
Loss of dARC1 did not change the amplitude of EJPs, suggesting that dARC1
does not play a role in basal synaptic transmission (Student's t-test p-values >
0.05; Figure 5, Supplementary Tables S3 and S4). Furthermore, overexpression
of dARC1 in either the muscle or the CNS does not alter EJP amplitude,
confirming that dARC1 does not play an integral role in synaptic transmission
(ANOVA p-values > 0.05; Figure 6).
We then assayed whether dARC1 plays a role in vesicular trafficking
during high-frequency stimulation. Vesicular trafficking is known to be an actin-
dependent process (Bader et al., 2004). Alterations in presynaptic actin
dynamics can be seen by changes in the ability of the synapse to recycle
synaptic vesicles under high calcium, high-frequency stimulation conditions. For
this analysis, we used 1.5mM Ca2+ and 20mM Mg2+ to prevent the muscle from
contracting under high Ca2 + conditions. No differences were found between
control and mutant larvae, as both mutant and control larvae released about 30%
less than baseline after five minutes of 10 Hz stimulation. These data suggest
that dARC1 does not play a role in synaptic vesicle trafficking (Figure 5).
Our findings suggest dARC1 does not play an essential role in basal
synaptic transmission, though it may function in mature synapses to mediate
long-term plasticity mechanisms. In order to address activity-dependent
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Figure 5: Electrophysiological analysis of the dARC1 mutant
Electrophysiological analysis shows no change in (A) basal synaptic
transmission, (B) high-frequency dependent vesicle recycling, (C) paired-pulse
facilitation, and (D) post-tetanic potentiation. Data shown for each of these
analyses include (-r) traces from a precise excision, the dARC1EsMl8 mutant, and
quantification of the results. Scale bars 10ms, 5mV as shown. (A) Overlayed
are the averaged traces from ten events in a single muscle at each of the Ca2 +
concentrations. (B) Traces from a single muscle are overlayed from the time
points t=0, 60s, 120s, 180s, 240s, and 300s. (C) Traces shown are the average
of ten events recorded from a single muscle with a 25ms delay between stimuli.
(D) Traces shown are from a single muscle. Pretrain is an average of the 10
events prior to the 10Hz stimulation. 10Hz is the average of the last 10 events at
high-frequency. Posttrain is the average of the 10 events immediately following
the high-frequency stimulation.
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Figure 6: Overexpression of dARCI does not alter basal synaptic
transmission The EJP amplitude was measured at 0.1mM, 0.2mM, and 0.4mM
Ca2+ to assay the effect of overexpression of dARC1 in synaptic transmission.
Genotypes assayed are (A) w;UAS-dARC1/+, (B) C155/+, (C) w; Mhc-GAL4/+,
(D) C155/w; UAS-dARC1/+, and (E) w; Mhc-GAL4/UAS-dARC1. (F)
Quantification of the EJP amplitude data in the overexpression study. (A-E)
Averaged traces from ten events in a single muscle at each of the Ca2 +
concentrations are overlayed.
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mechanisms, we analyzed mutant larvae for alterations in two forms of plasticity.
The first, paired-pulse facilitation has been shown to occur on the timescale of
milliseconds. In this paradigm, two action potentials are stimulated within a
defined interval. During close succession intervals, the second release event is
normally larger than the first under low calcium conditions. The second, post-
tetanic potentiation, occurs on the timescale of minutes. This paradigm involves
tow-frequency test (0.5Hz) stimulation, followed by high-frequency stimulation
(10Hz), and then resumes baseline stimulation (0.5Hz). After high-frequency
stimulation, low-frequency release events remain larger than the test stimulation
for one to two minutes (Bogdanik et al., 2004). Like paired-pulse facilitation, this
form of plasticity is seen under low calcium conditions and is likely to be
dependent upon residual Ca2 + effects (Zucker and Regehr, 2002).
For the paired-pulse facilitation paradigms dARC1E s M 18 did not show any
differences from control larvae, suggesting that dARC1 does not play a
significant role in this form of short-term plasticity (A2/A1 for 25ms: ESM18 1.30 +
0.08mV ESM115 1.21 + 0.05mV; p-value > 0.05) (Figure 5). During post-tetanic
potentiation, both mutant and control animals showed over a 2-fold facilitation
during the high-frequency stimulation, and a 130% potentiation which slowly
decayed over one minute. These two short-term plasticity protocols are likely
due to residual intracellular calcium and mGLUR activity (post-tetanic
potentiation), rather than being mediated by long-term synaptic modification
mechanisms (Bogdanik et al., 2004; Zucker and Regehr, 2002).
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The electrophysiological data we have presented suggests that dARC1
does not perform an integral role in basal synaptic transmission, nor short-term
plasticity mechanisms at the Drosophila third instar neuromuscular junction.
Alternatively, dARC1 may modulate these processes, but the subtlety with which
it acts may not be accessible in this preparation. This could be due to the
inherent stability of neuromuscular transmission, which has a much higher safety
factor than central mammalian synapses. Further, homeostatic mechanisms
may counteract the alterations due to loss of dARC1 to restore the functionality of
the synapse. In addition, there have not been protocols described for the
Drosophila neuromuscular junction with which we can assay long-term synaptic
modification with similar time-scales as what is predicted for the activity-
dependent regulation of dARC1 protein
Synaptic structure analysis of dARC 1ESM18
Although dARC1 may not play a role in synaptic transmission, it could
function in altering the structural properties of the synapse by modulation of the
underlying actin cytoskeleton. The development of Drosophila neuromuscular
junctions is highly reproducible between samples, allowing reliable quantification
of changes in the number of boutons at third instar NMJs. In order to assay the
role of dARC1 in the structural morphology of synapses, we quantified the
number of boutons of the muscle 6/7 NMJ in segment A3. For this analysis, we
used e-synaptotagmin 1 (sytl) to label and visualize synapses. Compared with
(c)Enrico Sakai Montana. All rights reserved. 179
controls, no statistical differences were found in the number of boutons at the
synapse (ARC 1 ESM295 71.6+ 4.0, dARC1ESM18 72.7 + 5.4 boutons, Student's t-
test p-value > 0.05; Figure 7). In mammalian synapses, ARC is upregulated in
response to activity. It may be that ARC plays a role in modifying the structural
parameters of synapses after maturation at higher levels of expression. In order
to test this, we overexpressed dARC1 presynaptically in the CNS and
postsynaptically in the muscle, and assayed for changes in bouton number. As
the case for loss of dARC1 function, no significant changes were found when
overexpressed in the nervous system (ANOVA p-value > 0.05). However, when
overexpressed in the muscle, the control line, w; Mhc-GAL4/+ had significantly
reduced bouton number than w; UAS-dARC1/+ and w; Mhc-GAL4,+/+, UAS-
dARC1 (Tukey-test p-value < 0.05). This reduction is subtle and may not have
biological significance, as the overexpression larvae are not statistically different
from the w UAS-dARC1/+ larvae (w; UAS-dARC1 107.4 + 4.7; C155/+100.9 +
3.5; w; Mhc-GAL4/+ 90.3 + 2.8; C155/+; UAS-dARC1/+ 107.3 + 3.5; w; Mhc-
GAL4,+/+, UAS-dARC1 105.4 + 5.2; Figure 7).
The structural data suggests that dARC1 does not function in modifying
synaptic structure at the Drosophila NMJ. Multiple homeostatic mechanisms
may play a role in compensation for loss of dARC1. In addition, the lof and
overexpression of dARC1 in our experiments occur constitutively throughout
development. Synaptic modification may be more sensitive to acute changes in
levels of dARC1. Inducible loss and overexpression of dARC1 with more precise
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Figure 7: Structural analysis of third instar neuromuscular junctions at the
body wall muscles 6/7 in dARC1 mutant and overexpression larvae
Synaptic structure was visualized using -sytl antisera, which labels synaptic
vesicles in the presynaptic terminals. All boutons were counted under a
40X/1.2NA oil immersion lens. (A) Comparisons between dARC1EsM29 5 precise
IEM18
excision larve to dARC1ESM8 mutant larvae show no difference in bouton number
(graphed at right). (B) Likewise, overexpression of dARC1 does not have
significant effects on bouton number at the third instar muscle 6/7neuromuscular
junction (graphed at right). Scale bars 10ptm.
.,
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temporal control may be required to examine acute roles for ARC in synaptic
physiology.
Behavioral analysis of dARC1
The electrophysiological and structural analysis did not show large
differences in synaptic properties between dARC1EsM 18 and control animals. In
addition, overexpression of dARC1 did not show significant differences.
However, these assays may not be sensitive enough to detect subtle alterations
in synaptic function mediated by dARC1. To address this issue, we studied two
aspects of the behavioral output of dARC1ESM8 flies.
Male courtship behavior can used to assay learning and memory in
Drosophila. The behavior is highly stereotypical, with chemical, tactile, auditory,
and visual cues required for plasticity in the males (Hall, 1994). Although this
behavior is stereotypical, males are conducive to cues which control whether
initiation of courtship occurs. This gating of the courtship behavior is mediated
by an unknown aversive cue which decreases the probability of mating initiation
by the male fly (Tompkins et al., 1983). It is hypothesized that males that have
been in contact with mated females are exposed to non-visual aversive cues,
thus becoming conditioned to decrease mating initiation (Joiner Ml and Griffith,
1997). Utilizing this behavioral paradigm, we assessed the ability of dARCiEsM 18
flies in memrnory formation and consolidation of mating behavior.
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The mating behavior is quantified as a courtship index (Cl) ratio. Cl
represents the fraction of time a male spends in courtship behavior over a 10
minute observation period. The ratio of Ctest:Clsham provides a quantitative
measure of behavioral modification due to training (sham males are placed in the
mating chamber without a female trainer). Thus, if no modification of behavior
occurs during training, then the Cl ratio is equal to 1. In addition, all testing of
trained and sham controls were done with decapitated females in order to reduce
variations due to female rejection behaviors. Both dARC1EsMl15 and dARC1EsM18
males trained on mated females showed a decrease in courtship when
subsequently exposed to mature virgin females, suggesting dARC1 does not
play a significant role in initial learning of mating behavior modification. In
addition, both wildtype and dARC1EsM18 showed indistinguishable decay in
memory at ten minutes and two hours after training, suggesting that dARC1 does
not play a significant role in short-term or long-term memory of mating behavior
learning (Figure 8).
The circadian behavior of Drosophila is mediated by an endogenous clock
used for predicting daily changes in the environment. Though sensitive to
exogenous cues such as light, the pacemaking clock can maintain rhythmicity
under controlled conditions which provide no external indications of time (Allada
et al., 2001). Since 1971, genetic analysis of the Drosophila circadian clock has
provided a robust system in which to study the circadian clock of an organism,
allowing the identification of genes which alter the clock on the order of 20% or
less, a magnitude of change few behavioral assays can distinguish (Konopka
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Figure 8: Courtship conditioning is not affected in dARC1 mutants The
dARC1 mutants were assayed for potential defects in learning and memory using
courtship conditioning. The courtship index (Cl) represents the fraction of time in
a 10 minute test period that a male spends in mating behavior. Memory is
expressed as the ratio of the Cl of males trained to a mated female to the Cl of
sham males. (A) Training of males to mated females decreased the Cl of both
genotypes to a similar extent, indicating that courtship conditioning remains
unchanged in a lof dARC1 mutant. (B) Short-term (10min) and long-term (2hrs)
memory is likewise unaffected during loss of dARC1 function.
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and Benzer, 1971). Using the locomotor activity as a read-out of circadian
rhythm, we assayed the role of dARC1 in maintenance of a stable, 24 hour
periodicity in Drosophila.
Wiltype and dARC1EsM18 flies were trained on a light-dark (LD) cycle
before being placed into a constant dark (DD) cycle. Automated tracking of the
locomotor activity continued for 13 days in DD. Normally, Drosophila exhibits an
anticipation to both the L-D and D-D transition by steady increases in locomotory
activity (Suri et al., 2000). Both dARC1ESM1l5 and dARC1ESM18 showed normal
anticipation of these transitions when kept in DD for 13 days, indicating no
defects in the normal functioning of the internal clock. In addition, dARCIESM18
did not show a skew in the activity plots over time, indicating that the functioning
clock did not have an alteration of the periodicity. Finally, analysis of the overall
locomotory activity showed that dARC 1ESM18 does not change general
locomotory activity in Drosophila (Figure 9). These data indicate that dARC1
does not play an integral role in circadian rhythm function or maintenance. In
addition, loss of dARC1 does not result in overall changes in locomotory activity.
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Figure 9: Loss of dARC1 results in no change to the circadian rhythm in
Drosophila Mutant dARC1 flies were assayed for changes in circadian clock
function through measurement of overall locomotor activity. (A) Daily locomotor
activity for dARC1 mutants trained on LD cycles did not show significant changes
in clock perpetuation when shifted to DD. (left) Sample locomotor activity for the
indicated genotype over the 13 day test period and (right) the average of the
daily activity for the genotype is shown. (B) Overall locomotion is also
unchanged for dARC1EsM18 flies, indicating that dARC1 does not play a role in
overall regulation of locomotion. Shown in the graph are mean locomotory
activity for Light hours (Red), Dark hours (Green) and overall average (Blue).
(c)Enrico Sakai Montana. All rights reserved. 189
Discussion
The dARC1 gene is one of two homologs of the mammalian activity-
regulated cytoskeleton associated gene ARC. We identified dARC1 in two
independent expression analyses showing that dARC1 transcription can be
upregulated in response to heat, central nervous system activity, and
hypercontraction-induced myopathy. In mammals, studies have shown that ARC
is regulated by neuronal activity (Lyford et al., 1995; Moga et al., 2004; Nedivi et
al., 1996; Nishimura et al., 2003; Steward et al., 1998; Tan et al., 2000). The
ARC mRNA and proteins localize to activated synapses within actin-rich domains
of postsynaptic dendritic spines (Lyford et al., 1995; Moga et al., 2004; Steward
et al., 1998). In addition, knock-down of ARC using antisense deoxynucleotide
oligomers leads to defects in LTP maintenance, correlating with a loss of long-
term memory consolidation in a spatial water maze (Guzowski et al., 2000).
However, genetic lof studies on the mammalian ARC have yet to be performed.
dARC1 is not required for synaptic transmission, short-term plasticity, courtship
modification and memory, and circadian rhythms
Although the role of ARC has been implicated in long-term memory
consolidation, we assayed the role of dARC1 in the Drosophila CNS across
multiple levels, given that this is the first genetic lof study of ARC function. Our
studies indicate that dARC1 does not perform an integral role in synaptic
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transmission, short-term plasticity, and synaptic structure at the third instar
neuromuscular junction. However, the large safety factor of the neuromuscular
junction may obscure subtle alterations mediated by dARC1. In addition
synaptic roles of dARC1 at other synapses have not been assayed. Further,
compensatory mechanisms may alleviate defects which occur due to loss of
dARC1 function at the synapse. Indeed, the effects of these homeostatic
mechanisms have been observed in maintaining proper function at the
Drosophila neuromuscular junction (Daniels et al., 2004; Davis et al., 1998; Davis
and Goodman, 1998a; Davis and Goodman, 1998b; Davis et al., 1996; Paradis
et al., 2001; Schuster et al., 1996a; Schuster et al., 1996b).
The behavioral analysis further supports the hypothesis that dARC1 does
not play a significant role in synaptic plasticity, as two complex behaviors are not
affected by loss of dARC1. However, dARC1 may play a more modulatory role
in these processes, rather than a central role in the overall behaviors. Recent
work in courtship behavior has demonstrated metaplasticity mechanisms may
mediate the consolidation of memories in the context of multiple related
experiences (Ejima et al., 2005). It remains a distinct possibility that dARC1
mediates long-term memory consolidation when presented with multiple related
experiences, rather than underlying the memory consolidation process directly.
Conflicting evidence for the role of mammalian ARC and dARC1
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This data presents a direct conflict with the roles proposed for the
mammalian ARC gene. Several reasons may account for this discrepancy.
First, the Drosophila genome encodes two homologs of the mammalian ARC
gene. This may lead to functional replacement/redundancy issues when
analyzing the single loss of dARC1. In the absence of dARC1, dARC2
expression may be sufficient to compensate for defects associated with dARC1.
Further, our analysis has been performed on genetic lof mutations in dARC1,
whereas the mammalian studies have been done using interfering
dexoynucleotide oligomers (Guzowski et al., 2000). There may be differences in
defects associated with acute versus chronic loss of ARC function at synapses.
It may be that genetic loss of dARC1 stimulates homeostatic compensatory
mechanisms which can functionally replace the roles mediated by dARC1.
Studies using conditional loss of dARC1 may help in determining whether this
occurs in vivo.
Understanding the molecular pathways which underlie the learning and
memory process may facilitate the development of therapeutic treatments
towards learning deficiencies and diseased states. The mammalian gene ARC
has been implicated in the process of long-term memory consolidation. Based
on the mammalian data, loss of dARCI should result in long-term memory
defects without effect on synaptic transmission, short-term plasticity, or initial
learning and short-term memory. However, our data suggest that the Drosophila
homolog, ARC1 does not play a role in synaptic structure and function,
courtship learning and memory, and circadian rhythms. Future studies on
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dARC1 and dARC2 will help in determining whether these proteins modulate the
memory formation and consolidation process through metaplastic mechanisms.
In addition, studies in sensitized backgrounds such as temperature-sensitive
activity mutants may reveal subtle modulation mediated by dARC1. Finally,
studies of dARCI mutants in the role of muscle remodeling in Drosophila may
yield insights into the cellular functions mediated by dARC1.
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Materials and methods
Fly strains and crosses
Flies were cultured on standard medium at 22°C. All crosses using appropriate
genotypes were cultured at 25°C. The P-element strain w[1118],;
P{w[+mGT7=GT1}BG01371 was obtained from the Bloomington fly stock center.
The excision of the P-element was done using a standard F3 P-element excision
screen. PFCR analysis was done using primers obtained from IDT DNA
Technologies (sequences can be obtained upon request). The overexpression
lines were made by cloning the dARC1 open reading frame into the pUAST
vector. The transgenic flies were generated at Genetic Services, Inc.
(Cambridge, MA).
Microarray analysis
The expression of dARC1 was assayed using protocols previously
described (unpublished data). The experiment was done using CantonS,
seizure TS, slowpokeTs, and sesB jive (Elkins et al., 1986; Jackson et al., 1985;
Rikhy et al., 2003). The transcriptional profile of CantonS and TS mutants were
obtained from flies raised both at room temperature and treated with four 5min
heat shocks separated by 60min rest periods. The labeled RNA was processed
in the MIT Cancer Center Biopolymers Lab and data obtained processed using
the Affymetrix Micoarray Suite software v5.0.
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Cloning of dARC1 for creating transgenic flies and protein purification
Primers consisting of the first and final 30bp of the dARC1 open reading
frame were used to clone the coding region of dARC1 from the cDNA libraries
obtained from the microarray analysis in the Mhc mutants (unpublished data).
Sequences corresponding to the restriction sites BamHI/Sall and Xhol/Xbal were
used to clone the sequence in frame to GST into the pGEX-4T vector
(Pharmacia) and the pUAST vector, respectively. Restriction enzymes were
obtained from New England BioLabs.
Northern and Western blot analyis
Total RNA was isolated from wildtype and dARC1EsM18 flies using Trizol
(GibcoBRL). 50 flies were homogenized in1ml of Trizol in 10flies/100[l sample
sizes. Total RNA was isolated using the manufacturer's suggested protocol.
The northern blot analysis and probe was done using the manufacture's protocol
accompanying the NEB Phototope Kit (New England BioLabs). The template
used for making the biotinylated probe was a PCR product obtained from
amplifying the 5' end of the dARC1 coding sequence which is specific to dARC1
and is not included in the duplication sequence.
Western blot analysis was done using standard procedures (Adolfsen and
Lttleton, 2001). Affinity purified (x-dARC1 was used at 1:1000.
Protein and antibody purification
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dARC1 protein was purified using methods previously described (Adolfsen
et al., 2004) Antibodies were generated in rabbits to both an N-terminal
fragment fused with GST, and a synthetically produced peptide (sequence
THSFGGTRDHDVVEEFIG) through Research Genetics (Invitrogen, Inc.). The
anitsera obtained was purified to the peptide utilized in the antibody generation
on an AKTA FPLC (Amersham Biosciences) as previously described (Adolfsen et
al., 2004). In addition, antisera was affinity purified to full-length dARC1 fused to
GST in a separate purification. Full length GST-dARC1 was loaded into a 10%
polyacrylamide gel and transferred onto nitrocellulose. The nitrocellulose was
stained with PonceauS and the band corresponding to the purified fusion protein
was cut from the membrane, blocked, and sliced into 1cm x .3cm strips. These
strips were incubated with antisera overnight at 4C. Antibodies bound to the
membrane were stripped from the membrane with 50mM glycine-HCI, pH 2.5
(lml). The solution was re-equilibrated to pH 7 using 1M Tris, pH 9.5. Finally,
resultant antibody was concentrated using 10K MWCO Amicon Ultra columns
(Millipore, Inc.).
Electrophysiological analysis of dARC1 ESM18
Electrophysiological analysis was done as previously described (Montana
and Littleton, 2004). Some differences were utilized in the analysis. Electrode
resistances used were 20-40MQ, pulled on a P-30 vertical pipette puller (Sutter
Instruments). In analyses using two-electrode voltage clamp, the second
electrode was normally 10-20MQ on a 1X MGU headstage (Axon Instruments).
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Only cells which had less than 10nA of leak current were utilized in the analysis,
with most having less than 2nA. All stimulus signals were generated through the
pCLAMP v8.0 program (Axon Instruments). mEJP recordings were done in
CNS-intact animals in 1.5mM Ca2 + and 3M TTX. All recordings were done in
HL3 using 4mM or 20mM Mg2+ at the indicated Ca2 + concentrations (Stewart et
al., 1994). Traces in the figures were plotted in Microsoft Excel by exporting the
trace values into a spreadsheet. Data was transferred onto a second computer
for analysis on pCLAMP v9.0.
Quantification of the electrophysiological recordings
mEJP analysis was done in a semi-automated manner using the event
detection analysis in pCLAMP v9.0 using a template obtained from mEJP
recordings done in CantonS based on 1000+ individual events. EJP analysis
was done by averaging ten events in each muscle and counting the average
amplitude as one measurement for the genotype assayed. High-frequency
vesicle depletion was quantified by dividing the EJP at the designated time point
by the first EJP amplitude. Paired-pulse facilitation was quantified by averaging
ten paired-pulse events from a single muscle, then dividing the average second
EJC by the average first EJC. Post-tetanic potentiation was quantified by
averaging 30s of EJCs at 0.5Hz to determine baseline amplitude. All EJC
amplitudes graphed are the EJC at the designated time point divided by the
baseline EJC amplitude.
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Immunohistochemical analysis and imaging
Structural analysis on third instar neuromuscular junctions was done as
previously described using c-synaptotagmin 1 antisera at 1:1000 and affinity
purified c-dARC1 at 1:500 (Littleton et al., 1993; Montana and Littleton, 2004).
Imaging was done on an AxioScope 2 confocal microscope and processed with
LSM software (Zeiss). All images shown are taken with a 40X/1.3NA oil-
immersion lens (Zeiss).
Statistical analysis of data
Statistical analysis of the data was done in several programs. Student's
T-test and ANOVA analysis was done using Microsoft Excel in the Microsoft
Office XP Professional Software Suite (Microsoft). KS-test analysis on mEJP
distributions was done using the KS-test applet at
http://www.physics.csbsju.edu/stats/KS-test.n.plot_form.html. Post-hoc analysis
of the ANOVA was done using the Tukey-test applet at
http://department.obg.cuhk.edu.hk/ResearchSupport/Leastsig_diffTukey.asp in
order to determine the least significant difference values.
Behavioral analysis of dARC1
Courtship conditioning assays were done as previously described (Ejima
et al., 2005). Similarly, circadian rhythm analysis was done as previously
described (Stoleru et al., 2004).
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Future Directions
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Future directions
The analysis we have performed has provided the groundwork for using
Drosophila as a model system to study diseased states of human cardiac and
skeletal muscle. This model system is not only amenable to large-scale genetic
screens for dissecting the gene network underlying muscle function, but also
provides a cellular model for understanding diseased states and how the cell
responds to genetic mutations which affect muscle function. The following
experiments will help in elucidating the mechanisms activated in response to
hypercontraction-induced myopathy in Drosophila.
Review of the results
We have described the isolation and characterization of a Drosophila
mutant which causes a hypercontraction-induced myopathy. This myopathy
included a degradation of the IFM in adult flies. These mutants harbor mutations
in the Mhc locus, which encodes all isoforms of the muscle-specific type II
myosin motor. The mutations mapped onto the ATP binding/hydrolysis domain
of the protein, suggesting an alteration in the ATP cycle of Mhc. The genetic
interactions of MhcSl and Mhc s 2 with known muscle mutants revealed that the
mutations led to hypercontraction defects, rather than decreasing contractile
activity, altering the dosage of Mhc protein in the muscle, or leading to
developmental defects in the architecture of the sarcomere.
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Interestingly, these mutations were isolated based upon a temperature-
dependent behavioral defect, showing temperature-dependent seizures in adult
animals. Electrophysiological analysis of this behavior showed that these
seizures were correlated with abnormal activity in the giant fiber flight system and
were dependent upon neuronal activity. It is likely that these seizures occur in
the muscle, but require nerve activity to trigger them. Further, analysis of the
third instar muscle 6/7 neuromuscular junction revealed no changes in the
synaptic structure, nor alterations in the functional activity of the synapse.
However, this analysis revealed spontaneous muscle contractions that were
independent of presynaptic input and external Ca2+.
From the data, we hypothesized that these mutations lead to a
stabilization of an intermediate of the contractile cycle, causing contraction to
occur spontaneously. In addition, this stabilization could potentially lead to
higher contraction forces in the muscle, compromising the structural integrity.
Interestingly, we found that all hypercontraction mutants that we assayed
exhibited temperature-dependent seizure activity. This activity may be due to
alterations in the regulation of contraction which could lead to changes in the
intracellular Ca2 + through buffering of Ca2 + by the troponin complex. Further, this
suggests the possibility that hypercontraction alters the overall state of the
muscle. This state may be similar to states resulting from hypertrophic
cardiomyopathies and muscular dystrophies.
Based upon the characterization of the Mhc mutants, we began a study of
the altered muscle state in hypercontraction mutants. Given the strong parallels
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between the genetics of hypertrophic cardiomyopathies and the genetics of flight
behavior in Drosophila, we hypothesized that the cellular response to these
mutations may be likewise conserved. Therefore, Drosophila may provide a
model system in which to study diseases caused by contractile dysfunctions.
In order to gain insight into this altered muscle state, expression analysis
was done. By analyzing changes in the transcriptional profile, we may begin to
understand the functional differences between normal and diseased muscle
states. Two important observations were made in this study. The first
observation is that, like the genetic data, the transcriptional response to
hypercontraction is similar to transcriptional responses found in diseased states
of human cardiac and skeletal muscles. This strengthened the hypothesis that
conservation exists in how the muscle responds to changes in contractile
function. This response includes the upregulation of genes in adult muscle which
are normally developmentally regulated, the upregulation of genes which function
in immune responses, and the downregulation of genes involved in energy and
metabolism.
The second observation was that the predominant response to
hypercontraction-induced myopathy was an upregulation of genes which regulate
and support the actin cytoskeleton. These genes most likely act at three key
structural sites in the muscle which include the nuclear membrane, the Z-line,
and the plasma membrane. This may indicate a remodeling of the structural
architecture which underlies muscle support utilized to both withstand the forces
generated during contraction and to provide leverage with which to transduce
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forces. Interestingly, several of the genes identified as upregulated in this
analysis have been previously identified in mammals. These genes, dARC1,
MSP-300, and dNeurochondrin have been shown to be regulated in response to
neuronal activity at excitatory synapses in the mammalian CNS.
The identification of these genes supported the idea of conserved muscle
response to mutation-induced changes in muscle function. Ca2 + has been
implicated as an important mediator of both muscle diseases and activity-
dependent synaptic strengthening. This overlap in identified genes suggests that
not only is the response to muscle dysfunction conserved, but the signaling
pathway underlying this response may also be utilized in different contexts.
Although the identification of differentially-regulated transcripts gives a
genomic view of how muscles respond to dysfunction, the functional implications
of this altered regulation remain unclear. Studying the loss-of-function phenotype
of these genes individually and in context of muscle dysfunction is important in
understanding the consequences of differential regulation. Given that at least a
subset of these genes seem to play roles in both synaptic plasticity and muscle
remodeling, understanding the roles within both contexts can give a more
comprehensive picture of the functional roles of the proteins these genes
encode.
To this end, we began by studying the loss-of-function phenotype of the
most upregulated gene identified in the expression analysis, dARC1, in the
context of activity-dependent synaptic modulation. The analysis revealed that
dARC1 does not mediate an integral role of synaptic function on several levels.
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These include basal synaptic transmission, high-frequency induced vesicle
recycling, short-term plasticity, and postsynaptic glutamate receptor trafficking
and clustering. In addition, dARC1 does not likely underlie critical roles in the
learning and memory of courtship conditioning, or circadian rhythm. These
results suggest that either dARC1 does not play a central role in these
processes, or mediates subtle aspects of these processes that are undetectable
by the assays.
The following chapter is a suggestion on the path I feel the project should
go in the future. There are two large questions that need to be answered, and
though these questions are difficult, these experiments can begin to address
them in the Drosophila myopathy model. The first question is, "Does the Ca2+
dysregulation that has been suggested and implied exist in Drosophila, and if so,
is it similar to that found in mammalian muscle disease?" The second, "What is
the functional consequence of differential gene regulation and how does it occur
in response to a single point mutation in Mhc?"
The importance of Ca2 + in hypercontraction-induced myopathy
Although the electrophysiological characterization of MhcSl/+ flies
suggested a dysregulation of Ca2+ , more experiments towards direct visualization
of the intracellular Ca2+ will determine whether this is the case. These
experiments can be done in the third instar body wall muscles, as these muscles
are relatively large and easily imaged for this type of analysis. Utilizing Fura-2 to
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quantitatively assay the intracellular Ca2 + concentration of muscles at rest, direct
comparisons between wildtype and hypercontracted muscles may be made.
Imaging of the muscle may reveal several possibilities. The first possibility is that
there is no quantitative difference in the intracellular Ca2 + between normal and
hyperconcontracted muscle, suggesting that the spontaneous contractions are
caused by Ca2+-independent mechanisms. The second is that Ca2+
concentrations are constitutively higher in mutant muscles. This would indicate a
chronic overload of Ca2 + in the muscle, affecting all Ca2+-dependent processes
throughout the cell. Finally, imaging could reveal Ca2 + concentrations oscillating
over time, which would lead to slow contraction waves as seen in third instar
neuromuscular junction recordings.
It may also be the case that Ca2 + is affected in an excitation-dependent
manner. Therefore, imaging of muscles before, during and after presynaptic
activation may yield additional insights into Ca2+ homeostasis in mutant muscles.
Indeed, in mouse models of hypertrophic cardiomyopathy, Ca2 + transient decays
during muscle activation have been shown to be significantly prolonged (Kim et
al., 1999). In addition, results in the mouse mdx model of muscular dystrophy
have shown that 20% of mdx fibers have a 10- to 30-fold increase in Ca2 + influx
(De Backer et al., 2002). These experiments will determine whether Ca2+
dysregulation occurs in hypercontraction mutants. Further, if dysregulation
occurs, imaging will determine whether this is a constitutive, oscillatory, or
excitation-dependent alteration in Ca2+ homeostasis.
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Pharmacological studies of Ca2 ' homeostasis
Another avenue to pursue in Ca2+ homeostasis is to use pharmacological
compounds to modify the defects associated with hypercontraction. Several
drugs have been characterized to alter Ca2 + handling processes in the cell.
Diltiazem acts as an inhibitor of L-type Ca2 + channels. Mice harboring the
R403Q mutation in cc-MHC have decreases in the SR Ca2 + , SR Ca2 + buffer
calsequestriin, and decreases in ryanodine receptors prior to the morphological
changes associated with hypertrophy. However, early administration of diltiazem
prevented these Ca2+-related defects as well as the pathological defects
(Semsarian et al., 2002). Treatment of Drosophila with diltiazem may alter the
effects of hypercontraction mutations. In addition, calcineurin inhibiting drugs
have likewise been utilized to prevent hypertrophy in mice (Sussman et al.,
1998). Assessing the effect of calcineurin-modulating compounds on the
Drosophila hypercontraction phenotype may yield insights into the conservation
of mechanism shared between flies and mammals, and may help in
understanding how Ca2 + plays a role in muscle dysfunction.
Revisiting the transcriptional regulation in hypercontraction mutants
The transcriptional profile of the Mhc mutants has revealed a potential
conservation of the response to muscle dysfunction, including the upregulation of
developmentally-regulated sarcomeric genes and immune-response related
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genes, and the downregulation of energy and metabolism genes. Although we
have complete genomic view of the transcriptional response to muscle
dysfunction in Drosophila, it is important to understand the functional
consequences of this differential regulation. To this end, comprehensive
characterization of the gene set identified will help direct future experiments in
interpreting the transcriptional response. This revisiting of the transcriptional
profile would occur along two lines of experimentation-1) Multi-layered
classification of the gene set to help identify differentially-regulated genes that
may yield insights in a reverse-genetic approach, and 2) Bioinformatics-based
approach to help identify how these genes are or are not co-regulated and what
proteins/molecular pathways mediate this differential regulation. These two lines
of experimentation will allow us to identify WHAT are the important players and
their functions (both endogenously and in context of a hypercontraction),
WHERE are they localized, and HOW are they co-regulated.
Classification of the dataset includes the identification of the expression
patterns of the differentially-regulated genes. This analysis can be done in a
high-throughput manner in wildtype and mutant Drosophila embryos. Many of
the genes which may represent a remodeling response in the microarray remain
uncharacterized. We analyzed the expression pattern for a small subset of these
genes in embryos. Our data suggests that a large proportion of the genes may
be expressed in the muscle. Performing in situ hybridization experiments on all
of the differentially-regulated genes will help in identifying which of the genes are
expressed differentially in the muscle, and which are expressed in other tissues.
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Comparing this expression pattern in mutant embryos may further identify which
of the genes that are expressed in the muscle are specifically upregulated in
mutant muscle. This analysis can help in narrowing the gene list to a smaller
subset for further study.
The second analysis that can be done in large numbers is to characterize
the subcellular localization and RNAi defects of genes in cultured Drosophila S2
cells. RNAi analysis has been done previously with a large number of genes
(-90) which putatively function in the regulation of actin in the context of lamellae
formation (Rogers et al., 2003). In addition, we have performed a preliminary
analysis of the localization of a small number of genes when overexpressed in
S2 cells as GFP fusion proteins. Using these methods, we can begin to classify
genes based upon localization and RNAi phenotype in S2 cell cultures. From
previous studies, we expect at least eight classes of defects from RNAi in
Drosophila S2 cells: 1) stellate morphology, 2) failure to spread with actin
accumulation at the cortex, 3) failure to spread with actin throughout the cell, 4)
increased width of lamellae, 5) increased membrane ruffling, 6) thin process
formation, 7) cytokinesis failure, and 8) no effect. Further, the GFP fusion
constructs will allow us to classify genes based upon subcellular localization.
Potential regulators of transcription
A bioinformatics-based analysis can be done with the data obtained from
the microarray to identify potential regulatory sequences which may mediate the
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transcriptional response seen in muscle dysfunction. Identifying the upstream
regulatory sequences which may participate in the differential regulation will help
in discovering which proteins mediate the gene regulation. This approach begins
with a primary gene set that is consistently upregulated across all
hypercontraction mutants assayed in the expression analysis. Genes which
have known or potential roles in regulating cytoskeletal structure in vivo are
prime candidates for the initial seed set with which to do the following analysis.
First, a list of all potential enhancer sites within 2kb upstream of the ORF
as well as within the first exon and intron of the gene is composed. These sites
can be determined by two ways. First, all characterized regulatory sequences
are placed into this list obtained from the TRANSFAC database (Wingender et
al., 1997). Second, from the initial seed set sequences, three algorithms can be
used to search for motifs which include AlignACE, MEME, and MotifSampler
(Bailey and Elkan, 1995; Hughes et al., 2000; Thijs et al., 2002). These
algorithms search for sequence motifs which occur more often in the seed set as
compared to the entire genome using position weight matrices. Position weight
matrices estimate the binding specificities of the motifs based upon the specific
sequence of any single predicted motif as compared to the frequency distribution
of the nucleotides in each position across all related motifs. These matrices
assume independence between positions of a particular motif, and thus do not
account for potential position interactions. Therefore, they provide a first-order
approximation of the binding interaction energies between the theoretical
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transcription factor and the particular instance of the motif, providing more
stringency than simple consensus sequence analysis.
After identification of all known and potential enhancer sites, a search for
modules of motifs can be done. Modules are defined by the occurrence of two to
four motifs bound by the following rules: 1) the maximum distance between
motifs is equal to a predefined distance (25, 50, 100, and 200 bp), 2) if two motifs
overlap in sequence, then the maximal overlap can be no more than half the
length of a single motif, 3) the module must be present in at least 4 genes within
the initial seed set, and 4) the module must be enriched within the initial seed set
when compared with the frequency of occurrence across the entire genome. For
the fourth criteria, it is required that the module must appear at least as
frequently or more frequently within the seed set of sequences as it does within
the entire genome. This type of analysis has previously been done on genes
which are integral to anterior-posterior axis formation in Drosophila (Kreiman,
2004). Using this analysis in context of the microarray can lead to identification
of sequences which are important to the regulation of the genes in the
microarray. In addition, these sequences can be further utilized to isolate factors
which may potentially bind them in vivo. However, bioinformatics approaches
tend to return a lot of background "noise," along with biologically-relevant
information. Therefore, as a first test of stringency, in situ hybridization anaysis
can be done on gene sets controlled by the same regulatory modules. In this
manner, gene sets can be identified that contain sequences which potentially co-
regulate them, and that this regulation may occur in the muscle of Drosophila.
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Functional studies of the genes identified as differentially-regulated
Reverse-genetic studies of the genes identified in the transcriptional
profile will aid in our understanding of the functional relevance of these genes.
Analysis has begun with the most upregulated transcript identified, dARC1.
Several of the genes identified in the microarray have been previously identified
in mammals to be regulated by neuronal activity. Understanding the roles of
these proteins in both cellular contexts can provide a more thorough picture of
the functions these genes may mediate. Our analysis has shown that in
Drosophila, dARC1 does not seem to play a role in synaptic function and
plasticity. However, the analysis did not assay its function in sensitized
backgrounds, nor did it investigate a potential role for dARC1 in modulation of
these processes. Studying the role of dARC1 in sensitized backgrounds may
reveal subtle aspects of function.
In addition, we did not study the roles of dARC1 in muscle dysfunction.
Although overexpression studies suggest that it may act on sarcomeric
structures, the subcellular distribution of endogenous dARC1 remains unclear.
Structural analysis of dARC1 mutant muscle may show subtle defects in the
ultrastructural properties of the sarcomere. Further, analysis of dARC1 mutants
in the context of hypercontraction backgrounds may reveal defects that remain
obscured in normal backgrounds.
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Finally, based upon data from the experiments outlined above, additional
reverse-genetic analyses can be done on novel genes based upon the resulting
classifications obtained. The multi-layered classification of the differentially-
regulated gene set will allow for more informed decisions on which of the
differentially-regulated genes should be further studied.
Genetic interaction studies with hypercontraction mutants
The advantage of Drosophila is its ability to be used for large-scale
forward-genetic screens in identifying novel components of characterized
pathways. Screening for modifiers of Mhc mutants may identify novel genes
involved in hypercontraction-induced myopathies. Indeed, many genes have
already been identified by screening for flight-defective mutants and modifiers of
this behavior (Ferrus et al., 2000; Homyk et al., 1980; Mogami and Hotta, 1981;
Vigoreaux, 2001). However, the TS defects of hypercontraction mutants provide
a novel behavior to screen for new interactions. Already, we have identified two
dominant TS mutations which show genetic interactions with the Mhc
hypercontraction mutants. These include Swing and Breakdance (Montana and
Littleton, 2004). These mutants map to cytological regions 42A and 88F based
upon recombination mapping of the TS behavior and non-complementation for
recessive lethality with characterized deficiencies. Screening for additional
interactions, as well as cloning the genes mutated in Swing and Breakdance will
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aid in identifying the underlying molecular and genetic components in muscle
function.
In addition to screening for new mutations, testing the ability of known
genes to modify different aspects of the Mhc phenotype can help determine
whether previously identified genes play a role in Drosophila. Inducing mutations
in the components of the calcineurin complex, as well as utilizing previously
isolated mutations in genes such as the L-type Ca2 + channel, calmodulin, and
CamKII may provide a parallel method in which to study the role of Ca2 + in
hypercontraction muscles (Gellon et al., 1997; Nelson et al., 1997). Recently,
overexpression of the human gene myosin-binding protein C (MYBPC3) in
Drosophila was shown to cause flightless behavior (Manh et al., 2005).
Mutations in MYBC3 can cause hypertrophic cardiomyopathies in humans
(Bonne et al., 1995). Interestingly, calmodulin was upregulated in these
overexpression flies and mutations in calmodulin acted as dominant suppressors
of the flightless defect (Manh et al., 2005). Therefore, using forward- and
reverse- genetic techniques will allow for the identification of novel genes
involved in diseased states of the muscle, as well as help in our understanding of
how the muscle compensates for or responds to changes in sarcomeric structure
and function.
Concluding remarks
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We have identified and characterized a model system for human muscle
diseases in Drosophila. The characterization has revealed general parallels
between hypercontraction-induced myopathies, human cardiomyopathies and
muscular dystrophies. In addition to these parallels, a novel muscle remodeling
response which acts upon the actin cytoskeleton and its support structures has
been revealed. This response may represent a functional compensation of the
muscle in response to altered contractile properties.
However, despite the similarities and parallels, it is still unclear whether a
mutation in Mhc triggers a conserved signaling response which results in the
altered transcriptional profile. Alternatively, contractile dysfunction in both
cardiac muscle and Drosophila flight muscles activates unrelated signaling
events. However, through necessity of functional compensation, a convergence
occurs within the altered transcriptional output. The future experiments outlined
above can begin to dissect the conservation of signaling within these two
systems.
Finally, this model system may provide two promising avenues in which to
expedite our understanding of muscle dysfunction. It provides a system to use
forward-genetic screens to identify novel genes required in the proper functioning
of muscles. This system is well established and is continually providing new
insights into the genetic components required in the muscle. Second, it provides
a cellular model in which to understand the pathways and signaling events which
are activated in response to contractile dysfunction caused by mutation. Further
characterization of this model may lead to a platform in which to identify novel
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compounds for the treatment of muscular dystrophies and cardiomyopathies,
bridging basic research with direct application to real-world problems.
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Appendix
Contained within this appendix are two tables to supplement Chapter 3.
These tables represent the complete list of genes identified in the expression
analysis as determined by the criteria we set. Genes are grouped according to
known functions or putative functions as determined by BLAST analysis through
NCBI. In addition, there are also two tables which summarize the
electrophysiological studies described in Chapter 4.
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Supplemental Table . Upregulatecd genes in the Samba mutants
Muscle Structure and Function
Samba SLR Average
3.00
2.95
2.25
2.10
2.14
2.44
0.92
0.81
0.74
1.04
1.04
1 33
3.15
0.85
0 85
0.58
1 02
0.89
1.05
0.72
0 69
1 04
0.69
0 91
0.85
0 87
0.65
0.61
0 47
0 43
1.85
0 20
0.20
0.38
-0.07
Samba SLR Average
1.54
1.36
0.93
1.75
5.45
0.89
0.39
0.32
0.27
0.80
0 79
0.68
0 51
0 04
0.43
0.13
041
0.21
1.16
0.05
0.04
0.42
0.35
0.23
Samba2 SLR Average
3.00
2.61
2.06
2.01
1 69
1.73
0.86
0 66
0.73
0.97
0 92
1.05
3.08
0.43
0 36
0.42
0.53
0 56
0.32
0.16
0.17
0.45
0.36
0.60
0.61
0 39
0.27
0.56
0 19
0.14
1.67
0 30
0.30
-0.34
-0.01
Samba2 SLR Average
2.48
112
1.17
1.76
2.22
0 30
0.97
0 88
0 45
-0.04
0 26
0 14
-0.02
0.56
0.67
0.91
116
0 58
1.29
0 59
0.56
0.23
0 38
0 26
Samba SLR Average Samba2 SLR Average
1.77 1.56
1 12 1 08
1 17 0 77
0.75 0.78
1 32 0 62
0 82 0 58
1.42 0 99
1.42 0 79
1 33 0 70
1.59 0.84
1.24 0.57
0.56 0.71
0.59 0.39
1 86 1 53
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Gene
CG 12505
CG5797
Act88F
CG5,775
MIp60A
Msp-300
CG9025
CG2471
Act57B
Mw
CG 18242
Ket
C013941
sqh
OcDNA:L.'24380
BG:DSO0180.8
CG2130
CG6.972
CG3$l97
MIp84B
CG5080
CG13311
CG 16743
CG10420
CG10732
CG5600
CG6831
CG50110
CG18061
CG 13124
CG8679
CG 6238
CG6416
CG6718
CG3652
CS Signal
579.33
3160.75
10493.42
11088.03
1224.45
51.25
681.72
1747 93
36098,75
1542. 8
25.17
824.138
63.37
5915.50
2484 60
3368.77
1732.22
1003.53
1146.35
10213 85
3T73.C5
102370
2764.35
381.52
682 .2
921.72
1285 95
4339.55
2908.05
5648 97
39.73
2558.80
20587 03
170.57
2323.30
CS SD
473.21
1297 21
5568.01
2289.31
228.54
6.06
163.60
110.18
3998.79
346.60
19 90
245,79
10.11
300.85
149 96
437.94
290 35
365 06
,262.79
2175.26
434 98
294.95
516.68
85 20
158 19
322.79
:255.85
1490.98
413 85
1278,30
17.30
308 93
68.51
46.14
'158 46
Mutant Signal
3353.40
22587.27
46679.65
45266.90
5334.03
216.33
1353.00
2697.70
63933.40
2914.55
60.45
1956.93
634.60
8105.55
3768.85
5163.53
4316.98
2027 10
1837.82
13503 95
5810.40
1722.98
3091.07
587.03
1358.20
1436.57
1864.32
6745.40
3550 10
7262.42
209.45
3621.90
24181.48
163.90
2702.08
Mutant SD
950.89
3160.28
4187.62
4213.05
1359.00
99.80
137.30
325,83
8460,42
793.42
50.53
735.75
167.74
1250.23
373.77
694.75
1700.51
569.87
412.87
2411.89
2137.56
444.21
829.46
124 80
478.58
271.83
532.21
2017.47
385.37
1263.31
19.82
277 15
1498.94
58.36
71.00
Average Signal FC
5.79
7.15
4.45
4.08
4.36
4.22
1.98
1 54
1.77
1.89
2 40
2.37
10.01
1.37
1 52
1.53
2.49
2.02
1.60
1.32
1.54
1.68
1.12
1.54
1.99
1.56
1 45
1.55
1.22
1.29
5.27
1.42
1.17
0.96
1.16
SAM FC Algorithm
5.79 ABCD
7.15 ABCD
4.45 ABCD
4.08 ABCD
4.36 ABCD
352 ABCD
1.98 ABCD
1.54 ABCD
1.77 ABCD
ABC
ABC
ABC
10.01 ACD
AB
1 52 B0
1.53 BD
B
B
B
B
B
B
B
B
B
B
B
a
B
B
5.27 D
1 42 D
1.17 D
1.57 D
1.16 D
Serine Proteases
S,Gene
CG18180
CG10745
SerggDc
Ser3
CG6639
CG8329
CG2229
Ser99,Da
gamrma Try
CG16705
CG18436
CG16'13
CG3088
Ser99Db
Ser4
CG10475
CG 1803
CG8869
CG3380
epsilon Try
Ser99D'3b
CG16996
CG6457
CG11836
CS Sigal
4379.4.3
960 7:;!
4669 130
445.65
27.67
3900.40
22230 53
56990.73
28654.15
5639.75
2064,77
3384 73
4043.72
34900 18
18174 '18
2838.75
321.67
34348 27
402.08
13451 20
34900 '8
3841.93
30226 00
646.47
CS SD
537 32
192 83
669 59
144.90
15.00
312.80
6991.20
8839.46
633 03
856.41
283.49
503 97
;67.26
9205.45
9936.79
827.32
162 74
9060.19
334.00
3180.71
9205.45
258.50
188.57
57 90
Mutant Signal
23790.50
2530.70
8698.35
1921.50
829.10
6232 42
41123.38
89887 33
35385.27
8179.75
278740
4158 73
4919.88
43105.52
33237 58
4147.27
596.48
45841.03
697.70
16101 92
43105 52
5726.92
37404.23
850.35
Mutant SD
8986.28
633.35
1328 14
572.37
658.37
1890.38
13910.11
20472.99
4746.18
3364.38
366 24
984 89
1719.49
15530.74
11891 70
1362.13
227 27
7184.86
189.33
5311.16
15530.74
585.73
2723 29
66.52
Average Signal FC
5.43
2.63
1.86
4.31
29 96
1 60
1.85
1 58
1.23
1.45
1 35
1.23
1.22
1.24
1.83
1.46
1.85
1.33
1.74
1.20
1 24
1.49
1 24
1.32
AM FC Algorithm
5.43 ABCD
2.63 ABCD
1 86 ABCD
4.31 ACD
AB
AB
AC
AC
AC
B
B
B
B
C
C
C
C
C
C
C
C
1.49 D
1.24 D
1.32 D
Mutant Signal Mutant SD
Unknown
Average Signal FCGene
CG6133
G109'12
G16844
CG 14245
CG15667
0G14109
CG 1054
CG16836
CG 14688
0G 18067
0G15065
CG13482
CG13323
(G13905
CS Signal
8031.15
7068.801
38055.23
16259 53
7377.00
1980.05
815.1
10103 85
3971.32
'11302.30
38819 95
3534 52
8670.601
433.25
CSSO
1705.86
758.75
4334 78
2452 59
1609 21
188 63
188.53
2971.50
810.32
1197.82
7129 63
1221.88
601.78
156.59
24253.92
15842 45
70761 65
29025.40
16408.32
3695.03
1869.23
20738 35
8682 10
27972.00
72595 70
5608.17
12579.53
1250.85
SAM FC Algorithm
5889.10
1486 85
11536.91
2621.06
3410 20
719.93
741.63
7988.03
2776.22
11626.79
22546 34
657 02
2776.76
421.65
3.02
2 24
1 86
1.79
2.22
1 87
2.29
2.05
2.19
2.47
1 87
1.59
1.45
2 89
3,02 ABCD
2.24 ABCD
1.86 ABCD
1.79 ABCD
2.22 ABCD
1.87 ABCD
ABC
ABC
ABC
ABC
ABC
ABC
1.34 ABD
AB
------------------------
---
226
CG 1l279
CG 15825
CG5676
CG 13323
CG 15043
CG6043
CG 14292
CG 15066
CG5778
CG5791
CG14401
BG:DS01759 2
CG9928
CG15893
CG1 572
CG9691
CG9192
CG96 16
CG 13324
.G DS00810 3
CG14998
CG16971
CGC10911
CG13249
CG6918 1
CG 15068
CG7418
CG4363
CG11671
CG2(.18 1
CG18170
CG13641
CG14428
CG16707
CG10103
EcDLNA:GHC08385
CG 17025
CG14052
CG9338
CG12368
3254 ,35
4883 15
8141.20
8670.60
1708.73
3188.65
10967.47
1381.92
10584.92
15083.83
2809.55
6750 (08
5092. 72
1383 17
2530.32
16512.90
282.52
1870.0
1664.70
23848 50
1337.10
1001.00
33529 75
1363. ?'0
3719.48
41245 75
6005.42
8822.412
762 55
426.05
58.811
183.8,5
2017 (05
3330.02
2766 40
568.15
126.83
41.33
3102.00
915.53
846.27
826 49
2690.70
601.78
378.12
469.35
1740.98
419 48
2383.18
2203.28
624 93
2837.57
1323.17
551.37
562.56
1500.13
59.83
129.18
395.07
3805.53
395 15
197.70
2661.42
439.91
864.56
8593.22
1024.38
2258.81
222.91
117.82
38.71
11341
321 18
640.53
450.54
113 89
17.07
17.79
199.59
175.96
7272.50
7317.65
13057 85
12579.53
2831.10
5231.17
21028.72
5336.48
21682.93
27492.90
4714 98
9565 88
6936.98
2642.20
3973.38
20503.27
873.57
379.30
2565.07
33557.88
1892.53
1566.00
46719.45
1728.65
4127.85
48850.27
9276.67
12990.33
1079 05
690.92
226.02
1084.20
3413.68
5061.60
3879 60
953.02
260.00
126.60
3915.18
1422.78
3740.34
1275 03
2257.59
2776.76
634.56
726.72
3456.51
3080 70
8150.02
14182.89
1498.27
2646.58
3164.13
1505.38
589.81
2766.71
543 83
176.75
476.43
5766.11
322.07
540.63
9434.27
463.03
1060.39
4937.07
3778.28
4383.57
383 76
203 71
36.78
318 83
472.31
337.79
140.62
122.76
52.37
29 48
325.79
169.41
2.23
1.50
1.60
1.45
1.66
1 64
1.92
3.86
2.05
1.82
1.68
1.42
1.36
1.91
1 57
1.24
3.09
2.10
1.54
1 41
1.42
1.56
1.39
1.27
1.11
1.18
1.54
1.47
1.42
1.62
3.84
5.90
1.69
1.52
1 40
1.68
2.05
3.06
1.26
1.55
1.28
0.98
0.76
0.59
0.64
0.93
0.40
2.50
115
1.35
0.98
0.82
0.86
1.09
0.89
0.52
2.20
1 68
0.70
0.67
0.67
0.70
0 49
0.42
0.51
0.38
0.34
0.11
0 09
0.36
1,66
2.42
0 48
0.51
0.20
0 51
0.90
1 63
0 36
0.43
0.49
0 48
0.46
0.39
0.92
0.40
0.71
0.83
0.38
0.03
0.36
0.19
-0.16
0 34
0 36
0.21
0.53
0.63
0.49
0.44
0.39
0.18
0 36
0.33
0.10
0.19
1.00
0.84
0.86
0.93
1.94
2 61
0.40
0.40
011
0.43
0.61
1 01
0.26
0.50
AB
AB
AB
1.34 AB
AC
1.64 BD
1.92 CD
B
B
B
B
B
B
B
BS
B
B
B
B
B
8
B
B
B
B
8
C
C
C
C
3.84 D
5.90 D
1. 69 D
1.52 D
1 40 D
1.68 D
2.05 D
3.06 D
1 26 D
1.55 D
Chaperones
Gene CS Sigral CS SD Mutant Signal Mutant SD Average Signal FC Samba SLR Average Samba2 SLR Average SAM FC Algorithm
CG14207 5914.20 261 78 15925.72 1255.96 2.69 1 55 1.17 2.69 ABCD
CG9434 1150 88 43045 2604.60 531 05 226 1.40 1 14 226 ABCD
/(2)efl 8818.3;3 993 11 17085.28 5677.13 1 94 1.16 0.43 ABC
CG7409 5338 63 1048.63 8019.98 898.07 1.50 0.59 0 58 ABC
Hsp22 1117.e5 228 99 3863.95 1026.84 3 46 1 05 1 50 3.46 CD
CG7033 987.67 225.75 1323.05 580.45 1.34 0.67 0.22 B
CG6489 247.25 117.63 413.20 258 84 1.67 -0.62 1 63 C
CG4461 18238 48 3071.19 23275.53 4541.44 1.28 0.10 0.45 C
Nuclear Biology
Gene CS Signral CS SD Mutant Signal Mutant SD Average Signal FC Samba SLR Average Samba2 SLR Average SAM FC Algorithm
CG10910 1754.30 344.36 5687.00 3933.69 3.24 0.57 2.33 AC
CG12040 1775 32 193.15 2498.35 426.09 1 41 0.52 0.28 B
CG3308 3484.42 996.67 5526 85 877 99 1.59 0.89 0.54 8
CG8547 2688.25 1001.73 4548.43 1114.29 1.69 0.97 0.41 B
CGI1878 3630.65 .14.91 425425 1478.98 1 17 051 -008 B
EG EG00)07,.7 467.30 :22 05 643.65 50.34 1.38 0.56 0.36 1.38 D
CG16859 1229.30 116.03 1858.65 193.98 1.51 0.62 0.55 1.51 D
CG5740 615.4(0 72 85 934.45 96.52 1 52 0.48 0 56 1 52 D
CG150O4 177.88 52.17 542.90 133.08 3.05 1 77 1 03 3 05 D
CtIBP 834.0(0 164.72 1349.53 146.40 1.62 0.37 0.32 1.62 D
NTX1 982.58 179.54 149130 157 48 1 52 0.42 0.41 1 52 D
CG9989 57.35 6.42 328.65 126.02 5.73 2 95 1.53 5 73 D
Dhh r 148.10 40.76 267.75 35.11 1.81 0.81 0.57 1.81 D
Metabolism and Energy
Gene CS Signal CS SD Mutant Signal Mutant SD Average Signal FC Samba SLR Average Samba2 SLR Average SAM FC Algorithm
lJro
CG61 1r8
CG 11089
CG 11796
CG2708
CG9468
ade3
CG9466
Amy-d
CG 14935
Ahcy13
C-G 7550
Hn
3828 03
12266.7 5
2243 70
9900 6 
723.5C
3016.1:
4453. 1 
200.90
27624.03
2033.3(0
5150.63
5582 40
8903 10
760.87
2(062.73
175 73
1540 84
279.40
769.88
I171 10
122.29
3184 90
596 79
17.58
5:20.83
1409 41
8116.85
23569.90
4336.67
14411.35
1280.53
5890 05
7857.55
18625
45391 60
2767.45
6185.53
8421.58
12669.20
795.42
5114.61
960.90
1400 83
166.20
1863.52
1743 49
27.86
11084.16
560.51
654.23
1403 62
1628 46
2.12
1 92
93
1,46
1.77
1.95
1 76
0.93
1 64
1 36
1.20
1 51
1 42
1 24
1.22
0 65
0 55
0.82
1 05
0.77
0.48
0.43
0 85
0.49
0.59
0.56
1 02
0.72
0 68
0.51
0.93
0.88
0.90
0.01
0.71
0.54
0.48
0 48
0.38
2.12
1 92
1 93
1.46
ABCD
ABCD
ABCD
ABCD
ABC
ABC
ABC
ABC
ABC
ABC
ABC
AB
AB
(c)Enrico Sakai Montana. All rights reserved. 227
ade5 7518.70 416.44 10628.00 2393.16 1.41 0.64 0.63 AC
Ugt35b 1888.28 213.64 3228.03 403.64 1 71 0.77 0 48 1.71 BD
Eflalpha 100E 1536 72 179.23 2451.50 401.82 1.60 0.81 0.44 1.60 BD
CG6687 2222.85 471.36 3341.50 900.79 1.50 1.03 0.27 B
Aats-asp 2270.40 130.40 3759.95 1029.67 1 66 0 84 0.36 B
CG10638 1254.0 273.48 1826.77 287.11 1.46 0.62 0.49 B
CG3011 2799.02 460.53 3726.50 670.58 1.33 0.77 0.25 B
CG8913 2248.50 340.39 3144.80 855.79 1.40 0.76 0 18 B
Cyp6wl 1559.75 388.99 1900.42 921.76 1.22 0.76 -0 19 B
CG7627 543.72 253.19 968.27 490.13 1.78 1.53 0.56 B
CalpB 1382.,.50 265.71 2177 20 394.85 1.57 0.88 0.50 B
CG9463 634.95 87 87 867.73 327.63 1.37 0.81 0.49 B
Gsl 1110.65 301.47 1716.90 478.96 1.55 0.73 0.43 B
Nmdmc 1619.,0 516 78 2506.95 508 25 1.55 0 65 0.41 B
CG6283 4915 5 515.61 5421.15 871.09 1.10 0.48 0.45 B
CG6767 6199.018 995.31 8859.13 1652.35 1.43 0.55 0.28 B
CG18658 2908.6i0 626.05 3538.18 816.96 1.22 0 53 0.24 B
CG9480 2389.15 690.66 2902.00 751.31 1.21 0.66 0.11 B
CG5,91 1329.(C5 141.55 1815.93 246.60 1.37 0.54 0.23 B
Transfernn 226092:3 1952.56 30755.90 10355.19 1.36 0 71 0.03 B
aralarl 2741 '75 190.33 3453.27 657.61 1.26 0.51 0.22 B
CG5802 3106.85 634.45 3872.35 791.09 1.25 0.56 0.15 B
fimp 3713.50 725.22 4371.08 966.72 1.18 0.53 0.16 B
AltnE3 532.92 121.80 679.82 406.70 1.28 0.73 -0.19 B
Cyp6a23 1204.()3 402.87 1522.25 1134.95 1.26 -0.52 0.79 C
LysP 1147.68 476.16 278798 1285.71 2.43 1 21 1.04 C
CG6910 3645.40 837.40 6365.37 1397 35 1.75 0.69 0 70 C
CG31'68 9541.95 1422.48 12109.57 1391.13 1.27 0.28 0.54 C
CG17531 257.97 204 76 310.47 186.90 1 20 -0 49 1 08 C
CG6640 1018.52 607.81 1260.65 917.06 1.24 -0.68 0 94 C
CG106522 2656.10 80.74 3115.77 90.32 1.17 0.16 0.28 1.17 D
CG9164 74.83 35 79 265.57 46.14 3.55 1.51 1 88 3.55 D
6-phosphofructo-2-kinase 546600 406.12 7274.90 471.70 1 33 042 0.46 1 33 D
CG17553 577.35 72.03 1004.45 135.29 1.74 0.39 0.54 1.74 D
CG1827 2294 3 70.94 2588.20 79.20 1 13 0 14 0.19 1.13 D
CG15093 3619 52 261 12 4498.65 202.75 1 24 0 28 0 33 1.24 D
CG8773 758.97 74.77 1088.70 103.40 1 43 0 19 0.34 1.43 D
elF-rE 5260 95 544 21 6897.50 504.38 1 31 0 29 0.17 1 31 D
,de 2 2163.4.7 287 51 3331 93 447.19 1.54 0.53 0.60 1 54 D
Adhr 383.45 46.38 544.15 52.98 1.42 0.30 0.37 1.42 D
CG3276 820.15 132 11 1270.23 168 68 1 55 0.39 0 10 1 55 D
CG18.3'777 295 22 46.88 455.53 56.35 1.54 0.45 0.48 1.54 D
Immune and Defense Response
Gene CS Signal CS SD Mutant Signal Mutant SD Average Signal FC Samba SLR Average Samba2 SLR Average SAM FC Algorithm
CG15231 42427.40 4856.65 75557.53 14440.08 1.78 0.90 0.64 1.78 ABCD
CG14:'46 575940 1111.98 1032965 2163.06 ! 79 0.51 094 ABC
CG18;'08 5831.C7 2335.65 15167 02 5451 39 2.60 1.73 0 94 ABC
CG8577 1668.35 596.13 2728.55 630.73 1.64 0.54 0.90 ABC
CG9681 3371 15 918 21 512270 451 33 1.52 0.54 0 75 ABC
CG14745 3775 27 515.56 5103 78 526.67 1.35 0 53 0 66 ABC
Ptasl 1 10208.55 1738.05 16501.80 2244.29 1.62 0.75 0.50 1.62 ABD
Drs 9503 17 5971.63 23327.32 13848 53 2.45 2 18 0 38 AB
IM2 3524 10 546 78 10114.92 4443.20 2.87 1 69 0.68 AB
Ag5r2 2235.52 281.23 4516.30 957.22 2.02 0.90 0.58 2.02 BD
CG13422 5253 4 2096.48 8299.97 3481 58 1 58 1 12 -0 08 B
CG4740 3523.00 3511.75 374717 1560.92 1 06 0.90 0 03 B
CG14027 978.63 329.45 1498.07 472.07 1.53 0.56 0.21 B
dronco 170581) 117.61 2129.80 11328 1 25 0.21 0 13 1 25 D
CG17352 848.95 27.44 1208.45 151.21 1.42 0.15 -0.01 1.42 D
Signaling
Gene CS Sigral CS SD Mutant Signal Mutant SD Average Signal FC Samba SLR Average Samba2 SLR Average SAM FC Algorithm
CG2656 686.60 120.30 1651.00 417.40 2.40 1.07 0 90 2 40 BD
grk 419 63 121.11 860.22 220 53 2 05 0.91 049 B
CG8242 4159.95 800.24 4652.40 432.34 1 12 0.59 0 32 B
puc 563.32 181.77 980.85 263.22 1.74 0.86 0.51 B
Lk6 1638.00' 491 59 232938 397 69 1.42 0.72 0 47 B
cact 2460.58 150.21 2833.92 799.24 1 15 . 0.49 0 14 B
CG93 1678.8:2 158.86 1721.63 331.92 1.03 0.24 0.01 1.41 D
CG1900 845.63 56.61 1111.63 93.70 1.31 0.65 0.38 1.31 D
Other
Gene CS Signal CS SD Mutant Signal Mutant SD Average Signal FC Samba SLR Average Samba2 SLR Average SAM FC Algorithm
CG12844 1776.85 403 16 4827.25 1585 35 2.72 1.68 1 05 ABC
CG5597 3465.5, 542.23 6448.83 1645.75 1.86 0.97 0.59 ABC
BONA G'05741 441.17 52 90 2125.75 1768 73 4 82 2.98 0 52 AB
ArinIX 3932.25! 595.35 6769.00 1654.79 1.72 0.94 0 42 AB
CG12843 2555.7() 93.63 4542.40 836.14 1.78 0.66 0 42 1.78 BD
CG7874 17192.10 1575.76 29292.35 5132.68 1.70 0 25 0.66 1.70 CD
CG8791 26948 168 57 607.88 91.08 2 26 1.78 1.50 B
CG42'50 3010.40 920.01 7131.32 4525.69 2.37 1.14 0.46 B
CG3246 2525.77 146.87 2888.42 705.42 1 14 0.54 0.14 B
BcDfVA.LD19727 785.75 314 96 1339 07 580.91 1.70 1.22 0.40 B
(c)Enrico Sakai Montana. All rights reserved. 228
Picot 9484.95 999.35 11448.53 1792.35 1.21 0.43 0.20 B
CG14499 929.,72 384.93 2767.92 2105.51 2.98 -0 08 2.40 C
CG16775 959.00 166.45 1843.38 147.49 1.92 0.85 1.09 1.92 D
CG12838 171.73 93.05 571.65 129.05 3.33 1.51 1.39 3.33 D
El, 631 97 323.32 1579.57 222.07 2.50 1 60 1.13 2.50 D
CHES-1-ike 452.58 31.34 572.45 38.55 1.26 0.35 0.28 1 26 D
(c)Enrico Sakai Montana. All rights reserved. 229
Supplemental Table II. Downregulated genes in the Samba mutants
_ .Metabolism and Energy
Samba SLR Average
-0.65
-0.65
-1.41
-0.51
-0.52
-1 00
-0.52
-0.50
-0.65
-1.27
-0.95
-0 72
-0.71
-0.57
-0.72
-0.74
-0.63
-0.60
-0.57
-0.62
-0.46
0.62
-0.57
-0.47
-0.55
-0.52
-0 47
0.50
-0.57
-0.42
-0.44
-0.48
-0 50
--0.39
-0 52
-0.62
-0.64
-0.51
-0.59
-0.55
-0 .58
-0.55
-0.41
-0.57
-0 51
-0.60
-0.55
-0.47
-0.42
-0.46
-0.46
-0.45
-0.60
-0.44
-0.56
-0 49
-0.36
0.10
-0.45
-0.47
-0.41
-0 49
-0 36
-0.43
-0 43
-0 43
-0.45
-0 42
-0.31
-0.34
-0.37
-0 34
-0.41
0.06
-0.46
-0.12
-0.19
Samba2 SLR Average SAM FC
-0.55
-0.55
-0.79
0.50
-0.33
-0.79
-0.45
-0.29
-0.26
-0.21
-0 33
-0 18
-0.48
-0.21
-0 25
-0.21
-0 21
-0.20
-0.21
-0.16
-0.27
-0.13
-0 17
-0 25
-0.18
-0.19
-0 22
0.18
-0 09
-0.19
-0.16
-0.11
0.04
-0.01
0.49
-0.28
-0.23
-0 34
-0 26
-0.29
-0.24
-0.27
-0.39
-0.23
-0.27
-0.17
-0.18
-0 26
-0.27
-0.21
-0.22
-0.22
-0O05
-0.23
-0.09
-0.17
-0 28
0.02
-0 17
-0.13
0.18
-0 09
0.01
-0.10
-0 09
-0.04
0.01
-0.03
-0,11
-0.04
-0.01
0.01
-0.71
-1 01
-0.76
-0.67
-0.08 0.83
(c)Enrico Sakai Montana. All rights reserved.
Gene
CG 12628
CG 12628
CCG15434
Mgstl
CG12400
CG12374
CG314576
CG7712
CG14482
(G9090
CG2022
CG 15328
C G9240
Qcr9
Cyt-c2
CG5703
CG4769
(;aodh 1
Qcr9
C( 12233
porln
CoVa
Oscp
Pgk
CG6666
A 7Psyn-b
CG4169
Pgl
A -'Psyn-d
CG7580
A TP:yn-gamnma
C GI7280
C:G386 I1
C' 18323
C',G6733
C'G3944
A TPsyn-Cf6
CG-38689
'Scs-fp
Lectl galC1
SdhB
C 3 7361
CG31274
C"L; 18624
CG.3214
C CG9140
CG9032
CC-;1 1015
Eno
CC 10664
C(3708
C(;91 72
CG;9244
C( ,7430
C(35028
ND 75
ciyP
CG 1746
C(G10219
CG 12203
C( 7181
BG.D.S09217 1
C(39297
bIw
CG(14235
Db
C G3321
Argk
CG11876
Ala
Cl,;9306
ClG'3731
C:; 1787
Cyp6a 17
Atpljalpha
C0;5932
CC0 10361
CS Signal
40046.32
40046.32
4219.42
21549.15
25448.63
19916.60
11247.50
10417.05
33671 85
28831.00
7045.95
19217.72
1890.20
41777 98
27063 40
10545.20
20515 48
58771 30
41777.98
9882 03
21333 23
42068.97
38607.57
12577 42
8758.80
20596 48
23846.32
17812.80
3'1379 77
64617 90
31854.50
48800 60
14424 13
52029 70
2095 52
6689.63
20446 35
2673 55
10672 78
4716.'75
17539.33
8822.63
5352.38
12437 97
8238 100
11373.07
18658.85
41741 80
23768.02
52932.25
2530 07
12964.88
24883.25
7598 .95
11147.13
9112.75
14248 05
1143.20
14958.43
3704 13
33129.50
7614 13
12649.13
47047.38
27217.30
30056.48
39531.58
26293.68
11637 13
62193 .67
17856 .37
24015.40
3004.35
868.415
3081 55
3173.70
2222.60
CS SD
5281 .32
5281 .32
881.60
390-7.22
3043.79
8451.89
2303.17
2126.08
4673,78
6283.12
379.48
2040.59
386.20
982;'.63
6308 54
1417'.29
360.5.84
11677.69
9827.63
963 76
1901 .80
6625,01
6437 13
137(6.53
949 57
3940 70
2924.41
3061.81
3251 80
7294 97
734!5.81
9680 91
1611 36
6656,.23
304 56
171.3.51
3390.73
217 76
2299 04
1370.15
1964.58
1287 43
732.59
2218 86
1198 12
1787'.74
4602 01
8831 34
284().71
8397' 34
561.02
2196.28
6474 12
676 01
1516.68
1194 53
4784 69
265 34
1867 67
681 46
567C 61
139 86
2005 65
680C 21
3162 60
5282 07
133,5.00
3563 36
1282 75
6455.36
459 11
2578 59
214.78
64 26
436.94
1112.19
117.33
Mutant Signal
27545.22
27545.22
1877.30
15155.70
18197.50
11086.25
7904.58
7878.10
25256.77
16693.35
4422.15
13859.22
1193.60
30038 05
19258.72
7586.15
15480.70
43830.82
30038.05
7467.67
15700.53
32941.30
.30420.60
9327.48
6485.82
15723 88
18031 63
14165.20
25902.75
52665.52
24783.53
.39793 63
11938.30
46846.13
241040
5083.22
'14854.85
1905.38
7778.25
3276.40
13496 55
7261 27
3893.80
8899.35
5905.52
9009.45
13868.05
34190 05
18408.20
40890. 17
1801 65
10427.65
20157.00
5812.90
9085.63
7301 55
12670.58
1151.35
12789 85
2992.68
25859.35
5940.98
14321 58
40110.13
25431.00
25688.93
34695.02
21866 40
9644 42
57974.38
15507.93
20501 50
2103.60
812.18
2391.30
2566.38
1839.67
Mutant SD
3004.29
3004.29
541.16
2230.68
2507.09
4505.97
1195.02
1142.33
5790.02
6255.57
1294.19
4234.36
240.63
5466.72
3957.62
1537.12
2848.26
9477.04
5466.72
1309 87
1478.96
7144.13
7824.83
960.10
1227.35
2977.87
2377 30
2117.98
6004.82
5725.21
4515.92
7554.27
4012.94
6673.83
118569
1107.71
1720.31
575.28
809.45
279.60
2650.93
1800.38
554.69
1396.22
487 97
1476.11
2908.16
6234.65
2225.28
6379.92
116.14
1146.43
4441 11
623 38
2087.80
219.17
1529.47
362.13
2809.62
570 66
3041.98
803.79
3411.33
9242.82
6783.57
6812.89
11314.41
4171 14
1653.46
9460.64
1888 51
3432.51
478.62
369 84
420 31
1201.43
38.88
Average Signal FC
0.69
0.69
0.44
0.70
0.72
0 56
0.70
0.76
0.75
0.58
0.63
0.72
0.63
0.72
0.71
0.72
0 75
0.75
0.72
0.76
0.74
0.78
0 79
0.74
0.74
0.76
0 76
0.80
0.83
0.82
0.78
0.82
0.83
0.90
1.15
0.76
0.73
0.71
0.73
0.69
0.77
0.82
0.73
0.72
0.72
0.79
0 74
0.82
0.77
0 77
0.71
0.80
0.81
0.76
0.82
0.80
0.89
1.01
0.86
0 81
0.78
0 78
1.13
0.85
0.93
0.85
0.88
0 83
0.83
0.93
0.87
0 85
0.70
0.94
0 78
0.81
0.83
Algorithm
ABC
ABC
ABC
ABC
ABC
ABC
ABC
ABC
AB
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
C
C
C
C
D
Muscle Structure and Function
G ene CS Signal CS SD Mutant Signal Mutant SD Average Signal FC Samba SLR Average Samba2 SLR Average SAM FC Algorithm
CG14022 5774.52 585.28 3454.55 114212 0.60 -1.05 -0.47 ABC
i
- - - :_
230
Ca-P60A 34574.30 4200.06 26608.38 5156.32 0.77 -0.48 -0.09 B
CG6514 2489.32 29.3 14 2070 82 413.95 0.83 -0.39 -0.11 B
fin 667817 1837.91 5141.45 1520.69 0 77 -0.63 0.15 B
CG 15306 18707.78 32C1.35 17391.75 6728.25 0.93 -0.48 0.13 B
7rrC41C 16283.97 5267.47 13494.35 3284.33 0.83 -0.46 0.14 B
Other
Gene CS Signal CS SD Mutant Signal Mutant SD Average Signal FC Samba SLR Average Samba2 SLR Average SAM FC Algorithm
Lsplbeta 1436 38 219 23 296.77 144.24 0.21 -2.70 -1.68 0.21 ABCD
Lsp2 :28329.52 4154.80 9717.88 2277.85 0.34 -2.09 -1.45 0.34 ABCD
CG11853 7114 35 2400.95 1325.10 347.53 0 19 -2.33 -2.90 ABC
nAcRbela-64B 1099 90 53 82 743.55 88.14 0.68 -0.67 -0.56 0.68 ABD
CG7630 42247.10 4527.39 31987.65 5240.01 0.76 -0.59 -0.30 AB
CG7592 1882 27 403.47 1101.27 561.63 0.59 -1.37 -0.13 B
CG15304 35859 13 579.7.78 29066.00 4856.57 0.81 -046 -0.16 B
(.G6749 1160.35 175.22 704.85 269.36 0.61 -0.74 -0.97 B
CG9399 9768 10 1524.34 8053 63 1419.23 0 82 -0.50 -0.31 B
CG11218 18924.30 2149 33 16201 00 1328.51 0.86 -0.32 -0 18 B
Rac1 1405.63 523.26 1122.32 327.85 0.80 -0.19 -0.19 B
CG8496 1119.388 317'.97 676.40 378.14 0.60 -0 28 -1.33 C
C( 11797 2738 30 444.30 1799.82 230.25 0.66 -0 37 -0.79 C
CG(14259 1176.93 97.92 765.70 171.84 0.65 -0.26 -0.76 C
CG 10812 7035.38 1196.93 5465.17 1188.63 0.78 -0.33 -0 63 C
S'dc 6142.97 493 50 4497.48 831.80 0.73 -0.17 -0.69 C
.:G3739 11828.82 258.8.32 8902.35 3309.73 0.75 0.10 -0.70 C
CG1839 705 30 57 :34 470.88 46.09 0.67 -0.20 -0.53 0.67 D
spt6 1068 67 84 91 738 75 30 32 0.69 -0.18 -0 12 0.69 D
polo 2545.85 281.46 1649.55 102.78 0.65 -0.42 -0.44 0.65 D
CG5213 2144 78 120 52 1333.35 245.85 0 62 -0.52 -0.48 0.62 D
CG9135 667.67 67 23 455.03 18.46 0.68 -0.28 -0.04 0.68 D
Unknown
Gene CS Signal CS SD Mutant Signal Mutant SD Average Signal FC Samba SLR Average Samba2 SLR Average SAM FC Algorithm
C'3,15353 9515.38 1117.45 6773.77 543.46 0.71 -0.40 -0.48 0.66 ABCD
BG:DS07851 4 9993.145 127 10 6089.98 2091.39 0.61 -0.43 -1 07 ABC
CCG1t3328 31256 57 813:2 46 23416.58 2622 74 0.75 -0 40 -0.27 ABC
CG 1'1373 7720.90 969 49 6011.07 1604.33 0.78 -0.57 0.20 B
CGi1752 9877.10 830 46 7273.65 1614.27 074 -0.51 -0.25 B
CC16826 55492 75 9188 67 45744 08 7860.30 0.82 -0.31 -0.21 B
CG10513 5395.08 1044.05 3552.60 1003.73 0 66 -0.45 0.74 C
CG17763 1518 35 436 28 1009 30 68.61 0.66 -0.45 -0.63 C
C-0;13026 3859.23 1048 24 3008.17 255.21 0 78 -0.29 -0.46 C
CG.5773 2703 830 793.56 2566.43 920.65 0 95 -().15 0.58 C
C-3;12057 5184 75 2135 89 5416 20 2492.86 1,04 0 45 -0.41 C
CC 10514 10446.47 574.22 7180 58 753.81 0.69 -0.34 -0.41 0.69 D
C-;12821 184.02 8.08 132.92 8.65 0.72 -0.11 0.02 0.72 D
(c)Enrico Sakai Montana. All rights reserved. 231
Table S3: Summary of the Electrophysiological Data in the Mutant Analysis of dARC1
Genotype n (muscles) Resting Potential (mV) EJP Amplitude (mV) [Ca2+ext (mM)
w; dARC1 ESM18 10 -64.39 + 1.82 1.96 0.31
4S~ 0.2
w; dARC1ESM18  15 -66.41 ± 1.32 14.86 ± 1.34
ES1 0.4
w; dARC1 ESM8 10 -66.25 + 1.69 29.56 + 1.05
42 1.05 1.5
w; dARC ESM18  18 -71.49 + 1.86 42.82 + 1.53
*Data expressed as value + SEM
Mutant
(c)Enrico Sakai Montana. All rights reserved. 232
Table S4: Summary of the Electrophysiological Data in the Overexpression Analysis of dARCI
) [Ca'+t 0 mM)
0.1
w; Mhc-GAL4,+/+,UAS-dARC1 9 -67.34 ± 1.42 23.11 ± 3.09
-76M45 L 1 42.764 .I41
A4.Z ?2.48 40,74±2.83 0.4
C155/w; UAS-dARC1/+ 8 -71.94 ± 1.59 39.42 1.43
w; Mhc-GAL4,+/+,UAS-dARC1 9 -74.05 ± 1.67 41.71 ± 1.89
*Data expressed as value ± SEM
Mutant
(c)Enrico Sakai Montana. All rights reserved. 233
